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The objective of this thesis was to investigate various
aspects of the epidemiology of human papillomavirus
(HPV) . Prospective studies were performed on a total of
334 patients attending two genitourinary medicine depart¬
ments in London. The patients had either clinical indica¬
tions for genital biopsy, urethral gonorrhoea, anogenital
warts or a current partner with anogenital warts.
Biopsy, scrape, swab and blood samples were taken. In
addition, a new method, the "Superglue (SG) technique"
was devised. HPV types 6, 11, 16, 18, 31 and 33 were
identified in the specimens by DNA extraction followed by
the polymerase chain reaction, Southern blotting and
hybridisation.
HPV DNA was detected in 31.8 to 96.6% of biopsies with
histological evidence of wart virus infection, 83.3% of
biopsies with neoplasia and 18.2% of those with other
histological changes. HPV DNA was detected in 31.3 to
61.1% of urethral loop specimens, 18.0 to 24.8% of ure¬
thral swab specimens, 6.3 to 12.5% of urine specimens,
37.5% of vaginal washes and 21.4% of rectal swab speci¬
mens. Fifty percent of samples obtained with the SG
technique containing human cells had detectable HPV DNA.
HPV types 6 and 11 tended to be found in biopsies from
lesions clinically associated with HPV infection and in
the urethras of men with warts seen near the urinary
meatus. HPV types 16 and 18 tended to be found in speci¬
mens obtained by techniques other than the biopsy method
and from clinically atypical lesions. Infections with
multiple HPV types were common. Different sites from one
patient sometimes had HPV types in common. Sexual part¬
ners did not consistently have HPV types in common and
there was a poor correlation between the detection of HPV
DNA and various lifestyle factors.
HPV DNA was found widely distributed in the anogenital
areas of men and women with and without clinically appar¬
ent anogenital warts. Sexual activity may not be the only
factor in the transmission of HPV infection. Sampling
from a single site of the genitalia on one occasion may
lead to significant underestimation of the rate of infec¬
tion with HPV.
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Although satirical writers in classical times appreciated
the role of sexual activity in the spread of anogenital
warts (AGW), there was widespread confusion extending to
the modern period between the clinical manifestations of
AGW, non-genital warts and condylomata lata1. It was not
until the 1950s , and more particularly the 1970s that
the sexual transmissibility of AGW became widely accep¬
ted. Interest in this field was initially limited, per¬
haps as the disease was not perceived to have any signif¬
icance other than cosmetic inconvenience. In the 1980s4
there was increasing evidence linking T-IPV infection and
cancer, and this was associated with a marked increase in
interest in human papillomavirus (HPV). Methodological
and, in particular, technical, advances occurring in the
1980s were essential to the further development of the
understanding of HPV.
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1.2 The Greek and Roman periods
Descriptions of abnormalities which were probably AGW
occur in the writings of the ancient Greeks and
Romans5'when the term "condyloma", literally meaning
"round swelling adjacent to the anus" was first coined.
Celsus, in the 1st century A.D. described different
physical types of warts, including those occurring in the
anogenital area8 and in the 2nd century A.D., Soranus
wrote a chapter entitled "On warty excrescences in the
female genitalia"^ . By the 6th century A.D., special
clinics had been established for the treatment of anal
condylomata1. Satirical lay writers frequently connected
perianal warts with anal sexual intercourse , although
there are no remaining records of what the Greek or Roman
physicians thought of the aetiology of AGW. Although some
dispute still remains8, it seems unlikely that syphilis
existed in Europe during the Greek and Roman periods, and
thus confusion with condylomata lata probably did not
occur.
1.3 The nineteenth and twentieth Centuries
In the Dark and Middle Ages, documentation was generally
less precise than in the classical period, but some of
3
the genital lesions described may have been AGW , and
there are sporadic records linking AGW with sexual activ¬
ity1. Even during the periods of the Renaissance and the
Enlightenment, however, there was much confusion between
syphilis, gonorrhoea and AGW1.
1.3.1 The non-specific irritant theory
From the early nineteenth century onwards, AGW had been
attributed to genital irritation caused by secretions
*D
"disordered through venery" , an idea which persisted
1 0
until the middle part of the 20th century-1- . According to
this theory, any irritant to the genital area could lead
to the production of warts, thus apparently explaining
the frequently observed association between gonorrhoea
and warts. Even as late as 1942, Kaplan1, when introdu¬
cing the treatment of genital warts with podophyllin
(which is still currently in use) , felt that an irrita¬
ting discharge was the most likely cause of the lesions.
Infectivity was, however, difficult to explain with this
hypothesis.
With the discoveries of the gonococcus, Haemophilus
ducreyi and Treponema pallidum, interest developed in the
concept that a specific causative organism might be
involved in the development of AGW. Various organisms,
particularly spirochaetes1 were put forward as possible
aetiological agents, but eventually it became clear that
these represented commensals rather than pathogens.
4
1.3.2 The unitary theory
The infectivity of common warts was not realised fully
until the end of the 19th century1. Soon afterwards it
was noted that the inoculation of extracts of skin warts
from one site on the body into the skin of other parts of
the body sometimes led to the production of plane or
common warts at the sites of inoculation-11. The concept
therefore developed that skin warts were caused by an
infectious agent, which filtration experiments estab¬
lished to be of viral size. Genital warts were thus
regarded by some as a special kind of wart, modified in
appearance and structure by arising from the genital
-|
epidermis , but caused by exactly the same virus as that
causing skin warts. This "unitary theory" was held at the
same time as the non-specific irritation theory.
1 9
Support for the unitary theory was based on the
histological similarities between skin warts and AGW,
the frequent coexistence of skin warts and AGW, the
similar treatment modalities for skin warts and AGW and
the observation that the incubation periods for skin
warts and AGW are similar.
The unitary theory also gained support from inoculation
experiments. Unfiltered13'13 '14 and filtered1 inocula
from AGW were shown to lead to the production of skin
warts elsewhere. However, there has been only one unsuc¬
cessful and one successful documented experiment1'13 in
which filtered extract from AGW led to the development of
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genital lesions in the recipient. In addition, there has
been one anecdotal report15 of a lesion developing on the
finger of a surgeon who pricked himself whilst operating
on a patient with condylomata acuminata. There have been
no successful experiments in which skin wart extracts
(filtered or unfiltered) have induced genital warts
following inoculation1. Observed incubation periods were
in the range 2 /2 to 11 months. None of the inoculation
experiments, however, was properly controlled and they
are unlikely to be repeated in view of ethical considera¬
tions .
1.4 The development of current concepts
In the mid-twentieth century, virus particles were seen
1 f>
using electron microscopy in samples from common and
anogenital17'18 warts. However, it was not until 1S713,
that AGW were clearly demonstrated to behave in a differ¬
ent epidemiological fashion from common warts, and the
unitary theory was therefore seriously questioned. Short¬
ly after this1^, technological advances allowed the
differentiation of wart virus types on the basis of DNA
homologies. It then became clear that AGW were separate
from, but related to other aspects of HPV infection.
It has proven extremely difficult to cultivate papillo¬
maviruses in cell cultures, as they require actively
differentiating cells within which to complete their life
cycle. Recently, however, HPVs have been successfully
6
0 0
grown in keratinocyte lines grafted onto nude mice and
in a collagen raft culture system containing cells der¬
ived from a CIN lesion Furthermore, typical condylo-
matous changes have been induced in heterografted human
foreskin tissue by HPV type 11^. Thus, HPV type 11 has
now been unambiguously identified as an inducing agent of
condylomata acuminata.
Parallel to these developments in our understanding of
the virology and epidemiology of HPV has been an evolu¬
tion in our appreciation of the complexities of the
interactions between papillomaviruses and their hosts. It
has become increasingly apparent that infection with HPV
is probably a necessary but not a sufficient factor in




2 .1 Viral structure
Study of HPVs has been hampered by several factors, such
as the impossibility of passaging HPV through a non-human
host, the inability to culture the organism in artificial
media, the difficulty of infecting human cell cultures
with HPV and the low concentration of viral particles in
AGW.
The HPVs have an icosahearai structure with 72 capso-
meres and an overall diameter of approximately 55nm .
The viral capsid is made up of a 53-59 kilodalton poly¬
peptide (constituting more than 80% of total viral pro¬
tein) and a 70 kilodalton polypeptide. The genome of HPV
is complexed with histones24 and comprises a circular,
double-stranded, super-helical DNA molecule of approxima-
tely 8,000 base pairs with a molecular weight of 5.2 x
lO^daltons.
Papillomaviruses were classified initially with poly-
omaviruses (such as simian vacuolating virus 40 [SV40]
and the human BK and JC viruses) as a papovaviruses2^ on
the basis of structural similarities. Genetically, how¬
ever, there are marked differences between papillomavir¬
uses and polyomaviruses27 and there are also different
8
antigenic properties28. Only one DNA strand of papillo¬
maviruses is transcribed, whereas half of each strand of
polyomavirus DNA is transcribed. Polyomaviruses produce a
lytic infection, whereas papillomaviruses typically
produce proliferative lesions. It is now therefore gener¬
ally accepted that papillomaviruses represent an entirely
separate group from polyomaviruses.
2.2 Species and site specificity
Papillomaviruses are found in a wide variety of verte¬
brates such as rabbits, hamsters, sheep, goats, deer,
p c
cattle, dogs, monkeys, amphibians, reptiles and birds .
p n
They are highly species specific , as well as being
specific to certain anatomical locations. Furthermore,
disease states associated with papillomavirus infections
seem to be a particular problem of domesticated animals
p nand polygamous animals . Because of the stability of the
virions to heat and desiccation, communication need not
necessarily involve direct contact. For instance, farm
animals can acquire cutaneous infections through abra¬
sions resulting from rubbing against contaminated
fences2^. Direct comparison of nucleotide sequences from
animal and human papillomaviruses21 suggests that the
papillomaviruses infecting different animals are distinct
from those infecting man, but that they have an evolu¬
tionary relationship. HPVs have only been found in humans
and infect squamous epithelia of keratinizing and non-
9
keratinizing surfaces. They have been found in the skin
and mucosae of genital, anal, urethral, oral and respira¬
tory regions.
2.3 HPV types
A unique HPV type is defined by the occurrence of less
than 50% cross-hybridization with all other known HPV
types in a liquid-phase DNA hybridization assay . Dif¬
ferent types are numbered according to the order of
discovery. Subtypes, for example HPV types 6a-f, are
defined as being the same virus type (as recognised by
liquid-phase hybridisation assays), but displaying poly¬
morphisms with respect to sites of cleavage by restric¬
tion endonucleases23. On this basis, 68 different gen-
otypes of HPV have so far been reported . Evidence sug¬
gests, however, that there are probably several more to
be identified.
The above classification system may need to be revised.
The correlation between DNA liquid reassociation kinetics
and base sequence is a complex one. Furthermore, trans¬
mission electron microscopy of DNA:DNA heteroduplexes
suggests that there is much more homology between various
types than is indicated by reassociation kinetic
studies34. An example of the difficulties of the current
classification system is illustrated by HPV types 6 and
11. These two HPV types show an overall nucleotide se¬
quence homology of 62%, yet give a value of 25% hybridi-
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sation in liquid reassociation kinetic reactionsJJ. A new
classification based on less than 90% sequence homology
in the open reading frames E6, E7 and LI has recently
been introduced in an attempt to adopt a more meaningful
approach to the classif ication of HPV types-23.
Diversity of papillomavirus types does not appear to be
due to a high mutation rate of the viral genome. The DNA
sequences of given types of virus have appeared stable
over a wide range of geographic locations and after
decades of propagation in immortal cell lines34.
2.4 The Genetic Structure of HPV
Recombinant DNA genomes have been constructed with the
d n n o o
plasmid vector pBR in Escherichia coli K-12 enabling
the study of the structure and function of the genomes of
various papillomaviruses. Most of the initial experi¬
ments on papillomaviruses were based on cellular trans¬
formation assays with bovine papillomavirus (BPV), but
more recent work has given us considerable information
concerning the functions of the various components of the
human papillomavirus genomes.
The genome of papillomaviruses is very conserved and
has been divided into "early" and "late" regions on the
basis of the stage in the life cycle at which the differ¬
ent genes are expressed. Evidence suggests, however, that
these terms are oversimplifications, but they have been
retained for largely historical reasons.
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2.4.1 E (Early) Region
The Early region contains 5-7 open reading frames
(ORFs) encoding transformation, replication and regula¬
tion functions. These genes are expressed soon after
infection, and prior to the initiation of DNA replica¬
tion. E3 and E8 are not found consistently in all papil¬
lomaviruses, and probably do not represent coding se¬
quences .
El is the longest and best conserved viral gene product
amongst the papillomaviruses . It is the main viral
replication protein.
E2 is a viral transcription regulator.
El and E2 control viral replication by forming a complex
which binds DNA at the origin of replication38. In con¬
trast to BPV, E2 represses transcription of E6 and E7
proteins"3 ' .
E4 is expressed late in the replicative cycle (despite
its name), but is not incorporated into the virions. In
HPV 1-induced lesions, E4 proteins are amongst the most
abundant viral proteins found in the cytoplasm of strati¬
fied keratinocytes, and may play a role in virus matura¬
tion. E4 proteins act by binding and disrupting certain
cytokeratins33 allowing the release of formed viral
particles38.
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E6 and 7 proteins are necessary and sufficient for immor¬
talisation of human keratinocytes in vitro39. Regulation
of expression of E6 and E7 appears to be at the trans¬
criptional level, by control of the initiation of their
mRNAs, and yet both E6 and E7 proteins function as trans¬
criptional transactivators36 . E6 proteins of HPV 16 and
18 complex the cellular p53 protein, which leads to
accelerated degradation of p5340-1. HPV 16 E7 binds to
A O
retinoblastoma protein and the cell regulatory proteins
kinase cdk2 and cyclin A . The levels of E6 and E7
proteins expressed in infected cells may thus be impor¬
tant in oncogenic conversion.
2.4.2 L (Late) Region
Late genes are expressed later in the viral life cycle
and are usually involved in the maturation of viral
particles. The late region contains 2 ORFs encoding the
major and minor viral capsid proteins.
LI This ORF contains sequences which are conserved in all
papillomaviruses and codes for the major 55 kilodalton
capsid protein.
L2 This ORF codes for a minor structural protein. It has
been proposed that the L2 polypeptide represents type
specific antigen, but this has yet to be verified with
DNA sequencing work33.
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The URR (also known as the long control region) contains
transcription regulatory sequences, plasmid maintenance
sequences and the origin of replication44. The non-coding
region is an 800 base pair length of DNA containing
promoter and enhancer elements43.
2.4.3 Nucleotide Homology
All papillomaviruses share some nucleotide sequences. The
most conserved areas are the carboxyl terminal half of
E^, the N and C terminal ends of E2, and . The least
conserved areas of the genome are the regulatory region,
E4, E5 and L2-
2.5 Genitotropic HPVs
At least 27 different HPV types have been isolated from
benign and malignant anogenital lesions33. HPV 6, 11 and
42 are the types most frequently found in condylomata
4- f)
acuminata , with types 6 and 11 accounting for 80-90% of
A *7all clinically apparent lesions . Other types found in
condylomata acuminata include HPV 44, 51, 53, 55 and
6733 . HPV types 16, 18 and 33 are most frequently found
in cervical neoplasia46. Other types found in intraepi¬
thelial neoplasia in the anogenital region are HPV 6, 11,
30, 31, 34, 35, 39, 40, 42, 43, 45, 51, 52, 56, 57, 59,
61, 62 and 6433. HPV types 6, 11, 16, 18, 31, 33, 35, 39,
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45, 51, 52, 54, 56 and 66 have been found in carcinomas
*3 *3
of the anogenital regiomJ .
The DNA of a few HPV types has been found integrated
with host cell DNA48"9. Based on these integration pro¬
perties and the frequency of detection in benign lesions
or invasive carcinomas, HPV types have been classified50
as "low-risk" (e.g. types 6 and 11) and "high-risk" (e.g.
types 16 and 18).
2.6 Multiple HPV infections
Patients with evidence of HPV infection at one anogenital
ET -1 *3
site frequently have infection at other anogenital
and non-anogenital sites54. Furthermore, there is evi¬
dence that infection with one viral type does not confer
n n
resistance to others . Individuals may therefore have
infections with two or more HPV types, sometimes in the
same lesion55"60. However, there is some evidence58 that
infection with one HPV type is rarely associated with




The human immune system responds to infection with HPV by
mounting a humoral and cellular response. The result of
that interaction may be any combination of clinically
manifest disease, subclinical infection, or most common¬
ly, ^ the induction of latency. Furthermore, the stabili¬
ty of any latency may be disrupted by the induction of
immunological dysfunction. In addition, the chronicity of
HPV infection in immunocompetent hosts suggests that
there may be a problem with papillomavirus antigen pre¬
sentation to the immune system, or a failure of the
immune system in recognising HPV-infected cells.
3 . 2 Immunohistolocrical considerations
Infection with HPV is thought to be restricted to the
epithelium, as virus particles appear incapable of pene¬
trating the basement membrane. Mononuclear cell inflam¬
matory infiltrates are the major morphological feature in
r n
regressing plane wartsDZ caused frequently by infection
with HPV 4, but are not seen routinely in other types of
regressing warts. Some of the components of these infil¬
trates are discussed below.
3.2.1 Langerhans1 cells
The first line of defence against HPV infection is
thought to be the Langerhans' cells, which are intra¬
epithelial dendritic antigen presenting cells (APCs).
Langerhans' cells can be subdivided according to the
markers present on their surfaces (for example T6, AT-
Pase, MHC II and S-100)44. Their functions are to process
and present a vareity of cutaneous antigens, and they are
capable of activating primary T cell responses.
Most studies suggest that there is a significant de¬
crease in the concentration of Langerhans' cells in
fi "3 4-cervical condylomata and CIN lesions . This reduction
applies to all Langerhans' cell subpopulations examined65
and is more significant in HPV 18-infected lesions com¬
pared with HPV 16-positive lesions64.
It has been observed that Langerhans' cells express¬
ing HLA-DQ are diminished in warty tissue, compared to
those expressing HLA-DR. As HLA-DQ is needed for the
presentation of antigens to T-cells by macrophages, a
reduction in the level of such Langerhans' cells was
proposed as a means to explain persistent infection with
HPV. However, it is currently unclear whether the reduced
Langerhans' cell concentrations are the cause or the
effect of persistent papillomavirus infections.
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3.2.2 T lymphocytes
T4 (helper/inducer) cells and T8 (suppressor/cytotoxic)
cells comprise the main immune response to tumours and
virally infected cells. In one report, reversed T4/T8
ratios were found in the peripheral blood of patients
with condylomata6 ', and such a ratio has also been shown
in the condyloma tissue itself 68i.
Intra-epithelial T cells with r 5 receptors may also
have a role in the recognition and elimination of HPV-
infected keratinocytes.
3.2.3 Natural killer cells (NK cells)
NK cells are not normally present in the epidermis, but
there is some evidence66 to suggest the presence of
markers consistent with their presence in condylomata
acuminata. This would therefore support the suggestion
that NK cells may be involved in the host response to HPV
infection.
3.2.4 Keratinocytes
HPVs infect but do not kill keratinocytes. HPV replica¬
tion depends on keratinocyte differentiation and it has
therefore been postulated68 that, as only complete viral
particles are assembled in terminally differentiating
keratinocytes, the majority of potential viral antigens
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are only found relatively distant from, and less access¬
ible to the immune system. The more accessible suprabasal
layer only contains free HPV DNA, which is considerably
less antigenic than complete viral particles.
Keratinocytes have been shown to be immunocompetent
cells and to produce immune regulating cytokines that
are likely to have a stimulatory effect on Langerhans'
cells68. HPV infection of the keratinocytes may alter
this function and possibly cause a reduction of cytokine
production that may, in turn, lead to decreased stimula¬
tion of Langerhans' cells and may explain why HPV infec¬
ted tissues become depleted of Langerhans1 cells. Thus
the consequences of keratinocyte infection may possibly
instigate the first step in a suppressive immune modula¬
tion .
T helper cells are not activated by HPV-infected kera-
r q
tmocytes, as these express no MKC Class 2 molecules .
Furthermore, T helper cells do not recognise papilloma¬
virus proteins presented by the local professional APCs,
as epithelial cells are not killed by HPV infection and
no papillomavirus particles or proteins are released, to
be taken up by APCs. It can therefore be seen why HPV
infection may fail to elicit an immune response. In this
model, destructive therapy for HPV lesions facilitates
the phagocytosis of disrupted HPV-infected cells by
scavenging macrophages and papillomavirus proteins are
thus presented to the immune system.
Cytotoxic effector T cells will recognise papilloma¬
virus derived peptides on the surface of keratinocytes in
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the context of MHC Class 1 molecules, but without any of
the second signals for T cell activation from the kerati-
nocytes, APCs or T helper cells. Effector T cells may
therefore ignore the papillomavirus antigen-displaying
7 0
keratinocytes, or be rendered tolerant .
In vitro studies have shown proliferation of peripheral
blood T cells from normal individual in response to HPV
16 E6 and LI proteins, thus demonstrating the antigeni-
7 "1
city of these proteins . It is currently unclear whether
such proteins are also immunogenic, i.e. whether they are
presented to the immune system.
3.3 The humoral immune response
Whilst cell-mediated immunity does seem to be important
in the course of HPV infection, the role of humoral
immunity is less clear. For example, patients with common
variable immunodeficiency (a disease characterised by a
failure of antibody production and only rarely a T cell
deficit) are not especially prone to warts, unlike, for
example patients with human immunoaeficiency virus infec¬
tion. Many of the early studies, however, were limited by
poor antigen specificity, impure antigen sources, small
quantities of antigen available and low assay sensitivi¬
ties .
Several lines of evidence44 suggest that the major
capsid protein contains type specific epitopes on the
virion surface and type common epitopes hidden within the
20
virion. Antisera raised against the L2 proteins also tend
to react in a type-specific manner.
Circulating antibodies in genital HPV patients are
principally to LI and E4, E6/7 and E2 (in that order) .
Such antibodies are also detected in individuals without
overt signs of disease (although presumably with sub-
clinical infection) .
Unfortunately, no study to date has demonstrated a
rising titre to any papillomavirus antigen following
acute infection. Furthermore, serological positivity is
often less than 50% in populations known to be infected




Different techniques measure different aspects of the
host-virus interaction with varying degrees of accuracy.
There is currently no accepted "gold standard" for the
detection of HPV. All methods have differing sensitivi¬
ties and specificities ana may be appropriate to use in
differing circumstances. Varying estimates of the preva¬
lence of HPV among healthy and diseased groups may be
explained, at least in part, by differing abilities of
different laboratories to detect and type HPV in given
samples74. Whatever the method used, it is important to
bear in mind that a negative result from one sample is
not necessarily indicative of the absence of HPV infec¬
tion, in view of the focal nature of such infections.
Furthermore, there may be fluctuations in the shedding of
viral particles with time50.
4.2 Clinical examination
Clinical examination with the unaided eye is the oldest
diagnostic technique. Unfortunately, however, there is
still no universally agreed terminology, with terms often
not defined. In particular, the term "condylomata acumi¬
nata" is frequently used interchangeably with "anogenital
warts". The classification system used in this thesis is
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based on that of Oriel75.
Classical condylomata acuminata are the most character¬
istic and most easily recognised clinical manifestation
of infection of the anogenital region with HPV, although
care has to be taken to avoid confusion with lesions such
as condylomata lata. The naked-eye detection of condylo¬
mata acuminata formed the basis of epidemiological stud¬
ies of anogenital HPV infection until the development of
sophisticated laboratory-based techniques. Most condylo¬
mata acuminata are visible to the naked eye, although a
hand lens or colposcope can significantly increase the
number of lesions seen.
Sessile warts are macular or slightly elevated papular
lesions which are most commonly seen on the shaft of the
penis, but are also occasionally found elsewhere in the
anogenital region. Verrucae vulgaris are hyperkeratotic
warts which are normally found in the non-anogenital
areas of the body, but which may also occur in the ano¬
genital region76-7.
4.3 Subclinical HPV infection
Subclinical HPV infection can be detected only by the use
of special techniques, most commonly the application of
3-5% acetic acid followed by microscopic examination.
Subclinical HPV infection can be found either alone or in
association with other manifestations of HPV infection.
For example, in one study of 51 men78, 45 of them were
found to have histological evidence of HPV infection in
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biopsies obtained using a colposcope, but only 8 of these
had epithelial changes which were visible to the unaided
eye.
4.4 Colposcopy
"Colposcopy" was the term initially used to describe the
examination of the female genital tract using a micro¬
scope, often following the application of acetic acid.
Colposcopy has become an established technique for the
investigation of the uterine cervix and gradually the
term has been extended to include the microscopic exami¬
nation of the whole female anogenital tract. The terms
"peniscopy"^, "androscopy"®®~1, "magnified penile
pn c n _ £
surface scanning" , "penoscopy" , as well as "colpo-
no nr Q
scopy" ' have been used to describe examination of
the male anogenital tract with the aid of a microscope.
The development of visible ("acetowhite") abnormalities
following the application of acetic acid to an area of
epithelium is due to hypercellularity, protein coagula-
9 0
tion and the predominance of nuclei in atypical
91cells . The sensitivity and specificity of this tech¬
nique depends on the operator and on the area studied.
Well defined criteria have now been established for the
interpretation of acetowhite changes of the cervix°^.
Abnormalities of epithelial surfaces of the external
anogenital region which may turn acetowhite, therefore,
include areas of inflammation such as folliculitis,
psoriasis, . eczema, candidiasis, chronic pruritus with
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lichenification, molluscum contagiosum, microtrauma from
recent intercourse, as well as HPV-related
lesions57''82'90'92and penile intraepithelial neo¬
plasia57,95. Lesions such as haemorrhoids, skin tags and
Q Q
naevi do not produce acetowhite changes0 . The specifici¬
ty of this technique when applied to the male genitalia
is generally low52'93'96~7, especially for scrotal le¬
sions97. Although predominantly applied to the genitalia,
acetic acid staining has also been used in the evaluation
of other HPV-induced lesions, such as juvenile laryngeal
papillomatosis98. Even in experienced hands colposcopy,
together with the application of acetic acid, may fail to
detect infected areas, and it is incapable of differenti¬
ating between infection with different HPV types.
4.5 Histopathology
The processes involved in the development of histological
changes associated with infection with HPV are poorly
understood. Infection with HPV type 6 is histologically
4 7
indistinguishable from infection with other HPV types .
Furthermore, the detection of histological changes in
infected tissue appears to be an insensitive index of
infection, as histologically normal tissue has been found
to contain HPV DNA99.
Infection with papillomaviruses requires direct physi¬
cal access to the basal cells, and it is speculated that
establishment of infection may depend on activation of
cell division during healing. The "transformation zone"
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between columnar and squamous epithelium in the cervix
(and also the nasal mucosa, larynx and at the border of
healing wounds) is highly susceptible to the mucosotropic
viral types30. This concept is supported by the observa¬
tion that condylomata acuminata tend to occur in areas
submitted to trauma during sexual intercourse. It is
postulated that trauma may induce multiple epithelial
fissures on sites submitted to a high degree of friction,
thereby facilitating virus introduction100.
Free viral DNA precedes capsid formation and is found
in the suprabasal layer of infected epithelia. Complete
virus particles are found in the more superficial granu¬
lar and corneal layers, eventually being shed into the
environment with the keratinocytes101. Furthermore, it is
believed that viral replication depends on keratinocyte
differentiation.
Papillomaviruses induce warts, which are localised
lesions with many different morphological and histologi¬
cal manifestations. Hyperplasia, a frequent finding of
epithelia infected with papillomaviruses, may result from
a combination of accelerated cell division of the basal
cells and delayed maturation of the superficial keratino¬
cytes, protracting their transit time to the surface.
Some types of warts remain strictly benign, with the
dividing cells confined as usual to the basal monolayer.
Others can become dysplastic to varying degrees, and may
exhibit nuclear atypia with continued viral replication
and division of suprabasal cells, abnormal mitoses, and
possible shifts in the chromosomal ploidy. In addition,
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some papillomavirus lesions can progress to carcinoma in
situ, and ultimately penetration of the basement membrane
and frank carcinoma with metastases.
The expression of genes from regions of the viral
genome which encode non-structural polypeptides probably
result in an altered response of germinal epithelial
cells to the factors that regulate their numbers and the
frequency of their division25. Furthermore, viral repli¬
cation interferes with the terminal differentiation of
the host cell1®2 and provokes cytopathic effects which
seem to depend on the virus type. In the genitotropic
HPVs, this effect is characterised by the perinuclear
vacuolation of koilocytes. The presence of koilocytosis,
reflecting a cytopathic effect of productive HPV infec-
c; n
tion, is regarded by many as a pathognomonic light
microscopic sign of biological activity of HPV. This
marker correlates best with classical condylomata acumi¬
nata and is less consistently present in non-condyloma-
tous manifestations of HPV infection2^'102.
4.6 Exfoliative cytology
Exfoliative cytology for the detection of HPV infection
is used most commonly for uterine cervical lesions, but
it has also been used in investigating the urethra,
vagina, anus and external genitalia. The main advantage
of this technique is that it is possible to sample from a
larger area than is usually practicable by biopsy. It is
based on the assumption that the koilccyte is pathognomo-
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nic of HPV infection. Exfoliative cytology does, however,
have a low sensitivity47, is unable to differentiate
infection between different HPV types, and depends on the
ability to reliably sample from the appropriate area.
4.7 Latent infection
Latent infection has been defined^® as HPV infection
which cannot be detected by the commonly used diagnostic
procedures of clinical inspection, colposcopy, Papanico¬
laou smear and punch biopsy. Many microbiologists, how¬
ever, use the term "latency" to indicate the presence of
the virus, but with no evidence of any associated histo¬
logical change. Latency may represent the most common
"104-
clinical outcome of infection . The reservoir of viral
DNA in infected but clinically normal epithelia is
thought to be the basal cell layer, since these are the
r)
only cells in the epithelium that divide .
4.8 The Polymerase Chain Reaction (PCR)
The development of the PCR has been described as one of
the most substantial technical advances in molecular
genetics in the past decade1®^.
4.8.1 Technique of the PCR
The primers used in the PCR are two single-stranded
oligonucleotides which are synthesised to be complemen¬
tary to known sequences of the target DNA. They define
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the two ends of the stretch of DNA to be amplified. The
two primers must not anneal to one another, and their
sites of annealing to the target DNA must be sufficiently
apart to allow the subsequent synthesis of new products.
The most commonly used primers in HPV work are chosen in
the LI ORF of the HPV genome, and these were used in the
studies presented in this thesis. These primers are
consensus primers with which a large spectrum of HPV
types can be amplified. However, problems may arise in
the investigation of tumours with these primers, as this
region may not be integrated into the host genome. Thus,
E6 ORF or E7 ORF might be appropriate for the investiga¬
tion of carcinomas, although the range of HPV types which
can be detected by this system is more restricted com¬
pared to studies using consensus primers.
The PCR method is based on the repetitive cycling of
three reactions. The first reaction is the denaturation
of the target double-stranded DNA, where heat is used to
break the hydrogen bonds which link the two complemen¬
tary strands of DNA. Next, the extremely specific step of
primer annealing occurs, when the two primers bind to
flanking sides of the region of interest. Finally, DNA
synthesis is initiated using heat stable Tag polymerase.
In this step, each annealed primer is extended in the
presence of excess deoxynucleotide triphosphates and a
new single strand of DNA is synthesised from each an¬
nealed primer. Each new strand consists of the primer at
its 5' end, trailed by nucleotides sequences which are
complementary to those of the corresponding template. The
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three reactions are then repeated, first by raising the
temperature, so that all double-stranded DNA is converted
to a single-stranded DNA, thus aborting any on-going
polymerisation. In this manner, the newly synthesised
products are then used as templates for new primer-exten¬
sion reactions (i.e DNA synthesis), thus resulting in a
geometric amplification of DNA products. It is the combi¬
nation of this geometric amplification, together with the
extremely high specificity of the annealing step which
give PGR its high sensitivity in detecting target DNA.
Typically 30-40 cycles are repeated. The "long products"
produced during the first amplification step have 3 '
endings of variable lengths. However, when these frag¬
ments take part in the next round of amplification,
"short fragments" are produced which exactly complement
the initial region of interest. During subsequent ampli¬
fication cycles, the short fragments increase geometri¬
cally, whereas the long fragments increase merely arith¬
metically. Thus, after, say, forty amplification cycles,
the number of long fragments present in the reaction
mixture is vanishingly small when compared to the number
of short fragments.
4.8.2 Advantages of the PCR
The principal advantage of the PCR is its sensitivity.
Theoretically, the amplification process of the PCR can
increase the number of DNA strands exponentially to 2n,
where n is the number of cycles. It is thus possible to
amplify specific sequences more than a million-fold in
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only a few hours105 and potentially detect one copy of a
target sequence in a given sample106-8. Although initial¬
ly requiring highly skilled operators and specialised
materials, increased automation and greater availability
of primers has meant that the technique has become more
widespread and costs per assay have diminished. Further¬
more, as the product may be generated in large quanti¬
ties, it is possible to use a range of detection systems
as well as radio-labelling.
4.8.3 Disadvantages of the PCR
The main problem with the PCR is contamination. Unwanted,
cross-reacting DNA may confound the reaction conditions
as a result of contamination at any stage, from the
initial taking of clinical samples to the final examina¬
tion of the results. Contamination can be minimised by
the careful collection of clinical material, the physical
separation of reactions occurring before and after the
PCR, the use of positive displacement or disposable
pipettes and the repeated use of positive and negative
controls throughout the experiments. In addition, the use
of anti-contamination primers and the "wipe" test may be
helpful109-10. A further aspect of the PCR is that it
gives no information on the host response to the presence
of the virus. Careful standardisation, quantification of
the amounts of HPV detected, and quality control of the
PCR are all needed before this technique can safely be
used in epidemiological studies concerned with the trans¬
mission and natural course of genital HPV infections.
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A particular problem associated with the use of consen¬
sus primers is the preferential amplification of one
particular HPV type, thus resulting in a significant
underestimation of the incidence of multiple infections.
The absence of a "gold standard", and the lack of
availability of established external quality controls
indicate that caution should be adopted when interpreting
results.
4.9 Southern blotting with hybridisation
In Southern blotting111, electrophoretically separated
denatured DNA on an agarose gel is transferred and fixed
to a membrane. The DNA is then hybridised with a labelled
HPV probe. The sensitivity of this process, is between
0.1 and 0.01 HPV genome copies per cell, depending on the
amount of cellular DNA and specific activity of the
probe . In combination with the PCR, it is theoretically
possible to detect one viral genome per specimen.
Southern blot DNA hybridisation techniques are general¬
ly regarded as the most accurate means of detecting and
"1 "1 7
typing HPV in biological samples , and come closest to
14the "gold standard" in HPV work . However, when the
same samples are analysed even by experienced laborato-
7 4
ries , there may be significant discrepancies both in
terms of which specimens are regarded as being positive
for HPV, and for which type. Unfortunately for routine




A variety of other techniques has been used to determine
the presence of HPV in tissues. None of these has the
combination of sensitivity and specificity offered by the
PCR in combination with Southern blotting with hybridisa¬
tion33 .
Electron microscopy allows the localisation of parti¬
cles in tissue samples to be detected, but cannot differ¬
entiate between HPV type and can only reliably detect
fully formed viral particles.
Antigen detection depends on the binding of specific,
labelled antibodies to viral antigens. Initial problems
with the specificity of antibodies have now been overcome
by the use of genetic engineering techniques. The late
structural proteins were the first HPV antigens to be de¬
tected, but it is now possible to detect early HPV anti¬
gens such as E4, E6, and E7 by a variety of techniques
including immunoflourescence and radioimmunoprecipita-
tion.
Problems with serological methods have arisen because
of the lack of specificity of the early detection sys-
101
terns . Furthermore, it is currently not clear to what
extent (if any) local infections with HPV generate sys¬
temic antibody responses.
33
5. EPIDEMIOLOGY OF ANOGENITAL HPV INFECTION
5.1 Introduction
Information concerning the major epidemiological parame¬
ters, such as length of incubation period, efficiency of
transmission, virus reservoirs outside the genital tract,
and non-sexual transmission of HPVs is limited. In par¬
ticular, there is a paucity of well-controlled partner
studies, where both sexual partners have been examined,
treated and properly followed up. Reasons for this re¬
stricted amount of information include the considerable
morphological variation of clinically apparent lesions"3,
the large proportion of lesions undetectable to the naked
O IT
eye and the previous low level of interest in this
infection. Further problems in our understanding of the
epidemiology of HPV infections have arisen in light of
recent observations from longitudinal studies that HPV
infection presents a constantly changing clinical pic¬
ture50, with clinically apparent, subclinical and latent
infection being found in the same patient over a period
of months. Technical difficulties compound these prob¬
lems, as we have no reliable in vivo or in vitro tech¬
nique for assessing the infectivity of HPV113, and the
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presence of infectious virions cannot be inferred as a
result of finding viral DNA. Epidemiological and techni¬
cal factors may thus explain some of the widely differing
incidence and prevalence figures reported for infection
of the anogenital area with HPV11^4.
More information is available concerning the epidemiolo¬
gy of anogenital HPV infections in women than men. There
are several reasons for this. Firstly, as part of screen¬
ing programmes for cervical carcinoma, large numbers of
cervical scrapes are taken from wide cross-sections of
the population. The collecting spatula or the resulting
slide stained by the Papanicolaou method can be relative¬
ly easily examined for the presence of HPV DNA. Secondly,
the rapid expansion of colposcopy sendees has generated
large numbers of biopsy specimens which are ideally
suited for HPV studies. In comparison to women, men have
lower rates of anogenital cancer and lack a standardised,
readily applicable method for sampling the anogenitai
region. Furthermore, there is no male counterpart of the
cervical screening and colposcopy services for women. For
these reasons, much of the information concerning the
epidemiology of anogenital HPV infections has been ob¬
tained from women. Differences in infectivity, persist¬
ence and susceptibility of the genital epithelium to HPV-
induced transformation between men and women may explain
differences in the epidemiology between men and
114-5
women .
The development of such concepts as the "high risk
male", the sexual transmissibility of HPV, and evidence
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suggesting a role for HPV in the development of penile
dysplasia and cancer means that the epidemiology of HPV
in the male anogenital tract warrants serious considera¬
tion. This review will therefore also particularly con¬
centrate on the epidemiology of HPV infections in the
male anogenital region.
5.2 Anogenital warts
The term condylomata acuminata and AGW are sometimes used
synonymously, yet other warty lesions without the typical
appearance of condylomata acuminata (Figure 1), such as
verrucae vulgaris (flat keratotic plaques) and planar
1G, — 1
(papular) warts, may occur on the anogenital area in
a similar distribution77. It is currently unknown whether
the HPV types and epidemiology of verruca vulgaris and
sessile warts of the anogenital area are identical. Some
evidence-1-1^ suggests that clinical appearance is not a
particularly helpful indicator of HPV type. Oriel117 has
suggested that verruca vulgaris of the anogenital area
may arise as a result of transfer of virus particles from
the hands, although he presents no evidence in support of
this contention.
There are currently no accepted methods for the de¬
scription of type and estimation of size of AGW, making
comparison between studies difficult. It is easy to
overlook small warts on naked eye examination, and mi¬





In the United Kingdom, condylomata acuminata are not a
reportable communicable disease, although are repdrted to
the Department of Health (DoH), and have been separately
recorded as new or recurrent cases from 1988. These
figures only represent cases presenting to genitourinary
clinics, and therefore omit those managed by general
practitioners and other medical specialities, and those
which do not present clinically at all. Despite these
problems, however, the DoH figures are generally regarded
as the most reliable estimate available. In 1980, 17,930
men and 10,246 women attended GU medicine departments in
England with genital warts. In 1990, the corresponding
figures were 45,705 and 32,935, representing an overall
"lipincrease of 358% over the ten year period^ . The rela¬
tionship of new cases of selected genitourinary condi¬
tions, including AGW, with time is illustrated in Figure
1 1 q
2 . It is unclear whether presenting behaviour has
altered over this period, although anecdotal evidence
from the clinic would suggest that patients, in the wake
of STD education programmes have become increasingly
aware of the potential importance of AGWs, and thus
i y o
perhaps more likely to present . Furthermore, there is
i y i
a suggestion that HPV infections of the genital tract
are occurring at an earlier age. A similar increase in
the numbers presenting with AGW has occurred in other
Western countries^'' 3-22-6 _ Unfortunately, however,
few data exist as to the true incidence and prevalence
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It has been estimated in the United States that 0.1%
of the general population127, 0.5% to 1% of sexually
active adults127, 1% of women attending a student health
clinic34, 1.5% of obstetric patients128 and 10% of STD
clinic attenders34 have AGW. In the United Kingdom the
estimated prevalence of AGW in the general population is
0.05%127. Of the 634,000 new cases attending genitouri¬
nary clinics in England in 1991, 83,000 (13%) had a new
diagnosis of AGW-1-15 .
AGW typically occur at sites subjected to trauma during
intercourse3'77'125-30. In the male, the majority of
1 1
lesions occur within the preputial sac , although the
*7 r O
whole anogenital area may be affected . Early reports
that warts are more common in uncircumcised men have
n o I
recently been challenged . Men are often unaware of
Q O
warty penile growths even if they are overt . The re-
1 O h
suits of one study suggest that AGW are more common
in whites than blacks, but it is unclear whether this is
a true reflection of the epidemiology of AGW, or is
related to different presenting behaviours.
5.3 HPV DNA and AGW
HPV DNA has been detected in 6935 - 100%133-4 of biopsies
from AGW. The failure to detect HPV DNA in some AGW
specimens may be explained in terms of technical problems
or limitations, viral copy number below the detection
limit of the assay system, and the possibility of infec¬
tion with HPV types other than those tested for. In
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addition, care should be taken to use a probe reflecting
the part of the genome which likely to be integrated.
The commonest HPVs found in AGW are types 6 and 11,
accounting for 3434 - 100%77,135, with HPV 6a the most
common subtype130. As HPV types 6 and 11 have an overall
*3 r
nucleotide sequence homology of 82%J , even under high
stringency conditions, cross-hybridisation may occur and
so one must be cautious in assigning separate infection
with these agents. HPV types 16, 1853'133, 3]_134,136 an^
3335 are found occasionally in AGW, often in association
7 7
with dysplasia . HPV 42 has been found m association
with benign"5 and dysplastic57 penile lesions. Infections
7 7 "17 7
with multiple HPV types occur '. There is some
evidence of geographical variation of HPV types found in
"17 0
AGW . HPV type may also depend on sexual orientation as
HPV type 11 appears to be more common in the male homo¬
sexual population, possibly reflecting a greater predi¬
lection for anal mucosal infection53.
There is conflicting evidence of possible associations
7 7between clinical appearance , anatomical location of the
170 77174
wart , light microscopic findings ', response to
treatment*1"57 and HPV type. HPV 6 may predominate in
7 7
condylomata acuminata and papular lesions whereas HPV
7 7
16 is more commonly found in papular lesions . HPV 6
seems to be relatively evenly distributed in AGW of the
7 7 17 0
male , although some evidence suggests that HPV 6a
predominates in preputial sac lesions, including intra-
meatal warts. HPV 11 may predominate in the coronal
sulcus77 and in more proximal lesions130. Sessile warts
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may be more likely to have dysplastic microscopic appear-
77
ances
5.4 Non-condylomatous clinically apparent HPV infection
Itch, burning and ayspareunia of the vulva have been
reported in association with HPV infection13®-4®. In the
male genitalia, HPV infection has been associated with
balanoposthitis®7'®3'^7 '141, although some reports3^
suggest that non-condylomatous genital HPV lesions are
rarely symptomatic. The epidemiology of these conditions
is not known.
5.5 Subclinical and latent infection
Many anogenital HPV infections are not visible to the
naked eye7®'^® and it has been estimated that genital
warts may represent only 1%142 to 10%34 of the total
spectrum of genital HPV infections. The difference be¬
tween these high rates of carriage of HPV and the relat¬
ively infrequent occurrence of clinical disease has been
explained by the "pyramid"®® or "tip of the iceberg"®'7
concepts in which clinically overt disease is regarded
merely as the tip. Below the tip is a much larger layer
of individuals with clinically occult disease, but viro-
logical evidence of infection with HPV. At a lower level
still of the pyramid is a large number of healthy indi¬
viduals. Exchange between the layers of the pyramid
occurs at an unknown rate in an unknown proportion of
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individuals. Based on these data34, the corresponding
figures for England are given in Figure 3.
Using cytological criteria applied to Papanicolaou
smears, the annual incidence of cervical HPV infection in
the unselected Finnish population has been estimated to
be 8%, with an estimated 79% of the female population
having at least one genital HPV infection between the
ages 20 and 79 year50. In the United States, between 1
and 4% of women in routine cervical screening programmes
have cytological evidence of HPV infection, rising to 16%
*2 n
of STD clinic attenaersJ^. Using DNA hybridisation tech¬
niques, 2-11% of those with cytologically normal smears
and 30-90% of women with abnormal smears in routine
-2 O
screening programmes have evidence of HPV infection .
Furthermore, there is some evidence of geographical
variation of HPV types found in subclinical lesions57.
The incidence of acetowhite changes in the population
is unknown. Acetowhite changes were found in 36% of
healthy male Swedish army volunteers, and HPV DNA was
found in 7% of biopsies from these areas83. Histological
changes in biopsies of acetowhite areas are often incon¬
clusive, and provide no information regarding HPV
-I n *2
type u . HPV DNA of the genitotropic types can only be





The distribution on the genitalia of acetowhite changes
approximately mirrors that of AGW in the
male52'91'94'97'103, usually at sites of trauma during
IT 9
sexual intercourse . The urethral meatus is also a
common site for acetowhite changes142 . There is some
evidence to suggest that scrotal lesions are more common¬
ly subclinical51 and that lesions on sites other than the
IT 9
penis occur only in men who have penile lesions . The
histological abnormalities of acetowhite areas appear to
r 9be the same regardless of the site . However, in view of
the lack of specificity of acetowhite changes, some
authors suggest that biopsy of acetowhite changes seen
on the penis is mandatory99 as dysplasia occurs in 5%52 -
33%95 of biopsies taken from acetowhite genital areas in
e;o q t; q£ Q7 qq i no .
men ' ' ' ' ' , depending on the population stud¬
ied. Partners of women with CIN have the highest inci¬
dence of PIN95. It should be noted, however, that not all
IT 9 _
areas of penile dysplasia show acetowhite changes . It
has been noted7^'25'94'12^'142 that "high risk" HPV
types (i.e. types 16, 18 and 31) are present in a larger
proportion of subclinical male genital lesions than in
clinically apparent AGW.
5.6 HPV and the upper genital tract
5.6.1 Bladder
Condylomata acuminata of the bladder have been occasion¬
ally reported144"7, usually in association with external
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genital lesions, and almost always in the context of
general ill-health or immunosuppressive therapy. When
bladder condylomata do occur, they frequently have an
aggressive course and may be associated with malignant
transformation145.
5.6.2 Prostate
There have been several epidemiological studies sug¬
gesting that men who develop prostatic carcinoma may
share risk factors such as early sexual debut, a history
of sexually transmitted diseases and multiple sex part¬
ners, with women who are at increased risk of cervical
"I / 0_ Q
carcinoma . Two groups have failed to find DNA from a
I Cfj "|
variety of HPV types in samples of prostate but
others115'152~4 have. HPV DNA has been found in approx¬
imately equal proportion of the samples, regardless of
the histological diagnosis, and does not seem to depend
on the whether the prostatic material is removed transur-
ethrally or suprapubically155. In addition, at least some
of the HPV DNA may be integrated into prostatic cell
•ICC
genomesX3D. Unfortunately, in none of the studies in
which HPV DNA was detected in the prostate has there been
comment on past history of genital warts in the patient
or in their sexual partners, nor was urethral carriage
assessed. It is possible that catheterisation prior to
prostatectomy (regardless of the surgical technique used)
may have introduced viral particles as far proximal as
the prostatic urethra, leading to possible contamination
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of the prostate with HPV. Furthermore, it is well estab¬
lished that pathological changes in the prostate are
frequently very localised in nature, so that there is
potential for large sampling errors. In addition, the
prostatic luminal epithelium, which is the proposed site
for HPV infection, is different from the cutaneous squa¬
mous epithelium characteristically infected with HPV.
5.6.3 Semen
HPV DNA has been detected in the cellular fractions of
semen specimens provided by men with intrameatal warts,
and it has been suggested that HPV DNA may be sloughed
1 cr
off from the urethral epithelium during ejaculation. .
However, another group1^7 failed to find evidence of DNA
from HPV types 6, 16 and 18 in a group of healthy volun¬
teers, although they did detect DNA from HPV types 2 and
5 in three individuals particularly at risk of genera-
Q A
lised HPV infection. Furthermore, a third group could
find no evidence of HPV types 6,11,16 or 18 in semen
samples from a group of 19 male consorts of women with
either condylomata acuminata or abnormal Papanicolaou
smears.
5.7 HPV in urine
Cytological assessment^'1^"^ of urine seems to lack
sensitivity in the detection of HPV. Similarly, the dot
blot method failed to detect HPV DNA in mid-stream
urine specimens from men with visible penile warts and
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from men who were the consorts of women with either
abnormal Papanicolaou smears or condylomata acuminata^4.
In addition, Southern blotting failed to detect HPV DNA
in urine specimens from 3 men with HPV in their semen
samples157. However, HPV DNA has been detected by the PCR
-1 r r\
in urine specimens from men with meatal warts , from
I /TO
male consorts of women with cervical cancer and
women163. The PCR did, however, fail to detect HPV DNA in
1 fi "1
14 presumed healthy males working in a laboratory . The
detection of HPV DNA in urine specimens obtained at the
lower centrifugation speed of 1800g, suggests that the
virus was cell-associated, rather than existing in a free
state161. It has therefore been suggested161 that HPV in
infected exfoliated urothelial cells might be present in
the ejaculate of these men, thus acting as a possible
route of transmission to sexual partners. However, the
only data so far available showing possible sexual trans¬
mission by this route come from male partners of women in
whom type 16 HPV DNA was detected in a cervical scrape.
Type 16 HPV DNA was found162 in the urine specimens from
2 (22%) of 9 men.
5.8 HPV and the urethra
The lining of the distal portion of the male urethra
undergoes a gradual transition from stratified columnar
epithelium to stratified squamous epithelium164. Thus,
there is a transitional zone between the two epithelia
which has been compared to the cervical squamo-columnar
junction151. It has been postulated151 that, because of
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the features of cellular turnover occurring there, the
urethra is more likely to become productively infected
with HPV at that site. The analogy with the cervix is
further developed165 by the observation that urethral
carcinoma tends to occur in areas of columnar epithelium
which have undergone squamous metaplasia as a result of
local infections or other irritation.
5.8.1 Condylomata acuminata
Condylomata acuminata of the male genitalia involve the
urethra in 0.5 to 5% of cases166-7. However, one study
from a British clinic for sexually transmitted diseases3
found that 23% of men with AGW had involvement of the
urethral meatus. The majority of urethral warts occur in
the distal 3cm of the urethra76,147, and are thus visible
on simple inspection of the meatus, preferably aided by
an instrument such as an endocervical or a paediatric
nasal speculum52,137.
5.8.2 Urethroscopy
Urethroscopy allows the detection of urethral condylomata
acuminata, but because of the risk of autoinoculation of
viral particles from meatal to bladder ends of the ure¬
thra94,147, and the low frequency of lesions at the
bladder end of the urethra94, it is not generally per¬
formed unless there are specific clinical indications76.
There is one report76 of acetic acid being instilled
within the lower urethra at cystoscopy. Many of these
patients showed acetowhite changes, regardless of the HPV
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status of the patient, and the procedure was abandoned by
the authors. Acetowhite staining of the urethral meatus
is also a common observation143' 15®, but its significance
is currently not understood.
5.8.3 Urethral sampling techniques
In view of the observation that the majority of urethral
HPV infections occur in the distal urethra, and that this
location is easily accessible, a number of techniques
have been used to obtain specimens from this area. Brush-
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es ' 'such as ureteral brushes have the advantage
that large numbers of cells are collected, but may the
disadvantage that this may traumatise the area and result
in the production of a sterile urethritis (personal
observation). The use of lignocaine jelly136 reduces some
of the immediate discomfort. Another approach is to use
swabs5z,10°. Although urethral swab specimens contain
fewer cells, swabbing is a well established and validat¬
ed method for the collection of urethral specimens for
the investigation of other urethral infections, such as
that caused by Chlamydia trachomatis.
5.6.4 Papanicolaou staining of urethral smears
Urethral samples examined cytologically by modified
Papanicolaou staining techniques have been taken from
male consorts of women with HPV infections53,7® and
groups of men with a wide variety of risk factors for
the acquisition of HPV165. Specimens were obtained using
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a cotton-tipped swab55'151'168 and brush75. However, when
compared directly to HPV DNA analysis of urethral sam¬
ples75, cytological assessment has been consistently
shown to have lower sensitivity and specificity than DNA-
based methods.
5.8.5 HPV antigen detection in urethral specimens
HPV antigen detection methods use labelled antibodies to
papillomavirus capsid proteins ana have the advantage of
allowing determination of the exact anatomical location
of the HPV infection. The main disadvantage is that these
methods often only allow the detection of completed viral
particles and so will miss latent infection. The use of
antibodies specifically directed against early antigens
may, however, avoid this problem.
Using such antigen detection systems, HPV antigen has
7 Qbeen found in the urothelial cells of urethral smears
and the metaplastic epithelium adjacent to urethral
j r q
warts . Antigen has been detected both in the
-] r Q *7 *7
nucleus and the cytoplasm . In one study using this
technique151, HPV antigen was present in 8 (47%) of 17 of
those with a history of genital warts within the previous
2 years, 6 (33%) of 18 of those whose sex partner gave a
history of venereal warts, and 11 (20%) of 56 of those
with no personal or partner history of genital warts.
5.8.6 HPV DNA in urethral specimens
HPV DNA has been detected in urethral condylomata54,155,
most commonly types 6 and 11. HPV DNA has also been
detected in 18% of clinical normal urethral biopsies from
men whose partners had abnormal cervical smears or who
had external genital warts^4. In other studies, HPV DNA
has been found in urethral smears from clinically normal
urethras of a variety of groups of men76,151, including
men with AGW76, and consorts of women with cervical
dysplasia76,136. Men with a history of AGW had the high¬
est percentage of urethral smears containing HPV DNA
(41%) , followed by those whose sex partner had a history
of venereal warts (33%) , and those with no personal or
sex partner history of genital warts (22%)1^1. Omar et
-1 C "|al favour antigen detection as a method of screening
for genital warts, on the grounds that it detects intact
viral particles, rather than just DNA. However, this
approach ignores the unclear relationship between the
detection of viral capsid and infectivity. HPV types 6
and ancj 2_s and 18136 are most commonly found in
urethral smears. Urethroscopy has been performed in men
with HPV detected on urethral smears and no abnormalities
r7 r -j -d r
found '. Urethral biopsies taken from clinically
normal areas were histologically normal in 5 of 6
7 f)
cases . The one abnormal biopsy was described as
"changes compatible with minimal HPV expression" and the
authors concluded that urethral samples can detect la¬
tent, rather than active, HPV infection76.
5.8.7 Urethral carcinoma
Urethral carcinoma is a rare tumour, usually of squamous
epithelial origin with a poor prognosis and possibly
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associated with a history of sexually transmitted dis¬
eases1^. The aetiology of this condition is unknown. HPV
6 DNA was detected by in situ hybridisation in the nuclei
of tumour cells in one study165. Southern blotting using
probes to 27 other HPV types failed to find evidence of
other types.
5. 9 HPV DNA in tissue with no histological evidence of
HPV infection
The results of some studies52'55'170-2 suggest that HPV
is found only in histologically or cytologically abnormal
1 7 7 — £ —
tissue. However, several groups have detected HPV
DNA in apparently normal epithelium adjacent to condylo-
matous and dysplastic lesions. Furthermore, there is some
evidence that such infections may be important in the
1 7 *7
recurrence of disease after treatment
The proportion of women with HPV detected in their
cervices depends on the detection method employed and
patient population. Cytological evidence of HPV infec¬
tion of the cervix has been found in approximately 1% of
women attending family planning clinics, with prevalence
"IOC
decreasing with age . However, cytological examination
underestimates the incidence of HPV infection. For exam¬
ple, in St Mary's Hospital, London,175, HPV DNA was found
in 10.5% of women attending the STD clinic with histolog¬
ically and colposcopically normal cervices. HPV DNA has
been detected in histologically and cytologically normal
cervices by a large number of groups55,175-87. Using the
PCR, up to 70% of normal cervices have been shown to
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contain HPV DNA182, but figures of 10-20%172 ' 184 ' 188 are
more commonly reported. HPV 16 and 18 appear to be the
-i o -| n r
commonest types detected in the normal cervix '
Whilst the possibility of contamination has been raised56
to explain some of the higher figures, it is now clear
that HPV infection in cytologically normal cervices is
widespread.
Some studies indicate that when treatment by laser,
cryotherapy or interferon results in a clinical cure,
then there is associated clearance of HPV DNA56,196.
However, there is some evidence for persistence of HPV
DNA in clinically and histologically normal areas which
1 Q"1 _ nhad been previously clinically infected" .
HPV has also been found in morphologically normal
vulval papillae128, oral tissue1"8 and normal colonic
1 Q4 . . 1OC , .
tissue . However, m a recent study m which a
variety of methods was used, including the PGR, very
little evidence of HPV infection was found in a wide
variety of premalignant lesions of the non-genital skin.
5.10 HPV DNA in the normal adult penis
It is difficult to gain access to a group of men who are
truly representative of the general population, particu¬
larly as some sampling procedures for the detection of
HPV are unpleasant.
HPV is not present in biopsies from coronal
papillae55,172, despite the fact that they may be clini¬
cally confused with condylomata acuminata196. Similarly,
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HPV has not been detected in biopsies of the penis with
no histological evidence of HPV infection or
carcinoma®^' However, HPV DNA from types 6,11,16
and 18 has been found in histologically normal penile
biopsies from men with either condylomata acuminata
elsewhere or who are sexual consorts of women with cervi¬
cal cytological abnormalities57' 94 ' 99.
Sampling procedures which are less invasive than biopsy
have also been used. In one study, of 53 0 men attending
a blood donor centre and a dermatology department in
Germany19®, HPV DNA was found in 5.8% of cotton wool
smears taken from the coronal sulcus and glans penis.
None of the men had clinically apparent warts. Samples
were analysed by filter in situ hybridisation. The
authors postulate that the higher frequency of cervical
swabs containing HPV DNA compared to penile swabs may be
due to the greater number of cells that can usually be
obtained from the cervix. A similar result was found by
Schneider199, and Eriksson et al83 detected HPV DNA in 8%
of urethral swabs from healthy Swedish army recruits.
p r
Using a similar method, Campion et al investigated 25
sexual consorts of women with chlamydial cervicitis.
There was no history of condylomata acuminata within the
relationship and one man had a positive penile scrape for
HPV. Three of 25 men had colposcopic and histological
evidence of HPV infection.
Recently100, 228 men attending a Stockholm STD clinic
consecutively were analysed for the presence of HPV DNA.
Samples were taken from the coronal sulcus and inner
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foreskin by a cytology brush (Cytobrush ) and from the
urethral meatus using a cotton-tipped swab. The specimens
were then subjected to PCR using primers for HPV types 6
and 16, followed by analysis using agarose gel and dot
blot hybridisation. Dot blot hybridisation results gave
significantly higher positivity rates. The authors found
that there was no difference between samples collected
from the coronal sulcus and the urinary meatus. Eighty-
one percent of men with condylomata acuminata had posi¬
tive HPV 6 signals on dot blot analysis. Slightly lower
percentages were recorded for men with a history of
condylomata acuminata (62%), consorts of women with
condylomata acuminata (67%) and men with no previous
known exposure to AGW. The authors expressed concern that
the dot blot method might have led to an over-estimate
because crude cell extracts used in the PCR assay and
denatured proteins could possibly have trapped the oligo¬
nucleotide probes used in the hybridisation step. They
therefore conclude that the true carriage rate for their
population lies between 43-76% for HPV type 6, and be¬
tween 13-46% for type 16.
5.11 The natural history of anogenital HPV infection
Very few longitudinal studies have been conducted on the
natural history of AGW. Only limited follow-up data are
currently available on the progression rates of latent
infection50,57, and it not known whether permanent regres¬
sion of latent HPV infections is possible.
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The most detailed information comes from the cervical
cytological studies from Finland by Syrjanen et al200-1.
During their five-year follow-up of untreated women, 40%
spontaneously regressed cytologically, 45% persisted and
15% progressed to carcinoma in situ. Using life-table
analysis, they found that neither grade of Papanicolaou
smear nor HPV type were of predictive value for spontane¬
ous regression, ana the colposcopic pattern was only a
poor predictor of regression or progression. The most
notable observation of this study is that genital HPV
infections run an extremely fluctuating course, varying
from clinically apparent lesions to subclinical and
latent infection. The majority of cases of subclinical
cervical HPV lesions cleared spontaneously within 5 to 6
years50,202 and it has been postulated57 that a focal
inflammatory response might be associated with a more
rapid resolution.
5.12 Anoaenital HPV infection and sexual behaviour
Barrett et al were the first to establish scientifically
that condylomata acuminata were sexually transmissible.
Later, Oriel2 traced 97 sexual contacts of 332 patients
with AGW. Sixty two (64%) of these people subsequently
developed AGW with incubation periods between 3 weeks and
8 months (although his follow-up period was only 9
months), with an average of 2.8 months. The data suggest¬
ed that infectivity was inversely related to the duration
of the AGW, an observation which has been correlated with
the decreased number of viral particles present in older
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lesions3^. Sexual activity has been established to be
important in the development of anal warts in homosexual
p r\ p 9 04
men but not heterosexual women .
Subclinical and latent anogenital HPV infection has
been found to correlate with sexual activity in the
majority of studies34'127'203~5, although not in all210-
3. Indeed, investigators in a study from Denmark and
Greenland2x3 and Latin America214 found paradoxically
that the earlier the age at first sexual intercourse and
the greater the number of sexual partners, the lower the
risk of HPV infection. HPV infection of the cervix has
j o Q p -] rbeen found to be age dependent or independent .
Similarly, HPV infection of the penis has been found to
1 no 01C 917-P
be age dependent . Technical reasons ' may
explain some of the discrepant results between the var¬
ious studies.
The age distribution of individuals with AGW is similar
p
to those with gonorrhoea and, depending on the methods
used for diagnosis, the prevalence of HPV infections in
STD clinic attenders varies from 12 to 41%21®. Patients
with AGW frequently have other sexually transmissible
infections2'3'13'113 ' 223-223 . Furthermore, infection of
the genital tract with other pathogens, in addition to
HPV, may make the eradication of warts more difficult .
In particular, infection with the human immunodeficiency
virus (HIV) may alter the clinical course of HPV infec¬
tions of the cervix223-7, other genital areas223 and
P O Q _ p 0anus^^ 0 . Kaposi's sarcoma shows some of the epidemio¬
logical characteristics of a sexually transmissible
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infection and occurs in the genitals even of those who
are HIV negative209. HPV DNA232 and papillomavirus anti¬
gens233 have been found in tissue from Kaposi lesions in
both HIV infected and non-infected patients, leading to
speculation that HPV may be involved in the aetiology of
such lesions.
Evidence of anogenital infection with HPV has been
found in the male sexual partners of women with AGW95'97,
R
cervical cytological abnormalities and biopsy-proven
cervical dysplasia83'93'234. Several studies fail to dif
ferentiate between women with cytological dysplasia and
AGW79'87'233. Techniques for assessing the men usually
PR P *7 PR *2 P 4-
include colposcopy '' ', histology of colposcopi-
cally abnormal areas85'87'95 ' 234 , as well as DNA hybridi-
pr o 7 or oct
sation of biopsy specimens '' and genital scrapes .
Using these methods, 50%-66% of men whose consorts have
abnormal cervical smears or AGW have evidence of anogeni¬
tal HPV infection52"3'88'95 '103 ' 159 . Subclinical lesions
in the male seem to be more common in those who have
R
recently changed their sexual partner . There is a
suggestion that the consorts of women with dysplastic
lesions of the cervix tend to have dysplastic penile
or q clesions The relative infectivity of condylomata,
acetowhite areas and latent infection is not known.
Studies are confounded by the multifocal and constantly
changing clinical status of anogenital HPV infection50,
P R
and the lack of adequate controls . Furthermore, in only
9 R f>
a few studies have the female consorts of men with
anogenital HPV infection been investigated.
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Some evidence suggests that women treated for condylo¬
mata acuminata develop recurrences unless the male
partner is also treated^37. Likewise, reinfection from
the urethras of untreated sexual partners has been pro¬
posed as a mechanism to explain why acetowhite areas may
1 n *3 n o o
be very resistant to treatment However, con¬
trolled trials have found that the simultaneous treatment
or otherwise of male sexual partners produced no differ¬
ence in the response to treatment of women with condylo-
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mata acuminata or cervical dysplasia . Nevertheless,
a higher rate of regression of cervical dysplasia has
been observed when male partners use condoms240.
It is generally assumed-1"3®'241 that infection with HPV
develops following direct contact between fully formed
virions entering through small abrasions in the skin and
the lowest basal cells of the epithelium. Messenger RNA
from the early ORFs are found in the basal cells, whereas
late transcripts (which signify completed virion produc¬
tion) appear only in the more differentiated epithelial
9 4 9
layers . Thus, in the absence of any method to directly
measure infectivity, it is thought that only the top
layers of the epithelium contain infectious viral parti¬
cles243"4. Such particles are released along with the
desquamated cells which are shed from the skin or mucous
1 O O
membranes .
HPV 6 and, to a lesser extent HPV 11, are the types
most readily transmitted by sexual intercourse3^. Trans-
missibility appears to be related to the number of virus
particles present, together with the duration and fre-
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quency of exposure59. It has been suggested245 that viral
shedding may be greater in infections with HPV types 6
or 11, as the resulting lesions have relatively large
numbers of virion-containing degenerative koilocytes. In
contrast, lesions resulting from infection with HPV types
16 or 18 (mostly intra-epithelial neoplasia) are rela¬
tively poor in superficial koilocytes. Comparing the
quantitative carriage rate of different individuals, it
has been observed59 that when both partners are infected,
one always has a much higher carriage rate than the
other. In addition, if only one partner was infected, the
copy number was much lower.
5.13 Possible vertical transmission of qenitotropic HPV
types
Applying the PCR to samples obtained from tampons, Fairey
9 A &
et alz^D were unable to detect HPV DNA in virgins, al¬
though they were successful with this technique in find¬
ing HPV DNA in tampon samples from sexually active
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women . Sun-Kuie et al , however, found colposcopic
and histopathological evidence of genital HPV infection
in 51% of the virginal women in their sample. Only one of
the women in the latter study had typical condylomata
acuminata and HPV DNA typing was not performed. It is
therefore currently unclear whether virginal women have
genital infection with HPV, and if so, to what extent
vertical transmission plays a role.
HPV DNA has been detected in the amniotic fluid of
clinically normal neonates born at Caesarian section248
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and cord blood of neonates , suggesting that transpla-
o a q
cental infection prior to delivery may occur . Further¬
more, HPV DNA has been detected in the foreskins of up to
40% of newborns delivered to mothers carrying the similar
viral types in their birth canal . DNA of the genito-
tropic HPV types has also been found in the conjunctivae
n r o
of neonates born to mothers with AGW^-3-3 and in oral
j on
scrapings from preschool children .
AGW have been recorded in children at birth254 includ¬
ing those born by Caesarian section98. Before 1980, only
n c c
19 cases of AGW, including intrameatal warts , were
reported in children98, predominantly in girls258. Over
the past decade, however, there has been a marked in¬
crease in the number of reported cases. It is not known
whether this increase is due to greater awareness of AGW
in children or a true increase in incidence, perhaps
reflecting the increased incidence of AGW in the adult
population. AGW in children usually contain HPV types 6
and 11, a"1 though the "high risk" types 16 and 18 have
q oalso been reported . The occasional finding of "non-
genital" HPV types 1 and 298,257 ^as tQ tjie sugges_
o c q
tion that transmission of HPV may occur from non-
genital sites of the parents or child during toileting,
bathing and other child care activities. Sexual abuse was
initially regarded as the main cause of anogenital warts
in children258'259-80, but this may not always be estab¬
lished258 .
Approximately 150-300 cases of juvenile laryngeal
papillomatosis (JLP) are reported per year in the
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USA261, with a peak age at the time of diagnosis occur¬
ring between birth and 5 years of age262. Subclinical
lesions probably go unreported263. Half to two-thirds of
children with JLP have mothers with visible condylomata
acuminata26^-6, and it has been estimated that the risk
of acquiring JLP from a clinically infected mother ranges
from 1 in 80 to 1 in 15,000 pregnancies261,267. The
lesions of JLP usually contain HPV types 6 and ll263. HPV
DNA has been found in the nasogastric aspirates of ap¬
proximately 3 0% of neonates263 and it has been
suggested ^ that infants may aspirate infected material
during vaginal delivery. Caesarian section is usually
n c "I
protective against JLP although JLP has been reported
occasionally in children born by Caesarian section2761.
However, Caesarian section is probably not warranted in
all cases of maternal AGW as the risk of JLP for the
1 on
child is so small .
Further evidence of widespread infection of children
with genitotropic HPV types comes from serological stud¬
ies using expressed fusion proteins to detected the
presence of specific antibodies to genitotropic HPV
types36'129'271-2. Antibody frequencies seem to be simi¬
lar to those found in STD clinic attenders129. In addi-
"] O Q
tion, in one study there was evidence of passive
transfer of antibodies against HPV from mother to neonate
which disappeared within 6 months of birth.
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5.14 Genitotropic HPV types at non-urogenital sites
5.14.1 Laryngeal papillomatosis
It is currently unclear whether JLP and adult laryngeal
papillomata represent two separate entities, or are
merely different manifestations of the same disease
process. However, children with JLP may subsequently
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develop problems with laryngeal papillomata as adults
4 and nearly one half of the cases of HPV-related laryn¬
geal papillomata first present in adult life2^2. HPV has
n i c _ *7
been found in adult onset papillomata of the larynx^ 3
[TIT 9 7ft - ft 0 —and in verrucous carcinoma of the larynx ' . Fur¬
thermore, the vocal cord epithelium has a relatively
n o -i
high susceptibility to experimental HPV infection °.
There is strong evidence that patients with JLP retain
latent HPV DNA in laryngeal epithelial cells for years.
HPV DNA sequences are present in laryngeal biopsies of
patients in remission1®2, and a case has been reported2®2
of recurrence of laryngeal papillomata in a 37-year old
man who previously manifested signs of JLP between 2 and
5 years of age. It has been postulated that recurrent
laryngeal papillomatosis in adults may result from oro-
genital contact, although this was not confirmed in one
9 ft A
recent study .
JLP rarely involves the trachea and bronchi, suggesting
that vertical transmission is an unlikely cause for the
presence of HPV in the lung. In support of this, Carey
poc
et al , investigating endobronchial squamous tumours,
which have a strong morphological resemblance to virus-
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associated tumours, found no evidence of HPV infection.
However, HPV DNA has been found in squamous carcinoma of
the lung274,286.
5 .14.2 Mouth
HPV DNA, mainly from types 6 and 16, has been found in
oral scrapings of those without clinical oral abnormali-
"1 O Q "1 Q *3 "| Q "3 I QO
ties ' , oral leukoplakia , oral lichen planus ,
oral papillomata288' 287 and squamous carcinoma of the
buccal mucosa279 and tongue88'279'287-8. Furthermore, HPV
6b and 16 have been found in oral scrapes from preschool
children129. Orogenital transmission of HPV is presumed
to occur289, but the role of fomites, oral/hand contact
and vertical transmission remain unclear.
5.14.3 Oesophagus
It has been proposed298 that clinically undetected oeso¬
phageal condylomata may occur when oral lesions are
present, and that these two phenomena are related. HPV
antigens have been found in oesophageal papillomata,
focal hyperplasia and carcinoma291-2. HPV DNA from types
ll2^3-4 an£ -j_g295 jias j-,een found in oesophageal carcino¬
ma. Proposed methods of transmission include passage
7 74-
through an infected birth canal , interpersonal spread
2 9 4
in areas of poor hygiene and orogenital




HPV 16 has been found in the squamous carcinoma of the
nasal cavities and paranasal sinuses, but not inflammato-
n n Q
ry lesions of these areas . In this latter study, HPV
status did not alter the clinical course of the lesions
and the role of HPV in the pathogenesis in the sinus
abnormalities is currently unclear.
5.14.5 Eye
HPV 16 DNA has been found in clinically normal eyes54,
? R 9 9 9 9
conjunctival papillomata ' , dysplastic and malignant
lesions of the ocular conjunctiva and cornea54,300 and
dysplastic lesions of the eyelid301. It is not clear how
HPV reaches the eye, but sexually transmitted organisms,
such as Ch_ trachomatis, can be transmitted to the eye
r\ *-)
through hand-eye contact and a loose association has
been demonstrated between cervical carriage of HPV and
the presence of HPV in the conjunctiva54.
5.14.6 Blood
HPV DNA has been isolated from the peripheral blood
mononucleocytes of women without clinically apparent HPV-
related disease303, cord blood of neonates34^ and pa¬
tients with clinical disease303. HPV has also been found
m serum samples . These observations suggests that
blood may have a role in recurrence following treatment
and the development of multifocal HPV infections.
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5.14.7 Fomites
The epidemiology of HPV is further complicated by the
detection of HPV DNA on inanimate objects. HPV does not
have a lipid membrane and so is relatively resistant to
physical destruction. HPV DNA has been found in under-
1 "I *3
wear of patients with clinically apparent lesions,
although the frequency of finding it did not seem to
correlate with the frequency of changing the underwear.
HPV DNA has also been found on surgical instruments used
for treating patients with clinical HPV-related
n
disease , although it does appear to be removed by
D n r
conventional cleaning procedures . Vapour produced
during treatment of warts by laser300 and
electrocautery307 also contains HPV DNA.
5.15 Anogenital neoplasia and HPV
There is considerable epidemiological evidence supporting
the concept of a sexually transmissible factor in the
genesis of cervical dysplasia30'313'314 ' 208-12 . Further¬
more, it has been proposed that specific HPV types
(primarily HPV 16 or HPV 18) may play a major role in the
aetiology of many, if not most, anal and genital tract
cancers34'46'173'214'313-4. The transcription of HPV DNA
D-l C
m tumours0 and the presence of HPV DNA and RNA in
cells derived from cervical cancers313-0 argue against a
passenger status of papillomavirus in tumours. Experimen-
a r o i *7
tal studies^10'OJ- have provided insight into how papillo-
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maviruses alone, or in combination with other factors,
may induce cellular proliferation, immortalisation, and
transformation.
Although circumstantial evidence of a link between HPV
and cervical carcinoma is strong, there are some incon¬
sistencies in the evidence. Infection with HPV appears to
be necessary for the development of certain malignant
4- f>
tumours, but not sufficient , as HPV is also found in a
substantial proportion of disease-free woraen1^'^1®.
Additional factors seem to be involved, for example:
coinfection with other agents such as herpes simplex
virus318-21, Epstein Barr virus300 and HIV323-5,
smoking , naturally occurring and contraceptive
*310 *3 9 9steroid hormones ' , dietary factors such as vitamin
"2 "3 "] _ O
A, beta carotene and vitamin C and local inflammato¬
ry responses such as mechanical trauma and radiation
exposure30. A synergistic interaction has been
proposed208,333 in which infection with papillomaviruses
leads to proliferation, with subsequent transformation in
the malignant lesion depending on other carcinogenic
insults.
Apart from the cervix, HPV DNA has been found in a
variety of neoplasias such as those of the vulva334-7,
vagina338-9, penis197,340-1 and anus230,342.
Bowenoid papulosis is a cutaneous condition, usually
occurring in the anogenital area, which has the appear¬
ance of erythematous macules, reddish or pigmented pa¬
pules, or leukoplakia-like lesions77. It appears to be
clinically benign, but has the histological characteris¬
es
tics of squamous cell carcinoma in situ. When occurring
on the penis it therefore has the histopathological
appearance of penile intraepithelial neoplasia (PIN)
grade 333'139. The clinical counterparts of PIN 1 and PIN
2 are currently not characterised. Bowenoid papulosis has
been found in association with HPV types 6, 11, 16, 18,
33, 34, 39, 40, 42 and 55343, although most commonly with
7 7 7 4-4.
type 16, which is found in up to 100% of cases
Giant condyloma of Buschke-Lowenstein (also known as
verrucous carcinoma) is a fungating, destructive, but
non-invasive tumour which most commonly occurs on the
prepuce of the penis. There have been occasional reports
of it occurring on the vulva, anorectal area343 and oral
7 4 ft
cavity . The aetiology of Buschke-Lowenstein tumours is
unclear, but there have been several reports of the
74 7 - ft
tumours arising in condylomata acuminata and the
4 7
majority are associated with HPV types 6 and 11 .
HPV DNA has also been found in neoplastic lesions of
the mouth, larynx, oesophagus and bronchi3®. Indeed,
current evidence suggests that HPVs may play an important
part in the aetiology of the majority of benign and
malignant tumours of the oral mucosa, as well as in head
7 7
and neck tumours .
5.16 The "hicrh risk" male
There are a number of studies suggesting that male sexual
partners influence the likelihood that a women will
develop cervical dysplasia349, and this concept has led
to the term the "high-risk male"33®. Male consorts of
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such women have earlier sexual debuts, more sexual part-
ners1^'^'1-, are more likely to travel away from home^^,
have a higher incidence of smoking and are more likely to
have penile cancer353"5. Furthermore, there is a four¬
fold increase in the risk of CIN in women whose husbands
who have previously been married to a woman with CIN308
and neighbourhood clusters of CIN have been reported in
association with cohabitation relationships between
affected women and specific men355. There is thus a
considerable amount of evidence of the influence of the
male on the development of cervical dysplasia in sexual
partners. The exact mechanism has yet to be finally
1 "2 O
established-1- , but the high frequency of clinically






The detection rate of HPV DNA may depend on the popula¬
tion studied"4. All studies in this thesis were conducted
in departments of genitourinary medicine. Thus, in order
to obtain a broad a view as possible of the epidemiology
of HPV infections, several different groups of patients
were studied. Furthermore, increasing evidence suggests
that such infections may be multifocal, and so specimens
from several sites from the same patient were taken.
It is difficult to determine the prevalence rate of HPV
infection in the general population. In the genital
dermatosis study, men with clinical indications for
biopsy were chosen not in the belief that they represent¬
ed the general male community, but that they would do so
more closely than patients with "conventional" sexually
transmitted diseases.
In the resistant anogenital warts study, a group of men
with clinically apparent AGW was selected on the assump¬
tion that they would be likely to carry HPV in large
quantities in their anogenital regions. Samples of wart
tissue were taken for analysis and the results compared
with those obtained from examining urethral and urine
specimens. In this manner it was hoped to assess the
distribution of HPV in the male urogenital tract.
Men with urethral gonorrhoea form a well characterised
group358 whose lifestyles have put them at risk of ac¬
quiring sexually transmissible diseases. A group of men
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with urethral gonorrhoea was therefore chosen for assess¬
ment in order to investigate the role of sexual activity
in the epidemiology of HPV infections. The details of
this study are given in the urethral gonorrhoea study.
In the multifocal study, a variety of samples were
taken over several months from several sites of patients
with and without AGW. In this manner it was hoped to
characterise more fully the multifocal nature of HPV
infection and its change with time.
Currently, the polymerase chain reaction (PCR) is the
most sensitive technique for the detection of HPV DNA .
Southern blotting111 allows the confirmation of DNA se
quences produced by the PCR and enables the type of HPV
to be determined. In view of their combination of sensi¬
tivity and specificity, the PCR and Southern blotting
techniques were chosen for the analysis of all specimens
in this study.
In view of the extreme sensitivity of the PCR, careful
measures were taken to avoid contamination of the speci¬
mens with extraneous DNA. Samples were taken under ster¬
ile conditions, using "no touch" techniques and wearing
sterile disposable gloves. Disposable equipment was used
at all stages apart from the biopsy sets and diathermy
loops, which were hand-washed, placed in an ultrasonic
cleaner (Olympus Keymed KS-2, Keymed U.K.) for 15 minutes
followed by autoclaving at 134°C for 20 minutes (Little
Sister 2, Eschmann Bros & Walsh Ltd, Lancing, W Sussex,
England) before reuse.
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2. Recruitment of Patients
Patients were recruited from the Jefferiss Wing, St
Mary's Hospital, London and the Patrick Clements Clinic,
Central Middlesex Hospital, London. All patients were
offered full screening for the common urogenital patho¬
gens .
2.1 Genital dermatosis study
A specific internal referral clinic, the penile dermato¬
sis clinic was set up within the genitourinary medicine
(GUM) department at St Mary's Hospital. The criteria for
referral were men with persistent penile dermatoses which
did not respond to treatment, or of which the diagnosis
was in doubt and the clinician felt that biopsy would be
helpful in establishing the diagnosis359. One hundred
consecutive patients attending this clinic agreed to
provide samples for this study.
2.2 Resistant anogenital warts study
Patients were referred to this clinic if they had any
anogenital warts which had not responded to the first-
line treatments of poaophyllotoxin (used for penile warts
only) and podophyllin with cryotherapy. Men with any
intra-anal or meatal warts were also referred.
2.3 Urethral gonorrhoea study
Men presenting consecutively to the routine GUM clinics
with an acute episode of urethral discharge or dysuria
were asked to participate in the study. The men were only
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included in the study if they consented and Neisseria
gonorrhoeae was subsequently grown from a urethral speci¬
men .
2.4 Multifocal study
Patients for this study were recruited from the main GUM
clinic at St Mary's Hospital and invited to take part if
either they or their sexual partner had a clinical diag¬
nosis of AGW.
3. History and examination of patients
A full history was taken, and information recorded on
specially designed sheets, which varied with each study
(Appendices I-IV). Fewer demographic details were col¬
lected from the men in the resistant anogenital warts
study compared to the patients participating in the other
three studies.
All patients underwent a full genital examination, with
proctoscopy if the man admitted to recent receptive anal
intercourse, or had symptoms suggesting possible anal
disease. All men with perianal warts underwent proctosco¬
py, regardless of their history. Patients taking part in
the dermatosis study underwent a thorough examination of
the whole skin surface and mucous membranes, followed by
microscopic examination of the anogenital area with a
Zeiss colposcope. Patients in the multifocal study had
their anogenital areas examined using a Zeiss colposcope
following the application of 3-5% acetic acid.
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4. Routine investigation and management of patients
Urethral specimens were taken using a lO/il plastic loop
(Nunc, Gibco, Paisley, Scotland), which was first smeared
on to a glass slide for Gram staining, and then directly
plated on to a medium selective for the growth of N.
gonorrhoeae (Appendix V) . The plates were then placed in
an incubator at 37°C with an atmosphere containing 6%
C02. Samples were subsequently collected and transported
to the laboratory before further incubation for 48 hours
under the same conditions. Colonies were identified
initially by the oxidase reaction (N,N,N',N1 -tetramethyl-
p-phenylenediamine, obtained from Sigma, St Louis, Mo,
USA) . Oxidase positive cultures were Gram stained, and
all those staining negative exposed to a immunofloures-
cent monoclonal antibody to gonorrhoeae (Syva Micro-
trak, Palo Alto, California, USA) . Further verification
was performed, if necessary, using standard carbohydrate
utilisation tests.
In the clinic, a presumptive diagnosis of urethral
gonorrhoea was made if intracellular Gram negative diplo-
cocci were seen on the smear. If this was the case, the
patient was offered treatment with a single 500mg oral
dose of ciprofloxacin, and referred to the Health Advisor
for counselling.
The finding of equal to or more than 5 polymorphonuclear
cells per high-power field on the Gram stain of the
urethral smear, in the absence of intracellular Gram
negative diplococci, led to a diagnosis of non-gonococcal
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urethritis. A two glass urine test was undertaken in all
cases, and the urine assessed for the presence of casts
of mucopus from the urethra and urethral glands (known as
"threads"). Non-gonococcal urethritis was treated with a
single dose of doxycycline 200mg, followed by doxycycline
lOOmg daily for 6 days, unless there were any contra¬
indications. The commonest alternative regimes used in
these cases were either erythromycin 250mg four times
daily or co-trimoxazole 960mg four times daily, both for
2 weeks.
Occasionally, the microscopist was unable to definitely
make a presumptive diagnosis of gonorrhoea. However, if
Gram-negative diplococci were seen in large numbers, and
there was a strong clinical suspicion of urethral gonor¬
rhoea, then a diagnosis of "suspicious pairs" was made
and appropriate treatment offered to the patient. Refer¬
ral to a Health Advisor was not, however, made until a
positive culture result was obtained.
For the women, an additional lOfxl plastic loop specimen
was taken from the cervical os and a cotton wool swab
specimen taken from the anus. These specimens were then
processed as for urethral loop specimens. Using the
original 10/xl plastic loop, further samples were taken
from the posterior fornix of the vagina. These latter
specimens were examined using wet film and Gram staining
techniques to enable the detection of Trichomonas vagina -
lis, Candida albicans and bacterial vaginosis.
If the patients underwent proctoscopy, plain cotton
swabs were inserted through the proctoscope and any
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obvious pus collected. If no beads of pus were visible,
then the rectal wall was generously swabbed. Swabs thus
obtained were then smeared on to medium for the culture
of Nj_ gonorrhoeae.
If the patient admitted to receptive oro-genital inter¬
course, pharyngeal swabs were taken with a cotton-tipped
swab and cultured for PL. gonorrhoeae.
If there was evidence of balanitis, sub-preputial swabs
were taken using a charcoal impregnated cotton wool swab
and placed directly in bacteriological transport medium
(Transwab, Medical Wire & Equipment Co Ltd, Potley,
Corsham, Wilts, England), prior to transport to the
laboratory. Once in the laboratory, the swabs were
smeared on to separate plates of McConkey agar and blood
agar, to be incubated at 37°C, the latter requiring the
addition of 7% CO2 to the atmosphere. A further plate was
set up with Sabouraua' s medium and incubated at 3 0°C.
Colonies growing by 48 hours were identified using stand¬
ard laboratoi-y methods.
All patients were offered serological screening for
syphilis. Treponema pallidum haemagglutination assay
(TPHA) and the Venereal Disease Research Laboratory
(VDRL) tests were used routinely, with the fluorescent
treponemal antibody-absorbed test (FTA-ABS) included if
indicated.
Counselling concerning testing for the human immunode¬
ficiency virus (HIV) was offered to all patients and, if
a request was made for it to be performed, written per¬




For the dermatosis study, men were asked to avoid apply¬
ing any creams to their genital area for at least two
weeks prior to their appointment, as it was felt that
this might interfere with histopathological assessment.
Biopsy was undertaken only after written permission had
been obtained from the patient.
Under aseptic conditions, l-2ml of 2% lignocaine with 1
in 200,000 adrenaline was injected using a disposable 26
gauge needle (B-D Microlance, Becton, Dickinson & Co, Dun
Laoghaire, Co. Dublin, Eire) under a representative area
O n
of the lesion . If the lesion was widespread, then
foreskin or shaft skin was taken preferentially, as these
areas were found to heal more quickly. A skin snip tech-
d r q
mque was used-33 (Figure 4), based on that used by
others80'88 '188 . Samples were divided, one half being
placed in formal saline for subsequent histopathological
assessment, and the other in phosphate buffered saline
(PBS) for DNA analysis. Silver nitrate was used to secure
, q n
haemostasis of the biopsy site . As only small samples
were taken, suturing was not necessary, and the wound
healed by primary intention. Urethral swabs were taken
by the accompanying nurse, and urine samples provided by
the patients. Patients were instructed to perform regular
wound toilet after the biopsy, and to avoid full sexual
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intercourse for the following 2 weeks. Patients were told
which symptoms would suggest wound infection, and ar¬
rangements made for any urgent medical attention re¬
quired. On the small number of occasions when this was
necessary, a short course of co-trimoxazole produced
rapid resolution. All patients were reviewed at two weeks
to assess wound healing, discuss the results of the
biopsy, and arrange any necessary specific treatment.
Prior to attending the clinic, all patients in the
resistant AGW study were advised to apply Betadine
antiseptic ointment (povidone-iodine 10% w/w, Napp Labo¬
ratories, Cambridge, England) to the clinically affected
areas, as the clinician responsible for the care of the
patients felt that this enhanced the clearance rate of
the lesions. Local anaesthesia was first achieved by
applying Emla cream (2.5% lignocaine with 2.5% prilo-
caine, Astra Pharmaceuticals, Kings Langley, England) to
the area and waiting for 20 minutes. One percent ligno¬
caine (without adrenaline) was then infiltrated beneath
the warts with a 26 gauge disposable needle (B-D Micro-
lance, Becton, Dickinson & Co, Dun Laoghaire, Co. Dublin,
Eire) . The warts were then removed by diathermy using a
Surgitron STW-60 (Meditronix Ltd, Spain) machine with
removable 5mm diameter loops (Figure 5) . Specimens were
placed immediately in PBS for subsequent DNA analysis,





Removal of perianal warts by the electrodessicator
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5.2 Urethral specimens
In initial experiments in which urethral specimens were
H Q Q C
collected by the use of a brush ' it was found that,
although this method provided adequate samples, it caused
too much distress for the patient, and occasionally was
associated with the subsequent development of a sterile
urethritis. Furthermore, since the PCR was being used,
only small samples of the urethral epithelium were neces¬
sary. The 10/il loop (Figure 6) normally used to investi¬
gate for the presence of urethritis in men was the first
sampling method tried. However, as will be seen in the
Results section, it was felt initially that this method
failed to provide adequate samples, and a cotton wool
swab (Figure 6) was used subsequently. The particular
type of cotton wool swab chosen was "STD-Pen for Males"
(Abbott Laboratories, Chicago, Illinois, USA), as these
swabs had been used within the clinic for a considerable
period of time for the detection of CL_ trachomatis, and
had proved to be acceptable to patients. Although it is
generally recommended that the swab be inserted 4cm into
urethra, patients rarely tolerated insertion beyond 2cm.
Samples were taken with gloved hands, carefully avoiding
touching the glans penis, and immediately afterwards
inserting the swab into a disposable, sterile container
for subsequent processing. When biopsy specimens were
taken at the same time, either a different member of




Swab and loop used in urethral sampling
8-4
5.3 Urine specimens
Urine specimens are normally provided as part of the "two
glass urine test" and their provision is well accepted by
patients. For the studies documented in this thesis, the
first 10ml of voided urine were collected directly into a
sterile, disposable universal container.
5.4 "Superglue" (SG) specimens
In the multifocal study, superficial layers of skin were
sampled by using "Superglue" (SG) cyanoacrylate glue
miwr
(Bison , Perfecta Chemie B.V., Goes, Holland) (Figure
7). One drop of SG was placed on a clean slide which was
immediately applied to the skin. After one minute, the
slide was gently removed (Figures 8 and 9) , and placed
in an individual slide box. This procedure was well
tolerated by patients. If possible, SG samples were taken







Removal of Superglue slide
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Figure 9
5.5 Other specimen types
Further specimens types were taken from patients in the
multifocal study in the conventional manner as follows:
Ayre1s spatulas for cervical scrapes and cytological
brushes ("Cytobrush", Rocket, London, UK) for endocervi-
cal specimens. Anal samples were obtained by inserting a
Cytobrush 1cm into the anal canal and rotating it through
360°. Tongue depressors were drawn along the buccal
surface of both sides of the mouth to obtain buccal
scrapes. The tips of the sampling instruments used in the
aforementioned procedures were broken off into individual
disposable bottles containing 10ml of phosphate buffered
saline (PBS). A vaginal sample was obtained by washing
the vaginal walls and cervix with 10ml of one normal
saline using a sterile syringe, aspirating the fluid and
repeating the procedure. Blood was obtained using the
"Vacutainer" (Becton Dickinson, Cowley, UK) system.
6. Laboratory processing of specimens
The laboratory processing of the specimens was performed
in a Class 1 microbiological safety cabinet (Medical Air
Technology Ltd., Manchester, UK) and the area where the
PCR equipment was assembled was kept physically separate
from that where amplification was performed and the PCR
products were identified. Equipment was not moved between
these areas. Positive displacement pipettes with disposa¬
ble tips or single-use Pasteur pipettes were used for
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distributing reagents for the PCR and for adding the DNA
samples to the reaction mixtures. All reagents were
autoclaved prior to use and mixed prior to distribution
to the tubes, to minimise opening and manipulation. HPV-
positive and HPV-negative controls were included in each
experiment and not brought into the area where equipment
was assembled. Laboratory staff were unaware of the
clinical status of the patients.
7. Processing of histological specimens
Specimens sent to the histopathology department were
processed routinely and stained with haematoxylin and
eosin. Staining with the periodic acid Schiff method was
additionally used for specimens in which a histopatholog-
ical diagnosis of nonspecific dermatosis (NSD) was made.
All specimens were reviewed by one histopathologist (Dr
Marjorie Walker, Senior Lecturer in Histopathology, St
Mary's Hospital Medical School, London). The histopatho-
logical criteria used for the diagnosis of viral warts555
were the presence of koilocytes and at least one of the
following: individual cell keratinization, giant cell
formation or hyperkeratosis. Acanthosis was not regarded
as being helpful in the diagnosis of wart virus infec¬
tion. Standard histological criteria for the diagnosis of
other dermatological conditions were used360.
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8. DNA extraction
In order to break up the tissue, each biopsy specimen was
placed in a sterile Eppendorf tube with 160/1.1 of 2 x
Summers' buffer, 164/tl of lysis mixture (Appendix V) and
three sterile glass beads and vortexed for lmin.
SG slides were abraded with a sterile disposable scal¬
pel blade and the resulting material immersed in I6O/1I of
2 x Summers' buffer and 164/il of lysis mixture. The
sodium dodecyl sulphate (SDS) in the lysis mixture dis¬
solved the cyanoacrylate in the specimen, releasing the
sample material from the specimen.
DNA was extracted from the biopsy and SG specimens by
protease/SDS lysis, followed by phenol extraction and
ethanol precipitation using a modification of standard
procedures361. To achieve this, the specimens as prepared
above were incubated overnight at 37°C to enable the
protease to inactivate proteins and the SDS to bring
about cell lysis. After incubation, phenol/chloroform
extraction was carried out to remove inactivated proteins
and cellular debris, using 320/^1 of Tris EDTA equilibrat¬
ed phenol (Appendix V). After centrifuging the samples at
14,000 rpm for 1 minute (Microcentaur, MSE, Fisons,
Loughborough, UK) , the upper, aqueous phase was trans¬
ferred to sterile Eppendorf tubes and the phenol extrac¬
tion step repeated. Next, 320/xl of 1:24 iso-amyl alcohol
in chloroform were added to the samples and, after cen¬
trifuging the samples at 14,000 rpm for 1 minute, the
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upper, aqueous phase was transferred to sterile Eppendorf
tubes. Twice the volume of ethanol (64 0/nl) and one-tenth
the volume (32/^1) of 5M NaCl were then added to the
samples. To enable efficient precipitation of the DNA to
occur, the samples were then frozen at -70°C for 1 hour,
after which they were centrifuged for 10 minutes at
14,000 rpm. The supernatant fluid from each sample was
discarded, and 200/xl of 70% ethanol was added to each
pellet. These were then centrifuged at 14,000 rpm for 5
minutes to further precipitate the DNA. After discarding
the supernatant, the pellets were dried in a vacuum
desiccator for 30min, to remove all traces of ethanol.
Once dried, the DNA pellets were resuspended in 40/xl of
double distilled water (ddE^O) and stored at -70°C until
DNA analysis could be performed.
Urethral swabs ana loops, cervical and buccal scrapes
and Cytobrush specimens were agitated in 10ml of PBS.
Vaginal washes were tested directly. All these samples
were subsequently denatured by heating to 95°C for iOmin
and then centrifuged at 14,000rpm for 2min to remove
cellular debris and other extraneous material. The super¬
natant fluid was then used for the PCR. Urine specimens
were centrifuged at 3000 rpm for 10 minutes, the superna¬
tant fluid discarded and the deposit kept. This was then
resuspended in 160^1 2 x Summers buffer. Blood samples
were centrifuged at 2000rpm for 5 minutes and the serum
decanted. This was used directly for the PCR.
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9. Detection of fi-qlobin gene
Only SG specimens containing human DNA were analysed for
the presence of HPV DNA. In order to determine whether
human DNA was detectable in the SG samples, part of the
human E-globin gene was amplified. Amplification was
carried out using 100/a1 of reaction mixture containing
5 OmM KCl, lOmM TRIS-HC1 pH 8.3, 0.01% w/v gelatin, 200/j.M
each of dATP, dCTP, dGTP and dTTP, 3.5mM MgCl2, 2.5 units
of Tag polymerase (GIBCO-BRL, Paisley, Scotland) and
0.2fiN each of two S-globin primers362 (Appendix V) . The
specimens were then subjected to 40 cycles of amplifica¬
tion. Each cycle included denaturation at 94 °C for 3 0
sec, primer annealing at 55°C for 30 sec and chain elon¬
gation at 72°C for 60 sec. Positive controls were a
fibroblast cell line derived from embryonic lung tissue
(MRC-5) (Medical Research Council, Clinical Research
Centre, Harrow, Middlesex, UK) and an epithelial cell
line derived from cervical carcinoma tissue (HeLa-229).
Double distilled water (ddH20) was used as a negative
control.
10. Analysis of DNA
10.1 Restriction enzyme digestion
The presence of HPV DNA was confirmed by Southern blot¬
ting of Bam HI restriction enzyme digested cellular
DNA . Twenty microlitres of each DNA-extracted sample
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were made up to a total volume of 25^1 with 10 units Bam
HI (GIBCO-BRL Life Technologies, Uxbridge, Middlesex,
UK) , sterile ddH20 and 10 x restriction buffer (Northum-
bria Biologicals Limited, Cramlington, Northumbria, UK) .
This was incubated for 1 hour at 37°C and then 4/xl of
dye (bromophenol blue/xylene cyanol in 40% glycerol) were
added. Dye was used to make the DNA visible and to in¬
crease its density, thus ensuring that the DNA remained
in the wells. Near full length genomic probes to HPV
6,11,16, and 18 were used as positive controls, together
with Caski cells (containing integrated full length HPV
16) and HeLa cells (fragments cf integrated HPV 18). The
human fibroblast cell line, MRC-5 , was used as the
negative control.
10.2 Polymerase chain reaction
Sequences within the LI open reading frame were chosen
for amplification, as they are known to be generally
conserved, but have sufficient divergence to allow dis¬
crimination between HPV types 6,11,16,18,31 and 33.
General primers GP5 and GP6 were used^^ (Appendix V)
which allow the amplification of specific areas of the LI
genome, depending upon the HPV type under investigation.
10 7
One hundred microlitres of the PCR reaction mixture
(Appendix V) were added to 50-100ng of DNA extracted from
the sample under investigation. This was then overlaid
with approximately 10 0 fxl of mineral oil to prevent evapo¬
ration, and subjected to 40 cycles of amplification using
a thermal cycler (Hybaid, Teddington, Middlesex, UK) .
94
Each cycle comprised denaturation at 94 °C for 20 sec¬
onds, primer annealing at 40°C for 1 minute and chain
elongation at 72 °C for 20 seconds. Samples containing
lOOpg of near full length genomic probes of HPV types
6,11,16 and 18 (Appendix V) were used as positive con¬
trols. Negative controls were a human fibroblast cell
line (MRC-5) and ddH20.
10.3. Separation of DNA fracrments by gel electrophoresis
The separation of the DNA fragments was carried out by
agarose gel electrophoresis, the percentage of agarose
gel used depending on the size of the DNA fragments
needing to be separated.
DNA fragments generated by Bam HI digestion (i.e. the
linearised whole genomes of the HPVs, approximately 7950
base pairs long) were separated. This was done on a 1%
agarose gel with 1 x Tris-Borate EDTA (TBE) buffer
(Appendix V) as the electrophoresis buffer, 10mA for
approximately 16-20 hours, followed by ethidium bromide
staining for 10 minutes to enable the fragments to be
detected. Ethidium bromide was used because it binds
irreversibly to DNA, and the product fluoresces bright
orange in ultraviolet light.
DNA fragments generated by the PCR were separated
using a 2% agarose gel made in TBE buffer, with 1/nl
ethidium bromide added, and run at 150V and 80mA for 45-
60 minutes using 1 x TBE as the electrophoresis buffer.
0X174 DNA (BRL, England) cut wich the enzyme Hae III
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(GIBCO-BRL Life Technologies, Uxbridge, Middlesex, UK)
was used to produce molecular weight markers between 72
and 1352 base pairs long.
After separating the DNA fragments, the agarose gel was
gently agitated for 30 minutes at room temperature in a
solution containing 1. 5M NaCl and 0. 5M NaOH in order to
denature the DNA, and then neutralised for 60 minutes in
a solution containing 1.5M NaCl, 0.5M Tris pH 7.5 and ImM
EDTA.
10.4. Transfer of DNA on to nylon membranes by Southern
blotting
Southern blotting was performed using a modification of
*2 C. "] _
standard protocols . DNA was transferred onto Gene
TM
Screen Plus nylon membrane (NEN Research Products,
Dupont, Wilmington, DE, USA) by the capillary blot
procedure, using 6 x SSC (0.9M NaCl with 0.09M sodium
citrate) as the transfer buffer. The Southern blot was
run overnight to allow adequate transfer from the gel to
the membrane. After removing the membrane from the South¬
ern blot, it was allowed to dry at room temperature to
rPMenable DNA to bind to the membrane (Gene Screen Plus
membranes consist of positively charged nylon membranes
which do not require baking to fix the DNA).
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10.5 Labelling of the probes, hybridisation and autora¬
diography
In the resistant anogenital warts study, near full-length
probes for detection of HPV types 6, 11, 16 and 18 were
used for the analysis of the restriction enzyme and PCR
products and so prehybridisation of the membranes used
was carried out at 65°C for 2 hours, using prehybridisa¬
tion mixture (Appendix V). In all other studies, oligonu¬
cleotide probes were available and so prehybridisation of
the membranes was undertaken at 55°C for 2 hours.
10.5.1 Random priming method
This method was used to label near full-length genomic
HPV probes of HPV types 6,11,16 and 18 (Appendix V) ,
which have sequences complementary to the DNA fragments
generated by restriction enzyme digestion and by the PCR.
The procedure involves the generation of a labelled,
complementary DNA strand to the original full length HPV
genomic probe by the action of a DNA polymerase. This
labelled strand then binds to complementary sequences on
the DNA specimen being evaluated.
TM
The Amersham Multiprime DNA labelling system (Amer-
sham International PLC, Aylesbury, Bucks, UK) was used.
lOOng of genomic probe were used per membrane, made up to
12^1 in ddH20, and denatured by heating at 97°C for 2
minutes. Random priming mix (Appendix V) was then added
to the probe and incubated for a minimum of 1 hour.
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Incorporated P-dCTP-labelled probe was then separated
from unincorporated 32P-dCTP (S-emitter, half-life 14
days) by running the reaction mixture through a Sephadex
G50 column (Pharmacia LKB Biotechnology, Sweden). Twenty
fractions of the reaction mixture were collected. Two
peaks of activity are usually found, the first represent¬
ing the labelled probe, and the second, the unreacted
"3 9P-dCTP. Those fractions of the reaction mixture which
emitted over 2,000 counts/second on the radiation detec¬
tor (Mini monitor 5-10 E, Mini Instruments Ltd, Essex,
UK) were pooled and subsequently used.
The probe was then denatured by adding 1 /^th volume of
1M NaOH and left to react for 10 minutes, followed by
neutralisation with the addition of 1/5th volume of 1M
Tris pH 7.5 and ly^th volume of 1M HCl . Finally, the
probe was mixed with the hybridisation mixture, and
allowed to react with the complimentary HPV DNA sequences
of the specimens under investigation on the membranes for
16-24 hours at 65°C.
Once hybridisation was completed, the membranes were
washed once with 2 x SSC/ 0.1% SDS at 65°C for 1 hour
and once with 0.1 x SSC/0.1% SDS at 65°C. This first wash
was of low stringency, thus removing non-specifically
bound, labelled material. The second wash was of high
stringency and removed all except probe bound to com¬
pletely complementary DNA in the specimen, thus allowing
differentiation between HPV types 6,11,16 and 18. The
membranes were then subjected to auto-radiography for
approximately 24 hours on Kodak X-OMAT S X-ray film
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between intensifying screens at -70°C and the films
developed using an automated developing machine (IGP Diirr
Medicine 430, Germany).
10.5.2 End-labelling method
Full-length genomic probes were not available for HPV
types 31 and 33, and the technique of end-labelling was
used to label the oligonucleotide probe complementary to
the products generated by PCR amplification.
Ten micromoles of the HPV 31 and 33 oligonucleotide
probes (1/xl per membrane) were added to the end-labelling
mixture (Appendix V) in a 1.5ml screw-capped Eppendorf
tube. The reaction mixture was incubated at 3 7°C for 1
hour, and then the 22P-cLATP-labelled probe was separated
from unincorporated 22P-dATP by adding 40/xl ddK20, 240/xl
5M ammonium acetate and 750/zl ice cold ethanol, and
incubated at -70°C for 30 minutes. This solution was then
centrifuged at 14,000 rpm for 10 minutes at 4°C and 1ml
of ice cold 80% ethanol was added to the pellet, which
contained the 22P-aATP-labelled probe. After the second
precipitation step, the pellet was redissolved in 200^1
ddH20 and added to the prehybridisation mixture (Appendix
V) , and the membranes were allowed to hybridise for
approximately 24 hours at 55°C. On completion of the
hybridisation, the membranes were washed twice with 2 x
SSC/0.1% SDS at room temperature for 5 minutes (low
stringency washes) and once with 2 x SSC/0.1% SDS at
55°C (high stringency wash) for 5 minutes. The membranes
were then auto-radiographed for approximately 24 hours on
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Kodak X-OMAT S X-ray film between intensifying screens at
- 70 0 C.
10.6 Re-hybridisation of DNA
As Gene Screen Plus™ membrane is not allowed to dry
completely (otherwise irreversible binding of probe may
result) , the membranes were incubated at 45°C for 30
minutes in 0 . 4M NaOH to remove both the bound oligonu¬
cleotide and full length genomic HPV probes. They were
then neutralised at 45°C for 30 minutes in a solution
containing 0.1 x SSC, 0.1% SDS and 0.2 M Tris pH 7.5.
Then it was possible to rehybridise the membranes with




1. GENITAL DERMATOSIS STUDY
1.1 Clinical features of the patients
One hundred men were recruited for this study. The age
range of the men was 18.6 to 68.6 years (mean 35.9
years). Seventy-five were Caucasian, 10 Afro-Caribbean
and 15 of other racial origins. Eighty-five of the men
were heterosexual, 11 homosexual and 4 bisexual. The men
admitted to a range of 1 to 1,000 (median 20) life-time
sexual partners. No men had typical genital warts at the
time of biopsy. Twenty men were circumcised, 6 9 were not
and this information was not recorded in 11 cases. Nine¬
teen men gave a history of anogenital warts, 76 did not,
and this information was not recorded in 5 cases.
The lesions had been noticed by the men over a range of
1 to 180 months (mean 31 months) . At the time of sam¬
pling, the predominant location of the dermatosis was on
the glans penis in 44 of the men, coronal region in 12,
frenulum in 2, foreskin in 14, shaft in 26 and scrotum in
2. The histological diagnoses of the biopsy specimens are
shown in Table 1.
1.2 Detection of HPV in relation to specimen type and to
histopatholocrical findings
HPV DNA was detected in one or more biopsy, swab or urine
specimens from 39 patients. Examples of this are shown in
Figures 10 and 11. The histopathological findings in the
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biopsy specimens in relation to the HPV types detected in
the three types of specimen are shown in Table 2. The
relation between HPV type detected, specimen type and
histopathological findings is presented in Tables 4 and
5 .
1.3 HPV in biopsy specimens
HPV DNA was detected in 29 of 100 biopsy specimens (Table
3). Seven (28%) of 25 biopsies from the glans, 3 (30%) of
10 from the corona, 1 (50%) of 2 from the frenulum, 9
(29%) of 31 from the foreskin, 8 (27%) of 30 from the
shaft and 1 (33%) of 3 from the scrotum contained HPV
DNA. Of the 20 circumcised men, 7 (35%) had HPV DNA in
their biopsy specimens, that is 3 (33%) of 9 from the
glans and corona and 4 (36%) of 11 from elsewhere on the
genitalia. Of the 69 uncircumcised men, 18 (26%) had HPV
DNA in their biopsy specimens, that is 5 (31%) of 13
from the glans, none of 6 from the corona, 1 (50%) 2 from
the frenulum, 9 (29%) of 31 from uhe foreskin and 3 (18%)
of 17 from elsewhere on the genitalia.
Of the 22 men who had histological evidence of typical
HPV infection, 6 (27%) had a history of anogenital warts;
of the 12 men who had histological evidence of neoplasia,
4 (33%) had a history of anogenital warts; of the 66 men
who had no histological evidence of either typical HPV




Agarose gel - penile dermatosis study














Ethidium bromide staining of PCR followed by agarose gel,
with positive controls (HPV types 6,11,16 and 18), nega¬
tive controls (MRC-5 fibroblasts and ddE^O), molecular
weight marker (<£X174) and specimens of DNA from biopsies
(BX) , swabs (S) and urine (U) . Samples BX-2a and BX-2b
are from two different sites on the scrotum of one pa¬
tient. Positive results are seen with samples BX-4, S-4,






























Southern blot - penile dermatosis study
Hybridisation of PCR products with HPV type ll-specific
probe on nylon membrane following Southern blot with
positive control (HPV type 11) , negative controls (HPV
types 6, 16 and 18, MRC-5 fibroblasts and dd^O) , molecu¬
lar weight marker (0X174) and specimens of DNA from
biopsies (BX) , swabs (S) and urine (U) . Positive result
are seen with HPV type 11 control, BX-4, S-4, BX-5, BX-6
and U-6.
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HPV DNA was detected in 32% of biopsy specimens with
histological evidence of typical warts, 83% of specimens
with neoplasia and 18% of specimens in which histological
evidence of either change was absent (Table 4) . The
detection of HPV DNA in urethral swab and urine specimens
did not vary substantially between those men with and
without histological evidence of HPV infection (Tables 5
and 6).
Wart specimens were associated most frequently with HPV
DNA types 6 or 11, specimens showing neoplasia most
frequently with type 16 and specimens having other histo-
pathological changes with a variety of HPV types, most
commonly HPV types 11 and/or 18 (Table 4) . Of particular
note, all three basal cell papillomata were associated
with HPV type 6 (Table 2).
Infection with two or more HPV types was found in 7
(24%) of 29 biopsy specimens containing HPV DNA (Table
5) .
1.4 HPV in urethral swab specimens
Urethral swab specimens were obtained from 8 5 men. Of
these specimens, 21 (25%) contained HPV DNA (Table 3).
HPV DNA was more commonly detected in urethral speci¬
mens from men with histological evidence of neoplasia
than from men with histological evidence of warts or
other histological abnormalities (Table 4). HPV type 18
was the type most frequently detected in urethral swab
specimens. Infection with more than one HPV type was
found in approximately one-third of the swab specimens in
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which HPV DNA could be detected (Table 3).
1.5 HPV in urine specimens
Urine specimens were obtained from 59 men. Of these
specimens, only 6 (10%) contained HPV DNA (Table 3).
HPV DNA was not detected in urine specimens from men
with histological evidence of warts, and only a small
proportion of those with neoplasia or other histological
abnormalities (Table 4) . HPV type 18 was the type most
frequently detected in urine specimens. Infection with
more than one type occurred on one occasion (Table 5).
1.6 Association between presence or absence of HPV and
type of specimen
A correlation between biopsy and swab and between biopsy
and urine was less obvious than between swab and urine
findings (Table 7). Ten (28%) of the 36 patients with HPV
present in biopsy or urethral swab specimens had at least
one HPV type in common.
1.7 HPV in relation to possible risk factors and demogra¬
phic details
The proportion of biopsy, urethral swab and urine speci¬
mens containing HPV are given in relation to various
possible risk factors and demographic details in Table 8
and Table 9. Although the numbers are too small for a
valid statistical analysis, there is a suggestion that
infection with HPV is more common in men admitting to at
least 20 lifetime sexual partners than those with fewer
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partners, and in those with a history of AGW compared
those without. An association between HPV infection
other factors is less clear.
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Table 1 Histopathological diagnoses of biopsy specimens
from 100 men with genital dermatoses
Category Histopathological diagnosis No. of patients
Wart Typical wart virus infection 22













ma annulare, plasma cell balanitis, lentigo, venous haemangioma,
sebaceous cyst wall, molluscum contagiosum, folliculitis and
drug rash.
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Table 2 HPV DNA types detected in relation to histonatholooical
findings of biopsy specimens from men with genital dermatoses
HPV DNA types detected in indicated specimens
Histo-
pathological Urethral
findings Biopsy swab Urine
Wart 6, 11 6, 11, 18 ns
Wart 6 - -
Wart 18 - -
Wart 6 - -
Wart 6, 11 ns ns
Wart 16 11. 18 ns
Wart 6, 11 - -
Wart - 18 -
Wart - 33 -
Neoplasia
Basal cell papilloma 6 6 ns
Basal cell papilloma 6 - -
Basal cell papilloma 6 - -
Dysnlastic wart 16 - -
PIN* 1 6 - -
PIN 2 - 18 18
PIN 2 + wart 16 ns ns
PIN 2 16 18 ns
PIN 2 6 - -
PIN 3 16 - ns
PIN 3 16 16 ns
Other
NSD 18 - ns
NSD 18 18, 31 -
NSD 6, 11, 18 18, 33 ns
NSD 18 - -
NSD ]1, 18 11 ns
NSD - - 16
NSD - 33 33
LS 11, 16 11, 18 ns
LS 18 6 , 11 ns
LS - 18, 31 ns
LS 11 11 11, 18
LS - 18 -
LS 31 - -
Lichen planus 31 ns ns
Lichen planus 16 16 -
Psoriasis - 18 18
Psoriasis 11, 18 11, 31 ns
Plasma cell balanitis - - 6
Venous haemangioma - 6
- = no HPV DNA detected; ns = no specimen obtained; PIN = penile
intraepithelial neoplasia; NSD = non-specific dermatosis; LS =
lichen sclerosus
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rable 2 H?V in relation :s tvoe of specimen f:
wirh genital dermatoses
Nc. of specimens of indicated type
oositive for HPV
Urethral
HPV cvoe Biccsy swab Urine
!n=100) (n=85) :o===l
Figures in brackets are expressed as percentages of all that
particular specimen type containing any HPV UNA
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Table 4 HPV in relation to histopatholoaical findings of
biopsy specimens from men with genital dermatoses
No. (%) of men with specified HPV
type in given specimen according
to histopathological diagnosis
HPV type Wart Neoplasia Other
(n=22) (n=12) (n=66)
Any type in biopsy specimens 7 (32) 10 (83) 12 (18)
urethral swab specimens 4 (21*) 4 (36*) 13 (24*)
urine specimens 0 1 (14*) 5
/ * ,
(13 )
any specimen 9 (41) 11 (92) 19 (29)
Type 6 in any ;specimen 5 (23) 5 (42) 4 (6)
Type 11 in any specimen 4 (18) 0 6 (9)
Type 16 in any specimen 1 (5) 5 (42) 2 (3)
Type 18 in any specimen 4 (18) 2 (17) 12 (18)
Type 31 in any specimen 0 0 5 (8)
Type 33 in any specimen 1 (5) 0 2 (3)
>1 type in any specimen 4 (16) 1 (8) 8 (12)
*urethral swab and urine specimens were not obtained from all
men. The figures in these instances refer to those men from whom
urethral swab or urine specimens were taken.
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Table 5 HPV in relation to type of specimen from all men
with genital dermatoses
No. of specimens positive for indicated type
Urethral
HPV type Biopsy swab Urine
(n=100) (n=85) (n=59)
Any HPV 29 21 6
6 11 (38)* 4 (19) 1 (17)
11 8 (27) 7 (33) 1 (17)
16 7 (24) 2 (9) 1 (17)
18 9 (31) 11 (52) 3 (50)
31 2 (7) 3 (14) 0 (0)
33 0 (0) 3 (14) 1 (17)
>1 type 7 (24) 8 (38) 1 (17)
Figures in brackets are expressed as percentages of all that
particular specimen type containing any HPV DNA
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Table 6 HPV in relation to type of specimen from men
with genital dermatoses and no histological
evidence of HPV infection
No. of specimens positive for indicated type
Urethral
HPV type swab Urine
(n = 55) (n=3 9)
Any HPV 13 5
6 2 (15)* 1 (20)
11 5 (38) 1 (20)
16 1 (18) 1 (20)
18 6 (46) 2 (40)
31 2 (15) 0
33 3 (23) -L (20)
>1 HPV type 5 (38) 1 (20)
Figures in brackets are expressed as percentages of all that
particular specimen type containing any HPV DNA
Table 7 Correlation between presence (+) or absence (-) of HPV







s + 13 8 U + 1 5 U + 4 2 0
w r r
a 13 51 - 12 41 3. 6 46 "1-L
b n n
ns 3 12 e ns 16 25 e ns 11 16 14
ns = no specimen obtained
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Table 8 HPV in different specimens in relation to possible
risk factors of men with genital dermatoses
Proportion (percentage) of specimens of






<35 years old 17/57 (30) 13/45 (26) 5/32 (16)
2:35 years old 12/43 (28) 8/36 (22) 1/27 (4)
Heterosexual 2S/85 (33) 16/72 (22) 4 /4 8 (8)
Bi/homo sexua1 1 /15 (7) 5/l3 (38) 2/ll (18)
Caucasian 20/75 (27) 16/67 (24) 4 /4 6 (9)
Non Caucasian 9/25 (36) 5/l8 (28) 2/l3 (15)
a20 partners 16/45 (35) 14/44 (32) 5/30 (17)
<20 partners 9/39 (23) 5/37 (14) 1/28 (4)
C^ never used 10/2 9 (35) 6/2b (21) 1/17 (6)
C^ sometimes used 11/44 (25) 1 °/3 9 (26) 3/28 (11)
C* always used 2/ll 1(18) 3/ll (27) 3/9 (11)
Smoker 14/39 (36) 9/37 (24) 2/20 (10)
Non-smoker H/44 (25) 9/42 (21) 4/36 (11)
History^ 9/19 (47) 6/l7 (35) Vs 1(12)
No history^ 19/76 (25) 14 / 64 (22) 5/49 (10)
proportion for each possible risk factor: number of men with
that specimen type containing HPV DNA, expressed as a proportion
of all men with that risk factor and whose HPV status for that
specimen type was known.
^history of anogenital warts given by patient
C'1 condoms
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Table 9 HPV in different combinations of specimens in relation
to possible risk factors of men with genital dermatoses
Proportion* (percentage) of specimens of
indicated specimen types positive for HPV
Possible Biopsy, swab or Urethral swab
risk factors urine or urine
<35 years old 24 /57 (42) 14 /4 9 (29)
a35 years old 15/43 (35) 9/37 (24)
Heterosexual 34/85 (40) 18/73 (25)
Bi/homosexual 5/l5 (33) 5/13 (38)
Caucasian 28/75 (37) 20/75 (27)
Non Caucasian 11/25 (44) 9/25 (36)
s20 partners 22/45 (49) 1-5/44 (44)
<20 partners 12/39 (31) 6/32 (19)
C^ never used 12/29 (41) 6/28 (21)
C^ sometimes used 16/44 (36) 11 /4 0 (28)
C^ always used 4/ll (36) 4/H (36)
Smoker 16/39 (41) 14/39 (36)
Non-smoker 17/44 (39) H/44 (25)
History^ IO/19 (53) S/19 (47)
No history^ 26/76 (37) 19/76 (25)
proportion for each possible risk factor: number of men with
that specimen type containing HPV DNA, expressed as a proportion
of all men with that risk factor and whose HPV status for that
specimen type was known.
^history of anogenital warts given by patient
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2. RESISTANT ANOGENITAL WARTS STUDY
2.1 Clinical features of the patients
One hundred and sixteen men were recruited for this
study. The age range of the men was 16.1 to 61.6 years
(mean 28.6 years). Fifty-four (46.6%) of the 116 men were
homosexual, 50 (43.1%) heterosexual, 7 (6.0%) bisexual
and 5 (4.3%) were of unspecified sexual orientation. This
distribution of sexual orientations was characteristic of
the clinic from which the study group was chosen. A
history of other previous sexually transmitted diseases
was given by 51 (44.0%) of the men. Two (5.9%) of 34 men
who had undergone testing for the human immunodeficiency
virus within three years prior to sampling of their warts
were found to carry antibody. Information concerning
number of sexual partners, whether or not they smoked,
ethnicity and condom usage was not obtained from these
men.
The men had been aware of their warts for an average of
18.1 months (range 0.5 to 120 months) prior to undergoing
biopsy. Histological assessment was performed on a random
samples of 54 (46.6%) of the biopsy specimens, and all
were found to have changes consistent with wart virus
infection. None of the specimens showed evidence of
dysplasia. The clinical appearance of the warts was
described as classical condylomata acuminata in 94
(81.1%) of the men, planar in 10 (8.6%), hyperkeratotic
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in 26 (22.4%), mixed type in 13 (11.2%) and pigmented in
one.
At the time of sampling, warts were seen at the meatus
in 7 (6.0%) of the men, the glans in 10 (8.6%), coronal
region in 10 (8.6%), foreskin in 8 (6.8%), shaft in 26
(22.4%), scrotum in 4 (3.4%), inguinal region in 5
(4.3%), perineal area in 3 (2.6%), perianal area in 78
(67.2%) and intra-anal site in 14 (12.1%).
2 .2 HPV in biopsies from anocrenital warts
HPV DNA was detected in 112 (96.5%) of 116 wart speci¬
mens. Types 6 and 11 were the most common (84.8% and
82.1%, respectively) and types 31 and 33 the least common
(0.9% and 2.7%, respectively) (Table 10). Infection with
two or more types of HPV was found in 84 (72.4%) of the
warts. The commonest multiple infection was with types 6
and 11, which occurred together in 58 (50.0%) of the men
and in combination with other HPV types in a further 21
(18.1%) men. HPV type 6 was found in 83 (99%) of the 84
multiple infections and type 11 in 79 (94%) of such
infections.
The distribution of HPV type found in the warts did not
vary significantly with the site of the biopsy or age of
the patient (data not shown).
2.3 HPV in urethral swab specimens
Twenty-two (19.0%) of the 116 urethral swabs contained
HPV DNA. The detection rate did not vary with sexual
orientation. Again, types 6 and 11 were the most common,
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but type 16 was detected relatively more often than it
was in the warts (Table 10). Fourteen (63.3%) of the 22
swabs contained a single HPV type. Multiple HPV types
were found in 8 (36.3%) of the swabs in which any HPV DNA
could be detected. HPV type 6 was found in 7 (87.5%) of
the 8 swabs containing more than one type, and HPV type
11 in all 8. HPV type 16 was the most common single HPV
type detectable, being found in 7 (50%) of the 14 swabs
in which only one HPV type was found.
2.4 HPV in urethral loop specimens
HPV DNA was detected in 11 (61.1%) of the 18 urethral
loop specimens. The detection rate did not vary with
sexual orientation. Whether the loop or swab specimen was
taken first had no appreciable effect on the rate of
detection. The distribution of HPV types was similar to
that seen with the swab specimens (Table 10). In 5
(27.8%) of 18 specimens there was evidence of a single
HPV type, which was HPV type 16 in all cases. Of the 6
loop specimens in which multiple HPV types were detected,
HPV type 6 was always present and HPV type 11 found in 5
(83.3%) .
Of the 11 men who had HPV-positive loop samples, only 5
had urethral swab specimens that were also HPV-positive.
In all cases where both loop and urethral swab specimens
contained HPV, at least one HPV type was common to both
specimens.
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2.5 HPV in urine specimens
HPV DNA was detected in only 1 (6.7%) of 15 urine samples
tested. This was found to comprise HPV types 16 and 18.
The patient had only perianal warts and no history of
warts elsewhere. Analysis of the wart specimen revealed
HPV type 6 alone. No urethral loop sample was taken and
HPV DNA was not detected in the urethral swab specimen.
2 . 6 Association between location of warts at time of
biopsy and HPV detected in the urethra
The location of the visible warts in relation to the
results of HPV DNA detection in urethral specimens is
shown in Table 11. Six (85.7%) of the 7 men who had
clinically apparent meatal warts had HPV DNA detected in
their urethral swab specimens. Thereafter, it can be seen
that the further away visible warts were from the meatus
at the time of urethral sampling by swab or loop, the
smaller the proportion of urethral samples containing HPV
DNA. The association was not seen with loop samples, but
the number examined was small.
2 . 7 Association between HPV types detected in warts and
in the urethra
The relation between the location of warts and the HPV
type in the urethra is shown in Table 12. HPV types 6 or
11 were found in diminishing frequency in the urethra as
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the warts were located more distally from the urethral
meatus. In contrast, there appeared to be no such associ¬
ation for HPV types 16, 18, 31 or 33.
Of the 22 swab samples in which HPV DNA was detected,
10 (45.4%) had at least one type in common with the
corresponding warts. Furthermore, 6 (54.5%) of the 11
loop samples in which HPV DNA was detected had at least
one HPV type in common with the corresponding warts.
2 . 8 HPV in relation to possible risk factors and demo¬
graphic details
There was no clear association between age or sexual
orientation and the detection of HPV DNA in any sample
(Table 13) .
122
Table 10 HPV in relation to type of specimen from men
with anoaenital warts
No. of specimens positive for indicated type
Urethral Urethral
HPV type Biopsy swabs loops
(n = 116) (n=85) (n=18)
Any HPV 112 22 11
6 95 (85) * 9 (41) 5 (46)
11 92 (82) 10 (46) 5 (46)
16 10 (9) 8 (36) 6 (55)
18 20 (18) 6 (27) 4 (36)
31 1 (1) 2 (9) 1 (9)
33 3 (3) 2 (9) 1 (9)
>1 HPV type 84 (72) 8 (36) 6 (54)
^Figures in brackets are expressed as percentages of all that
particular specimen type containing any HPV DNA
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Table 11 Location of warts in relation to detection of urethral
HPV DNA from men with resistant anoaenital warts
"k 4f
Location No.of Swab with Loops with Total No.*
patients HPV DNA (%) HPV DNA (%) (%)
(n = 116) (n= 116) (n = 18)
Meatus 7 6//7 (85.7) 4/6 (66.7) 6 (85.7)
Glans 6 X/6 (16.7) 1/3 (33.3) 2 (33 .3)
Corona 6 4/6 (66.7) N.L. 4
Foreskin 4 °/4 N.L. 0
Shaft 19 1/19 (5.3) 2/3 (66.7) 3 (15.8)
Scrotum 2 o/2 1/1 1 (50)
Inguinal 2 °/2 N.L. 0
Perianal 67 10/67 3/5 (60) 13 (19.4)
Intra-anal 3 °/3 N.L. 0
*Location of clinically apparent warts seen nearest to the
urinary meatus at the time of biopsy
n = total number of patients or of samples taken
^
= total number of patients in each category with swabs or
loop specimens containing HPV DNA
•^Numerator signifies the number of samples with HPV DNA
detected in that particular group
N.L. = No loop sample taken
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Table 12 Location of warts in men with resistant anocrenital
warts in relation to urethral HPV type





6 or 11 16,18,
31 or 33
Meatus 6 6 (100) 5 (83)
Glans 2 2 (100) 1 (50)
Coronal 4 1 (25) 3 (75)
Shaft 3 1 (33) 2 (67)
Scrotum 1 0 1
Perianal 13 3 (23) 11 (85)
Location of clinically apparent warts seen nearest
to the urinary meatus at time of biopsy
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Table 13 HPV in different specimens in relation to possible
risk factors of men with resistant anogenital warts
Proportion (percentage) of specimens of






<27 yrs 61/61 (100) 60/61 (98) 10/61 (16) 6/g (67) 0/R (0)
2:27 yrs 53/55 (96) 52/55 (94) 12/55 (22) 5/g (56) 1/;L1 (9)
Hetero 48/5Q (96) 47/50 (94) 12/50 (24) 8/14 (57) 0/£) (0)
Bi/homo 61/gl (100) 60/61 (98) 9/gl (15) 2/3 (67) l/7 (14)
proportion for each possible risk factor: number of men with
that specimen type containing HPV DNA, expressed as a proportion
of all men with that risk factor and whose HPV status for that
specimen type was known.
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3. URETHRAL GONORRHOEA STUDY
3.1 Clinical features of the patients
One hundred men were recruited for this study. The age
range of the men was 17.0 to 55.6 years (mean 26.7
years) . Fifty-two of the men were Afro-Caribbean, 34
Caucasian, eight African and four from other racial
groups. Information on the ethnic origin of two men was
not available. Seventy-six of the 100 men described
themselves as heterosexual, 19 homosexual, and five
bisexual. The mean number of lifetime sexual partners was
43, with a range of 3 to 200; in addition, one bisexual
man claimed to have had 1000 lifetime sexual partners. A
history of genital warts was given by six of the men. One
of 85 of the men who gave blood specimens at the time of
presentation had serological evidence of syphilis. Fifty-
eight of the men were cigarett.e smokers. Of the 98 men
who provided information on condom usage, 27 claimed
always, 59 sometimes and 12 never to have used them.
3.2 HPV in urethral swab specimens
HPV was detected in 18 of 100 urethral swabs specimens.
HPV types 11, 16 and 18 were the most common (Table 14) .
Infection with more than one HPV type was found in 8
(44%) of the 18 urethral swabs containing HPV DNA (Tables
14 and 15) . DNA from HPV types 16,18 31 or 33 was found
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in 15 (83%) of 18 urethral swab specimens in which any
HPV DNA could be detected.
3.3 HPV in urine specimens
HPV was detected in 11 (12.5%) of 88 urine specimens. HPV
types 11 and 16 were the most common (Table 14) . Infec¬
tion with more than one HPV type was found in 3 (27%) of
the 11 urine specimens containing HPV DNA (Table 14 and
15) . DNA from HPV types 16,18 31 or 33 was found in 8
(73%) of 11 urine specimens in which any HPV DNA could be
detected.
3.4 HPV in relation to possible risk factors and demogra¬
phic details
The proportions of urethral swab and urine specimens
containing HPV are given in relation to various possible
risk factors and demographic details in Table 16. Al¬
though the numbers are small, there is a suggestion that
infection with HPV is more common in urethral swab
specimens taken from men less than 27 years old compared
to older men, heterosexuals compared to non-heterosexuals
and non-Caucasians compared to Caucasians. An association
between HPV infection and other factors is less clear,
however the numbers were too small for a valid statisti¬
cal analysis.
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Tab! p 14 HPV in relation to tvne of specimen from men
with urethral gonorrhoea
No. of specimens positive for indicated type
Urethral
HPV type swab Urine
(n = 100) (n=88)
Any HPV 18 11
6 5 (28)* 3 (27)
11 8 (44) 6 (54)
16 6 (33) 6 (54)
18 7 (39) 2 (18)
31 2 (11) 0
33 2 (11) 0
>1 HPV type 8 (44) 3 (27)
Figures in brackets are expressed as percentages of all that
particular specimen type containing any HPV DNA
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Table 15 Single and multiple types of HPV found in urethra
and urine of men with gonorrhoea
No. of specimens positive for indicated type
HPV tvoe Swab Urine
(n =18) (n=ll)
6 alone 0 0
11 alone 3 3
16 alone 3 3
18 alone 4 2
31 alone 0 0
33 alone 0 0
6 and 11 3 0
6, 11 and 16 1 3
6 and 18 1 0
11, 16 and 18 1 0
16, 18, 31 and 33 1 0
31, 33 1 0
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Table 16 HPV in different specimens in relation to possible
risk factors of men with urethral gonorrhoea
Proportion (percentage) of specimens of
indicated specimen type positive for HPV
Possible Urethral swab Urethral Urine
risk factors or urine swab
<27 years old 13 /55 (24) 10/55 (55) 5/50 (10)
a27 years old 12/45 (27) 8/45 (18) 6 /3 8 (16)
Heterosexual 2 2 / 7 6 (29) 16/76 (21) 10 /6 9 (15)
Ei/homosexual 3/24 (13) 2/24 (8) 2/l9 (5)
Caucasian 6/34 (18) 4/34 ( 12) 3 /2 8 (11)
Non-Caucasian 19/64 (30) 24/64 ( 22) S/58 (14)
a20 partners 6/33 (18) 4 /33 (12) 2/29 (7)
<20 partners 15/56 (27) 21/56 (20) 7/4 9 (14)
C^ never used 4/27 (15) 2/27 (7) 2 /25 (8)
C" sometimes used 20/59 (34) 15/59 (25) 8 /53 (15)
C^ always used 1/12 (8) 1/12 (8) 1 /7 (14)
Smoker 16/60 (27) 13/60 (22) 6/53 (11)
Non-smcker 9/36 (25) 5/3 6 (14) 5/31 (16)
*propcrtion for each possible risk factor: number of men with
that specimen type containing HPV DNA, expressed as a proportion
of all men with that risk factor and whose HPV status for that




4.1 Clinical features of patients
Nine women and 9 men took part in the study. All pa¬
tients were heterosexual. The mean age of the women was
24.0 years (range 16.1 years to 36.2 years) and that of
the men 28.4 years (range 22.9 years to 36.3 years) .
Clinical details of the patients are shown in Tables 17
and 18; there were 4 pairs of partners (F1-M3, F2-M8, F3-
M2 and F7-M9), the partners of the other patients not
being available for study. Patient F6 was referred by her
general practitioner because of a suspicion of genital
warts seen at the time of taking a cervical scrape. There
was no evidence of anogenital warts at the time of as¬
sessment in the clinic, but a papillary lesion noted in
the vagina was biopsied and found to be a skin tag. Apart
from this, all other biopsies taken from clinically
apparent warts were confirmed histologically as such.
Biopsy of acetowhite changes on the labia of patient F8
showed changes of HPV infection.
To facilitate interpretation of results, specimens were
divided into three groups. "Biopsy" specimens consisted
of biopsies from clinically abnormal and acetowhite
areas. "SG specimens" consisted of samples obtained using
the SG technique. The term "non-biopsy" is used to de¬
scribe all other types of specimens.
Examples of the results are shown in Figures 12 and 13.
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Figure 12
































Ethidium bromide staining of PCR followed by agarose gel,
with positive controls (HPV types 6,11,16 and 18), nega¬
tive controls (MRC-5 and ddH20), molecular weight marker
0X174 (0X174 DNA cut with Hae III enzyme) and specimens
of DNA from patient F3. Abbreviations for the specimen
descriptions:
SG = Superglue specimenBS
AW = specimen taken from
acetowhite area
LLMN = left labium minus




CS = cervical scrape
CW = cervical wart
W = external wart
RC = rectal cytobrush
P = perianal
Positive result seen for HPV controls, superglue speci¬
mens from the fourchette and perianal area, as well as an
acetowhite area on the left labium minus. Cervical






























Southern blot - multifocal study
Hybridisation of PCR products with HPV type 11-specific
probe on nylon membrane following Southern blot. Abbrevi¬
ations as for Figure 12, and:
G = glans
RLMJ = right labium majus
S = scrotum
SH = shaft
Positive result seen for HPV type 11 control, in addition
to superglue specimen from the scrotum of patient M2 and
the fourchette of patient F2.
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4.2 HPV in biopsy specimens
Biopsies were taken from warts and acetowhite areas in
women (Table 19) but only from warts in men. HPV DNA was
detected in 5 (83%) of 6 biopsy specimens, with histolog¬
ical evidence of HPV infection, from women (Tables 17 and
19) and in 7 (78%) of 9 from men (Table 20) . None of 4
biopsies of acetowhite areas in the women contained HPV
DNA, nor did the biopsy of the skin tag (Table 19) . Two
(25%) of 8 cervical biopsies contained HPV DNA, of which
one was histologically abnormal (Tables 17 and 19).
4.3 HPV in non-biopsy specimens
In women (Table 19), HPV DNA was detected in the follow¬
ing specimens: 4 (36%) of 11 cervical scrapes, 2 (25%)
of 8 from the urethra, 3 (37%) of 8 from the vagina, 2
(33%) of 6 from the rectum and 0 of 5 buccal scrapes.
Both cytologically abnormal cervices (Table 17) contained
HPV DNA.
In men (Table 20), HPV DNA was detected in the following
specimens: 3 (37%) of 8 from the urethra, 1 (12%) of 8
from the rectum and 0 of 5 buecal scrapes.
None of the serum samples (taken from all 9 men and 6
of the 9 women) contained HPV DNA.
4.4 HPV in "Superqlue" (SG) specimens
Forty SG samples were taken from women (Table 21) and 41
from men (Table 20) . Thirty-seven (92%) of those from
women and 18 (44%) of those from men contained the £-
135
globin gene. Of the samples containing the E-globin
gene, 18 (49%) from women and 9 (50%) from men contained
HPV DNA, detection rates which compare favourably with
those of non-biopsy procedures.
Of SG samples from acetowhite areas, HPV DNA was de¬
tected in those from the labia of 4 of 5 women (Tables 17
and 21) and in those from the glans of 2 of 4 men (Tables
18 and 20) .
Of the 6 men with shaft warts (Table 18) , HPV DNA was
detected in the shaft SG specimens of 4 of the 5 men
whose shaft SG wart specimens contained the 2-globin gene
(Table 20) . Similarly, HPV DNA was detected in the
fourchette SG samples from all 3 women with fourchette
warts who had this sample taken (Tables 17 and 21).
4.5 HPV in relation to sample site and time of sampling
Of the 12 possible sites in women (Tables 19 and 21)
from which samples could have been taken on each occa¬
sion, 0-8 (mean 2.8) contained HPV DNA. Of the 8 possible
sites in men (Table 20) from which samples could have
been taken on each occasion, 1-5 (mean 1.25) contained
HPV DNA.
Of the 8 patients from whom samples were taken on more
than one occasion (Tables 19-21) , 5 had HPV DNA detected
in fewer sites and 2 in more sites than when first seen.
In one patient, the number of sites in which HPV DNA was
detected initially increased, but then decreased.
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4.6 Types of HPV detected
Of the 56 samples in which HPV DNA was detected, 23 (41%)
had evidence of infection with a single type, 27 (48%)
with multiple types and 6 (11%) with undetermined types
(Tables 18-21) .
The distribution of HPV types in the various categories
of specimens from women and men is shown in Table 22. HPV
types 6 and 11 were found most frequently in the majority
of specimen categories. However, the other types sought
were found predominantly in the non-biopsy and SG speci¬
men categories.
Samples taken from different sites of the same patient
frequently contained the same HPV type. This is illus¬
trated by samples from patients F4 and M4, the majority
of which contained HPV type 6. However, in patients in
whom multiple HPV types were detected, not all the types
were found in each specimen.
4.7 HPV in pairs of partners
Partner pairs F1-M3, F2-M8 and F3-M2 had HPV types in
common. Partner pair F7-M9 did not (Tables 19-21) .
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Abbreviations used on Tables 17 - 22
Pt = patient code
p
~
= partner in the study as indicated
ns = no specimen obtained
NAD = no histological or cvtological abnormality detected
wart = histological changes of condylomatous wart virus infection
¥
= clinical status of partner as reported by study patient
CIN 1 = cervical intraepithelial neoplasia grade 1
WVI = histological changes of non condylomatous HPV infection
bdline = borderline mild dyskaryosis
koil = koilocytic atypia
Time = duration in months since first sample taken
neg = HPV types 6,11,16,18,31 and 33 not detected
*
= biopsy from clinically apparent wart
+ = specimen contained HPV of types other than those tested for
£~ = fi-globin gene not detected
- = no specimen of this type detected
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Table 17 Clinical, histological and cvtoloaical details of





















































































































































Table 19 HPV DNA in biopsy and non-biopsv specimens from
women in multifocal study in relation to types of
specimens and times at which taken
HPV DNA in sites and tvoes of specimen indicated
Pt Time Vulval Cervical Cervical Urethral Vaginal Rectal Buccal
biopsy biopsy scrape loop wash swab scrape
F1 0 neg 6 ns neg neg neg neg
4 neg neg neg neg neg ns ns
12 ns ns neg ns neg ns ns
F2 0 6,11,31* ns ns ns ns ns neg
4 ns neg neg ns 18, 31 6, 11 ns
F3 0 6,11* ns 6,11,33 6,11,33 ns ns ns










neg S neg ns ns ns
F6 0 neg ns neg neg neg neg ns
F7 0 neg ns + neg 16 ns neg
F8 0 neg neg neg ns ns neg ns
F9 0 6, 11* neg neg neg neg neg ns
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Table 20 HPV DNA in bioosv. non-bicpsv and SG specimens
from men in multifocal study in relation to types of
specimens and rimes at which taken
HPV DNA in sites and types of specimen indicated
SG specimens from






Glans Shaft Scrotum Anus
Ml 0 ns ns ns ns IS" 1S" ns neg
7 ns ns ns neg IS¬ 13 neg IS"
M2 0 ns ns neg neg IS" 1S" 6,11,18 IS"
4 6, 11 6 neg ns neg ns ns ns
M3 0 neg ns ns neg neg 18 ns ns
4 ns neg neg ns neg neg IS" ns
M4 0 6, 11 6,11,16 6,11 ns 6,11 + ns S"
3 ns ns ns ns neg IS" IS" IS"
M5 0 6 neg neg ns 18 6 ns ns
M6 0 6 neg neg neg 6,31 £" ns ns
M7 0 ns ns ns ns IS" £" ns ns
1 S , 33 S neg ns ns ns ns ns
2 6 , 11 ns ns ns ns ns ns ns
3 ns ns ns ns IS" neg IS" £"
M8 0 neg neg neg ns £" 18 ns neg
M9 0 6 neg ns neg £" IS" IS" £"
U2
Table 21 HPV DNA findings SG specimens from women
in multifocal study in relation to tvoes of specimens
and times at which taken






F1 0 neg neg ns ns neg
4 + 13 ns ns +
12 neg neg neg ns neg
F2 0 6,11,33 33 S,11,33 ns 13, 33
4 6 neg neg S" ns
F3 0 6,.11,13,33 ns ns ns 6,11
2 neg neg + neg ns
F4 0 6, 11 S,16,18 ns ns 6,11,18
F5 0 6 neg 6 ns ns
F6 0 ns 3~ neg neg ns
F7 0 neg neg neg ns neg
F8 0 ns ns ns ns ns
F9 0 6, 11 S" 11 ns ns
U3
Table 22 HPV type in relation to tvnes of specimens
in multifocal study
Number of times (%) HPV ot specified type













6 5 (50) 2 (67) 7 (41) 11(34) 7 (64) 4 (57) 4 (31)
11 4 (40) 1 (33) 3 (17) 8 (24) 3 (27) 2(29) 2(15.5)
16 - - 1(6) 1(3) - 1(14) -
18 - - 1(6) 5 (15) - - 5(38.5)
31 1 (10) - 1(6) - - - 1(7.5)
33 - - 2 (12) 5 (15) 1(9) - -
+ - - 2 (12) 3 (9) - - 1(7.5)
>1 type 4(80) 1 (50) 4 (36) 9 (50) 4 (57) 2 (50) 3 (33)
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5. COMPARISON OF FINDINGS FROM DIFFERENT STUDY GROUPS
The HPV findings from the biopsy, urethral swab and urine
specimens of men with dermatoses not typically associated
HPV infection, men with resistant anogenital warts and
men with urethral gonorrhoea were compared (Tables 23-
27) .
5.1 Detection of HPV in different sample sites
There was little difference in the detection rate of HPV
DNA in urethral swab and urine specimens between men
with dermatoses not typically associated with HPV infec¬
tion, men with resistant anogenital warts and men with
urethral gonorrhoea (Table 23).
Concerning biopsy specimens, HPV 18 was the most common
type detected in men with genital dermatoses and types 6
and 11 the most common in men with resistant anogenital
warts (Table 24). Eighty-one percent of all biopsy speci¬
mens contained HPV types 6 or 11 and 16% contained types
16 or 18. In contrast, only 45% of urethral swab speci¬
mens contained HPV types 6 or 11, whereas 39% contained
HPV types 16 or 18. Thus, in all three studies the "high-
risk" HPV types were disproportionately more common in
urethral swab and urine specimens than in those found in
biopsy specimens (Tables 25 and 26) .
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5.2 Association between HPV detected and patient details
Demographic and possible risk factor details of the men
in the genital dermatoses, resistant anogenital warts and
urethral gonorrhoea studies were analysed. The mean age
of the men in all 3 combined studies was 30 years.
Biopsy specimens were taken from men in the genital
dermatoses and resistant anogenital warts studies.
Combining the data from these two studies, HPV DNA was
detected in 75 (56%) of 135 heterosexual men compared to
61 (80%) of 76 bisexual or homosexual men and 98 (76%) of
128 men less than 30 years old compared to 43 (49%) of 88
men aged 30 years or older.
Demographic data were available from the men with
penile dermatoses or urethral gonorrhoea. The combined
data from these two studies (Table 27) do not convincing¬
ly demonstrate evidence of sexual transmission, that is,
there was no clear association between the detection of
HPV DNA and age, number of lifetime sexual partners and
claimed condom use.
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Table 23 HPV in relation to specimens taken and study group





















^dermatoses not typically associated with HPV infection
-^biopsies not taken from men with urethral gonorrhoea
U7
Table 24 HPV in biopsy specimens in relation to study group
No. (%) of biopsies from
specified study group positive
for indicated HPV type
HPV type Other Resistant Gonorr-
dermatoses warts hoea
(n=66) (n=116) (n=0)
Any HPV 12 (18) 112 (97)
6 1 (1.5) 95 (82)
11 5 (8) 92 (79)
16 1 (1.5) 10 (9)
13 8 (12) 20 (17)
31 2 (3) 1 (1)
33 0 3 (3)
>1 HPV type 4 (6) 84 (72)
*dermatoses not typically associated with HPV infection
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Table 25 HPV in urethral swab specimens in relation to
study group
No. (%) of urethral swab specimens
from specified study group
positive for indicated HPV type
HPV type Other Resistant Gonorr-
dermatoses warts hoea
(n=55) (n=llS) (n=100)
Any HPV 13 (24) 22 (19) 18 (18)
6 2 (4) 9 (8) 5 (5)
11 5 (9) 10 (9) 8 (3)
16 1 (2) 8 (7) 6 (6)
18 6 (11) 6 (5) 7 (7)
31 3 (5) 2 (2) 2 (2)
33 2 (4) 2 (2) 2 (2)
>1 HPV type 6 (11) a (7) a (8)
*dermatoses not typically associated with HPV infection
U9
Table 26 HPV in urine specimens in relation to study group
No. (%) of urine specimens
from specified study group
positive for indicated HPV type
HPV type Other Resistant Gonorr-
dermatoses warts hoea
(n=39) (n=16) (n=88)
Any HPV 5 (13) 1 (6) 11 (13)
6 1 (3) 0 3 (3)
11 1 (3) 0 6 (7)
16 1 (3) 0 6 (7)
18 2 (5) 0 2 (2)
31 0 0 0
33 1 (3) 0 0
>1 HPV type 1 (3) 1 (6) 3 (3)
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Table 27 HPV in different specimens in relation to possible
risk factors of men with genital dermatoses or
urethral gonorrhoea
Proportion* (percentage) of specimens of








§<30 years old 47/197 (24) 42/l97 (21) X1/l00 (11)
§>30 years old 24/105 (23) 19/104 (18) 7/63 (11)
§Heterosexual 52/143 (36) 44/]_gg ( 22 ) 14/126 (11)
§3i/homosexual 19/98 (19) 16/98 (16) 4/37 (11)
Caucasian 26/iog (24) 20/101 (20) 7/'74 (9)
Non-Caucasian CT\CO00CM (31) 19/82 (23) 1 /IX (10)
a20 partners 21 / 7 7 (27) 18/77 (23) 7/5 9 (12)
<20 partners 21/88 (24) 18/93 (19) 8 /77 (10)
C^ never used 10/56 (18) 8/56 (14) 3/42 ( 7)
C^ sometimes used 31/gg (31) 25/98 (26) 11/81 (14)
C^ always used 5/23 (22) 4/23 (17) 2/16 (13)
Smoker 30/99 (30) 22/97 (21) 8/73 (11}
Non-smoker INJ o \ CD O (25) 14/78 (18) 9/67 { 13)
*proportion for each possible risk factor: number of men with
that specimen type containing HPV DNA, expressed as a proportion
of all men with that risk factor and whose HPV status for that
specimen type was known.
C" condoms





The detection rate of HPV DNA may depend on the popula¬
tion studied and careful selection and definition of the
study population characteristics are essential121. In
prevalence studies it is important to assess rates of
infection in as wide a range of the population as possi¬
ble, yet the unpleasant nature of some of the sampling
methods, coupled with associated ethical considerations
limit the accessibility of much of the population. The
four studies included in this thesis were designed in an
attempt to obtain as wide a perspective of the epidemiol¬
ogy of anogenital HPV infection as possible.
Men with clinical indications for genital biopsy were
chosen in the genital dermatosis study, not in the belief
that they represented the general male community, but
that they would do so more closely than patients with
"conventional" STBs. Although recruited from a department
of genitourinary medicine, the men were unusual for this
source in that they were generally older, had fewer
lifetime sexual partners, and did not have any clinically
apparent STD at the time of biopsy. Men with genital
dermatoses require biopsy procedures for full investiga¬
tion, and tissue samples thus obtained have been studied
extensively in other clinical settings2^®. It was there¬
fore anticipated that men who did not have conventional
STDs, yet in whom biopsy material was available, would
provide a useful group in which to study HPV infection.
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Biopsy specimens were obtained from a wide variety of
sites from the male genitalia and many of these specimens
had histopathological features which were not typically
associated with HPV infection. Furthermore, it has been
•5 r q
shown^33 that the range of histopathological diagnoses
seen in such a clinic is broadly similar to that seen in
dermatology and urology departments. A large amount of
information concerning possible risk factors for the
acquisition of HPV infection was collected from this
group of men and compared to the presence of HPV in
biopsy, urethral swab and urine specimens. In this man¬
ner, it was intended to investigate the incidence of
infection with FPV in relation to demographic factors and
to compare the results of different sampling techniques.
Increasing evidence suggests that HPV infection of the
female anogenital tract is multifocal884. Less is known
of the distribution of HPVs in men. On the assumption
that men with extensive AGW would be likely to have a
large viral load, men attending a clinic for ablative
treatment of anogenital warts were studied. Such a group
had the additional advantage that tissue removed as part
of treatment could be analysed for the presence of HPV,
and the results compared to those obtained from samples
from different sites of the same men.
The results of several studies118'221'223have shown
that 20%118 to 32%884 of men presenting to genitourinary
clinics with genital warts have evidence of at least one
other STD. In particular, the incidence of gonorrhoea in
such men varies from 0%888 to 9.9%884. These studies
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rely on the clinical identification of condylomata acumi¬
nata, and the question of how often men with gonorrhoea
are infected with HPV has not been previously addressed.
Men with gonorrhoea were therefore studied in an attempt
to shed some light on the sexual transmissibility of HPV
infections. In addition, it was postulated that the
presence of a urethral discharge might increase the
diagnostic yield for HPV in urethral swab specimens.
To further investigate the nature of multifocal anogen-
ital HPV infection, to determine any change of infection
with time, and to evaluate infectivity of HPV infection,
a small group of patients and their partners was sampled
extensively over a period of several months. Different
sampling methods could be compared, and a novel technique
(the "Superglue" (SG) method) investigated.
2. Methods used in the studies
Wide variations in reported prevalence rates of genital
HPV infections may be related, at least in part, to the
use of different methods of obtaining and preparing
samples184, as well as the use of different techniques
for the detection of HPV. The most common method for
screening for the presence of infection with HPV is by
clinical examination. As already discussed, this detects
only a minority of anogenital HPV infections. Colposcopy,
with the aid of acetic acid staining, detects more cases,
but, particularly when applied to areas other than the
cervix, is neither sensitive33'143 nor specific90'93'97
for the detection of HPV infection.
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2 .1 Biopsy-
Biopsy of the cervix92 and vulva265-0 are well-estab¬
lished in clinical practice and widely performed. Less is
known about the cutaneous pathology of the penis141,264.
s ?
Although men may be reluctant to undergo penile biopsy ,
in experienced hands the refusal rate is low52 and the
method safe259. In particular, men with persisting geni¬
tal dermatoses are willing to undergo the procedure in
"ICQ
order to establish the diagnosis . Punch biopsies are
commonly used for obtaining specimens from the vulva, and
have also been use in men97,122, but the skin snip tech¬
nique259 was used in these studies as it was found to be
technically easier and produced satisfactory samples with
good subsequent healing.
Skin biopsy provides a sample which includes the lower
epidermis, an area which is difficult to access by other
sampling techniques, yet is the site of productive infec¬
tion with HPV29. The biopsy procedure also has the advan¬
tage of allowing the assessment, in a standardised
fashion260, of histopathological changes which might be
associated with the presence of HPV. However, the taking
of biopsies only permits the detection of abnormalities
in a small area and thus may lead to an underestimation
of the infection rate. A negative result thus does not
necessarily exclude infection. Furthermore, tissue sent
for HPV studies is not exactly the same as that sent for
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histopathological review, but rather an immediately
adjacent sample, thus introducing a potentially signifi¬
cant sampling error57.
2.2 Cytology
There are well defined criteria for the cytological
assessment of cervical scrape specimens557. Attempts to
extend these criteria for the detection of HPV in ure¬
thral swab specimens79'151'158 and urine
specimens157'159-50 have been unsatisfactory. In addi¬
tion, smears from keratinising squamous epithelia are
usually scanty, contain only anucleate squames, and are
C O
difficult or impossible to assess cytologically .
Epithelial cells, however, are easily removed from the
urethra, a principle which is well established in diag¬
nosing urethritis in the male. Urethral swabs designed
for the detection of Ch_ trachomatis and the lQfj.1 "blue
loop" routinely used for the investigation of urethritis
in the male were initially chosen for the studies, as
they have been found previously to be both acceptable to
patients and effective in sampling the urethral epitheli¬
um for urogenital pathogens. Initial analysis of urethral
specimens by Southern blotting showed that more DNA was
present in the swab specimens than in those obtained by
the loop method. It was on the basis of this finding that
swab samples alone were taken from the rest of the men.
However, when both loop and swab samples were taken from
the same patient, 5 of the 6 patients whose swabs con¬
tained HPV DNA also had HPV DNA-positive loop specimens.
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Furthermore, HPV DNA was detected in 5 loop samples but
not in the corresponding swab. Use of the loop would,
therefore, seem to be more sensitive for the detection of
urethral HPV infection than that of the swab. It is
possible that the use of brushes83'85'x38 may have al¬
lowed the collection of specimens from the urethra with
more HPV, but this procedure was found to be unacceptable
to the patients and resulted in the production of a
sterile urethritis (personal observations). Similarly,
it was found that vigorously scraping the entire penile
skin, including the foreskin and glans with a plastic
spatula85 or cytological brush100 was also unacceptable.
Furthermore, it has recently been established100 that
urethral swabs are as effective as abrading the preputial
area in the detection of infection with HPV.
2.3 Superglue method
The SG technique has been used to assess changes in the
stratum corneum388. In this study, the SG technique was
chosen as it allowed the sampling of the skin surface
with minimal trauma. Not only is this process more ac¬
ceptable to patients than formal biopsy, but it also
allows the monitoring of HPV-induced changes without
inducing the brisk inflammatory response associated with
biopsy. Inflammatory responses may alter the natural
history of HPV infection389 and thus the SG technique was
proposed as a means of assessing the natural history of
HPV infection which would only marginally affect the
process which it was designed to measure. Although the
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number of cells harvested by this technique is small, the
use of the PCR for the detection of the human S-globin
gene allowed confirmation of the presence of human cells.
2.4 Other sampling techniques
HPV has been found in cervical scrapes313, urethral
specimens from women370, urine1^1-3, vaginal
7 4-7771 7 7 7 i o q
samples ', rectal swabs , buccal scrapes and
serum samples303. All these specimens, as well as SG
samples, were included in the multifocal study in order
to investigate the widespread nature of anogenital HPV
infections.
2.5 Laboratory methods
The PCR and Southern blotting were used to detect HPV
DNA, as these methods are highly sensitive and
specific33, allowing the detection of very few viral
particles. Consensus primers from the LI area of the HPV
genome were used to direct the amplification of DNA
sequences common to many HPV types. The typing of the
HPVs was then dependent upon the subsequent hybridisation
with specific probes. The extreme sensitivity of the
methods used meant that sample size could be small and
genital trauma minimised. As great care was taken during
the collection of clinical material, and both positive
and negative controls were used at all stages of analysis
of the specimens, the results are thought to reflect the
true occurrence of HPV in the specimens, rather than
contamination.
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3. Genital dermatosis study
Biopsies from a wide variety of sites from the male
genitalia were obtained, many of which had histopatholog-
ical features which were not typically associated with
HPV infection. Furthermore, it has been shown359 that
the range of histopathological diagnoses seen in the
penile dermatosis clinic is broadly similar to that seen
in dermatology and urology departments.
A large amount of information concerning possible risk
factors for the acquisition of HPV infection was collect¬
ed from this group of men and compared to the presence of
HPV in biopsy, urethral swab and urine specimens. The
median number of sexual partners is given, as there was a
small number of men claiming a very large number of
sexual partners, and it was thus thought that the arith¬
metic mean would be unrepresentative. HPV DNA was more
commonly found in all specimen types from men with larger
numbers of lifetime sexual partners. Although less
convincing, HPV DNA was also more commonly found in men
less than 3 5 years old and in those who did not use
condoms. These observations are consistent with sexual
transmission. The detection of HPV DNA more commonly in
smokers that in non-smokers is consistent with the find¬
ing of condylomata acuminata205 and occult anogenital HPV
infection more commonly in smokers, although differing
sexual practices between smokers and non-smokers may
contribute to this phenomenon. Furthermore, the observa-
1S0
tion that HPV was more commonly detected in men with a
history of anogenital warts than those without, is com¬
patible with the concept of latent infection and is
consistent with the findings of others151. The lower
incidence of HPV DNA in biopsies from homosexual and
bisexual men compared to heterosexual men contrasts with
the converse in urethral swab and urine specimens.
Sexual orientation has been shown by others59 to influ¬
ence the epidemiology of genitotropic HPV infection. On
the basis of these observations it is therefore tempting
to speculate that the differing sexual practices may
influence the epidemiology of anogenital HPV infection.
The observation that HPV DNA was found in approximately
similar proportions of biopsies from whatever site of the
male genitalia, and regardless of whether the patient was
circumcised, confirms the widespread distribution of HPV
infection in men. Disruption of skin integrity may
promote infection with HPV at sites of genital derma¬
toses. On the basis of this evidence, however, the
possibility of a uniform distribution of HPV DNA through¬
out the intact male genital tract cannot be excluded.
Such a distribution would contrast with the occurrence of
condylomata acuminata at specific sites, frequently those
traumatised during intercourse5, and suggests that fac¬
tors other than the presence of HPV DNA may also be
involved in the development of clinically apparent dis¬
ease .
HPV DNA was found in only 32% of genital warts in this
group of men, possibly reflecting the unusual sample of
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warts. Only genital lesions which were clinically atypi¬
cal were referred for biopsy, so that classical condylo¬
mata acuminata were not seen. It is thus possible that
this sample of warts may have contained a large propor¬
tion of warts caused by non-genitotropic HPV types.
However, the observation that HPV types 6 and 11 were the
most common in biopsies with histological evidence of
warty change is consistent with previous reports59'134.
Furthermore, the detection of HPV type 16 in the majority
of biopsy specimens with histological evidence of dyspla-
7 7 Q ^
sia is in agreement with the findings of others ' J .
Eighteen percent of biopsy specimens with no histologi¬
cal evidence of warts or dysplasia contained HPV DNA.
This is contrary to the observations of other groups
investigating the male urogenital tract, who have not
been able to find HPV DNA in biopsy specimens that did
not have histological evidence of warts or
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dysplasia ''' . It is, however, in agreement
with reports of others who have investigated the male
Q Q
genital tract . Furthermore, as we have seen, DNA from
the genitotropic HPV types has been detected in the
absence of histological abnormalities in the cervix184,
neonatal foreskin353, the oropharynx193 and
conjunctiva54. The predominance of HPV type 18 in biopsy
specimens with no histological evidence of warts or
neoplasia is difficult to explain. It would seem unlike¬
ly that this HPV type is involved in the pathogenesis of
such a wide range of conditions. Perhaps the disrupted
epithelial structure associated with the underlying
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dermatological condition might facilitate the entry of
the HPV into the basal layers of the epithelium and thus
permit the replication of the HPV. Alternatively HPV
type 18 might be a passive contaminant from other parts
of the body, a recent sexual contact, or an inanimate
object304 .
The detection of HPV DNA in 25% of urethral swab speci¬
mens is in broad agreement with the findings of
1^1 7
others '. Contrary to what had been expected, HPV
DNA was found less frequently in the urethral swab and
urine specimens from men with histological evidence of
HPV infection or dysplasia than in those from men with no
such changes (Table 5). This suggests that the relation¬
ship between urethral HPV infection and clinically appar¬
ent warts might be a complex one, and the matter was
further investigated in the study of men with resistant
anogenital warts. The finding of HPV DNA in 10% of urine
specimens, none of which was from men with histopatholog-
ical changes of warts, suggests that the epidemiology of
HPV in urine might also not be straightforward.
As large numbers of each specimen type were taken from
the men in this study, the opportunity was taken to
compare the detection of HPV in biopsy, urethral swab and
urine specimen types (Table 6). The correlation between
the presence or absence of HPV DNA and type of specimen
was found to be generally poor. Furthermore, there was
no discernible relationship between HPV types found in
the different specimens from the same man (Table. 2).
It was not surprising to have found HPV types 6 and 11
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most commonly in biopsy specimens with histological
changes of HPV infection (Table 2) . It was surprising,
however, to have found "high risk" types proportionally
more often in urethral swab and urine specimens (Table
5) . These observations suggest that the three different
sampling methods may measure distinctly different aspects
of the epidemiology of HPV infection in the urogenital
tracts of men.
4. Men with resistant anoqenital warts
This group of men was chosen on the assumption that they
would be infected with large quantities of HPV. It was
proposed, therefore, that study of these men might pro¬
vide an insight into the distribution of HPV in those
with extensive, clinically apparent HPV infection. In
particular, it was hoped that further information would
be gained about HPV infection of the urethra and its
relation with clinical disease. Fewer demographic de¬
tails were collected from this group of men compared to
the studies of men with genital dermatoses and men with
gonorrhoea.
The finding of HPV DNA in 96.6% of wart specimens in
this study is consistent with the 69% to 100%1^4 found
in other studies. The small proportion of warts without
detectable HPV DNA presumably represents infection with
HPV types not tested for, small quantities of viral DNA,
or inadequate extraction of DNA from the samples.
Twenty-five men had HPV DNA detected in their urethras
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and a further one man had HPV DNA in his urine. Thus,
overall, there was evidence of genito-urinary tract
infection with HPV in 26 (22.4%) of the men. This com-
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pares with one study in which HPV DNA was sought in
the urethra using a cytological brush to remove cells and
Southern blotting to determine the HPV type; 25 (33%) of
75 men with genital warts were HPV-positive in the ure¬
thra and 9 (36%) of these 25 men had HPV types 16, 13 or
31. Wikstrom et al11^, using the PCR in combination with
the dot blot method, found that 46 (89%) of 52 men with
anogenital warts had HPV DNA in their urethras. It is
unclear whether this reflects a true difference in the
epidemiology of HPV between the populations studied, or
methodological differences.
The sample of men chosen in this study was unusual,
containing a large proportion of homosexual men with
perianal warts which had been present for some considera¬
ble time. As newer warts contain more viral particles
7 /T Qthan older ones , it is possible that the urethral
carriage rate would have been greater if a larger propor¬
tion of men with newly developed warts had been examined.
Furthermore, urethral carriage was more common when warts
were visible near the meatus, and the preponderance of
men in this study with perianal warts may have led to a
further underestimation of the typical carriage rate. It
is noteworthy that the association of urethral HPV DNA
carriage with proximity of clinically apparent warts to
the meatus occurs with HPV types 6 and 11, but not with
the other types considered (Table 12) . The data from
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this study suggest that types 16, 18, 31 and 33 may be
true colonisers of the urethra, whereas types 6 and 11
may be occurring in the urethra as a result of contamina¬
tion from adjacent warts.
A large number of warts were apparently infected with
multiple HPV types. It is possible that this observation
arose as a consequence of large amounts of HPV DNA in the
wart specimens causing cross hybridisation. However, it
is hoped that the rigorous experimental conditions used
make this an unlikely explanation.
Fifteen percent of the HPV types detected in ware
specimens were of the "high-risk" types, that is HPV 16,
18, 31 and 33. In comparison, 49% of the HPV types from
urethral swab specimens and 54% of those from urethral
loop specimens were "high-risk" (Table 10) . These find¬
ings are thus in agreement, therefore, with those from
men with genital dermatoses.
About half the men had one or more HPV types in the
urethra that were in common with those in the warts,
again suggesting that urethral HPV infection is not
simply an extension of infection of the external genita¬
lia .
5. Men with urethral gonorrhoea
In addition to allowing the assessment of urethral car¬
riage of HPV in men whose lifestyles have put them at
risk of acquiring a STD, it was postulated that the
presence of a urethral discharge might increase the
diagnostic yield for HPV in urethral swab specimens.
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The detection of HPV DNA in the genito-urinary tracts
of 25% of men with urethral gonorrhoea compares with the
finding of HPV DNA in the genital tracts of 20% of men
attending a STD clinic in the UK375 and the USA376 with¬
out evidence of condylomata acuminata but with HPV DNA
detectable in genital swabs. One other group of work¬
ers103 found HPV DNA in 191 (84%) of 228 men attending a
Swedish STD clinic. The validity of this latter result
has yet to be confirmed, the authors accepting that they
may have overestimated the incidence.
There was a larger proportion of men in this study of
Afro-Caribbean and African origins compared to those seen
in the other studies. This is may be due, at least in
part, to the fact that approximately half the men were
recruited from the Central Middlesex Hospital, which
serves a predominantly black community.
The lack of correlation between the presence of HPV DNA
and the number of life-time sexual partners of the men
seen in this study argues against sexual transmission, as
does the reported condom usage, although the reliability
of such reported behaviour is open to question. Further¬
more, the finding that a greater proportion of heterosex¬
ual men than homosexual or bisexual men had HPV in their
urethral swab and urine specimens is in contrast to the
findings in men with genital dermatoses.
HPV DNA was detected in 12.5% of urine specimens from
men with gonorrhoea and, overall, evidence of genito¬
urinary infection with HPV was found in 25 (25%) of the
men. As only 88% of the men had urine specimens taken,
167
it is likely that the genito-urinary infection rate was
even higher. Furthermore, as we have seen, it is possi¬
ble that some of these men could have had HPV in their
external genital skin, even though none of them had
clinically apparent warts at the time of sampling.
Fifty-seven percent of the HPV types detected in ure¬
thral swab specimens and 47% of those in urine specimens
were "high-risk" types (Table 14) . These observations
are, therefore, consistent with those from the studies of
men with genital dermatoses and men with resistant ano-
genital warts.
6. Multifocal Study
This study is different from the other three studies, in
that while only 18 patients took part, they were willing
to undergo sampling from multiple sites, often on several
occasions. It was thus hoped to obtain information
concerning the behaviour of HPV infection in individuals
rather than in populations.
The detection of HPV DNA in 11 (65%) of 17 biopsies
with histological evidence of HPV infection is consist¬
ent with the findings of some59, although lower than
those of others154. Because it was possible to detect HPV
in a wide variety of other specimen types, it seems
unlikely that low sensitivity of the method is the expla¬
nation. Infection with HPV types other than those tested
for is perhaps more likely, particularly in view of the
large number of specimens noted to have infection with
untyped HPVs.
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The detection of HPV DNA in 12-36% of non-biopsy speci¬
mens confirms the value of obtaining these specimens.
Much work has been done on cervical scrapes, but, until
recently, few other specimen types had been assessed for
the presence of HPV DNA. In fact, the data in the cur¬
rent study suggest that cervical scrapes are no more
likely to contain HPV DNA than other non-biopsy specimen
types.
The proportion of 3G samples containing the S-globin
gene was much higher in women than in men. However,
there was no difference between men and women in the
proportion of S-globin-containing SG samples in which HPV
DNA was found. It is possible that this observation may
be related to the fact that the skin of the male external
genitalia is more cornified than the female counterpart.
The surface layers of cornified skin contain predominant¬
ly anucleate squames which, therefore, do not contain the
S-globin gene. The ability to harvest infected cells by
the SG method was confirmed by the observation that SG
samples taken from areas with clinically apparent warts
contained HPV DNA in the majority of cases.
The presence of HPV DNA in S-globin-containing SG
samples from areas which did not develop acetowhite
staining is consistent with the finding of HPV DNA in
histologically normal skin175. Furthermore, it suggests
that staining with acetic acid may have limited value in
evaluating the extent of infection with HPV and treatment
strategies of anogenital HPV infections. It is possible
that areas without acetowhite changes, but with detect-
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able HPV DNA, may represent passive contamination of the
skin with HPV from another site of the patient, or from a
sexual partner, or they may represent infection of the
epithelium with HPV which has not produced sufficient
cellular changes to generate visible alterations follow¬
ing the application of acetic acid. The failure to
detect HPV DNA in four biopsies and in three of nine SG
samples from acetowhite areas is consistent with the
cr n
knowledge that not all acetowhite areas develop as a
result of infection with HPV. Furthermore, the finding
of HPV DNA in only four of six S-globin-containing GG
samples from men with acetowhite areas of the glans is in
Q -3
agreement with the suggestion that acetowhite changes
of the glans may develop as a result of subclinical
balanitis not related to infection with HPV.
The persistence of HPV at various sample sites after
treatment is in accord with the finding of others1551 that
treatment of clinical and histological abnormalities may
not necessarily result in the eradication of infection.
It is likely that persistent infection may explain, at
least in part, the high recurrence rate of warts regard-
17 7
less of the treatment method . However, the occurrence
of common HPV types in sexual partners, as noted previ-
ouslyb^, suggests that there may be an opportunity for
reinfection to also play a role in the persistence of
disease.
Eight percent of the HPV types detected in biopsy
specimens, 43% of those in non-biopsy specimens and 37%
of those in SG specimens were "high-risk" types (Table
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22) . Once again this illustrates that the epidemiology
of different HPV types varies with specimen type.
For a given patient, specific HPV types were frequently
found in common in the biopsy, non-biopsy and SG speci¬
mens. This observation was also true for those who had
infections with multiple HPV types, which constituted a
large proportion of all infections in this study (Table
22) .
7. Implications of the findings
7.1 Methods
Consensus primers from the LI component of the HPV genome
were used in the studies as these allowed the simultane¬
ous amplification of several HPV types. The use of
primers in regions of the HPV genome which are retained
after integration, such as the transforming genes E6 and
~\7 7
S7 would have possibly increased the number of speci¬
mens in which HPV had been detected. However, the nu¬
cleotide sequences of these genes are not sufficiently
conserved between HPV types to allow the reliable use of
consensus primers.
Southern blotting and PCR involve DNA extraction, and
thus do not localise HPV DNA within the tissue sample. A
positive HPV DNA signal might, therefore, arise from
contaminant DNA from a recent sexual contact. The devel¬
opment of in situ PCR877-8 may be helpful in the future.
By assessing the amount of virus present, the use of
semi-quantitative PCR814 may also shed some light on the
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epidemiology of HPV infections.
The clinical and biological significance of the detec¬
tion of small numbers of HPV genomes remains to be re¬
solved. The number of HPV DNA copies within cancer cells
may vary from large to small, eg. Caski cells contain
approximately 400-500 copies of HPV 16/cell, whereas SiHa
h r7r7
cells contain 1-2 copies of HPV 16 per cell . It would,
therefore, seem that a small number, perhaps even a
single copy of HPV DNA, is capable of contributing to the
neoplastic phenotype of a malignant cell if the viral
genome is integrated in this way with the continued
o 77
expression of E6 and E7 . However, the presence of
infectious virions cannot be inferred as a result of
finding viral DNA. Currently, we have no reliable in
vivo or in vitro technique for assessing the infectivity
of HPV-14. Furthermore, it is currently very difficult
to cultivate HPV in vitro, a situation which renders the
screening of antiviral compounds problematical. Serology
may be helpful in view of the multifocal and variable
clinical nature of HPV infections, but, as indicated
previously, much work needs to be done before this tech¬
nique can provide clinically useful data.
The insensitivity of acetic acid staining of the exter¬
nal genitalia for the detection of HPV infection has been
confirmed by the Multifocal study. The general introduc¬
tion of this technique for men would have significant
resource implications with no clearly established bene¬
fit2^4 '239_ Furthermore, the use of this method may
create unnecessary fear and anguish in potentially
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healthy individuals57 and enthusiastic calls for the
widespread use of colposcopy for areas other than the
Q 0
cervix should be resisted.
Urethral swab, urethral loop and urine specimens appear
to measure distinctly different aspects of the epidemiol¬
ogy of HPV in the anogenital tract. Although only a
small number of urethral loop specimens were collected,
the evidence suggests that these produce a higher yield
of HPV from men than do urethral swab specimens. The
optimum circumstances for the collection of specimens
remain to be defined. For example, it is currently
unclear from where the HPVs in urine specimens originate
and it is possible that larger volumes of urine±o1 or
early morning urines may produce greater yields of HPV.
In addition, different specimens from the same patient
not infrequently contained different HPV types. Further
studies are required to assess exactly what these speci¬
mens are measuring.
7.2 Multifocal infection
Multifocal infection of the anogenital area is recognised
to occur in infection with iNL. gonorrhoeae, C. trachoma-
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tis and, most recently, HPV . Furthermore, a woman
with neoplasia in one area of her anogenital tract is
predisposed to neoplasia elsewhere , an observation
which is consistent with the proposed role for HPV infec¬
tion in the development of anogenital neoplasia. The
data from all four studies suggest that, if just one
sample had been taken, the occurrence of infection,
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including multiple infection, with HPV would have been
underestimated. To determine the true extent of anogeni-
tal HPV infections, multiple samples need to be taken,
possibly over several months. In particular, the fre¬
quent use in studies of cervical scrape specimens to
assess the epidemiology of HPV infections has been seen
to be fundamentally flawed. The use of pooled specimens
from different parts of the genitalia may increase the
r7 CT
diagnostic yield of HPV infections .
The "high-risk" HPV types were consistently more common
in urethral specimens than in wart specimens. Further¬
more, HPV types 16, 18, 31 and 3 3 appear to be true
colonisers of the urethra, whereas the detection of HPV
types 6 and 11 in the urethra may be a result of contami¬
nation from adjacent warts.
7.3 Infection with, multiple HPV types
Multiple infections with different HPV types have been
reported^-5' ' ' 77', although this has been disputed
3 OA
by others . The use of full length genomic probes, high
stringency hybridisation conditions and positive controls
for all the HPV types, suggest that the results of the
current studies are indicative of true multiple infec¬
tions, rather than cross-hybridisation.
7.4 Role of sexual activity in the acquisition of HPV
The data in the current studies indicate that sexual
activity may not be a major factor in the epidemiology of
anogenital HPV infections. They are, however, consistent
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with the proposal that sexual transmission of HPV results
in the ubiquitous deposition and incorporation of the
virus in the squamous epithelium of the whole genital
*3 ft 1
tract . In this model, most HPV infections remain
dormant and never come to clinical attention. Under the
influence of, as yet, poorly defined host factors, the
virus may propagate and cause clinical recognisable
epithelial alterations of various types.
There is now a considerable body of information sug¬
gesting genital-genital and ano-genital transmission of
HPV. Oro-genital transmission of HPV is presumed to
n q q n o "5
occur and it has been postulated that recurrent
laryngeal papillomatosis in adults may result from oro-
genital contact. Direct evidence for oro-genital trans-
n o a
mission of HPV is, however, lacking . It is possible
that safer sex practices, particularly the wider practise
of oral sex may lead to a future epidemic of oral HPV-
associated lesions. Cutaneous warts and AGW can occur
simultaneously and it is therefore feasible that warts in
the anogenital region might occasionally develop from
other cutaneous warts1^. The roles of fomites, oral/hand
contact and vertical transmission remain unclear.
The apparent lack of association between cervical
infection with HPV types 6, 11 ,16 or 18 and measures of
sexual behaviour reported in some studies has been at¬
tributed215 to misclassification of HPV status. Through a
series of empirical simulations that assumed different
levels of sensitivity and specificity for detection HPV
n i tr
infection, Franco showed how even low levels of mis-
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classification of HPV infection status could distort the
true relationship between HPV and measures of sexual
activity. It is difficult to assess whether these factors
have significantly affected the results in this thesis.
7.5 Role of HPV in neoplasia
HPV type 16 is frequently found in dysplastic lesions
such as PIN95 and penile carcinoma197, and a causal link
has been postulated949. However, because HPV infection of
the male urogenital tract by "high-risk" HPV types is
widespread, any proposal to link infection by these types
with neoplasia must take the common occurrence into
account. Indeed, it provides a situation not dissimilar
from that encountered in establishing a causal link
between "high-risk" HPV types and cervical carcinoma94
against a background of commonly occurring "high-risk"
types. The ubiquitous occurrence of many types of HPV has
TOO *5
been taken by some authors as evidence against their
role in malignant transformation. However, the analogy
between the equal ubiquity of tobacco smoking and its
causal link with lung cancer suggests that a role for HPV
is still possible. Additional host cell modifications,
potentially mediated by endogenous as well as exogenous
factors, are presumably required for malignant conver¬
sion to follow from infection with HPV99.
7.6 Concluding remarks
Reproducible, standard methods are needed for the deter¬
mination of the presence of HPV. The data from the cur-
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rent studies suggest that sampling from a single site is
unlikely to be reliable, no matter what assay technique
is used. Careful selection of control groups is also
important. Given the marked site and species specificity,
it is possible that different HPV types may have differ¬
ent epidemiologies. Different types of HPV may be more
infectious than others, as suggested by the observation
that some types only seem to occur in immunosuppressed
subj ects.
Prevalence studies for HPV infection are based on an
unknown mixture of new, persisting, recurrent and unde¬
tected infection. The interval between infection and
detection of viral DNA and of development of clinical or
colposcopic lesions is unclear. Furthermore, it is not
known how long these lesions persist and how frequently
they recur. The relative infectivity of the different
stages of infection is likewise not known, although it is
often assumed that latent infection is less infectious
than condylomata acuminata, as intact viral particles are
not produced in latent disease.
The exact mode of entry of HPV into host cells is not
known. The molecular mechanisms for the induction of
1 OO
proliferation or latency need to be defined further-1-00,
as do the means by which HPV apparently evades the immu¬
nological surveillance mechanisms of the host. An impor¬
tant aim of future work should be to try to develop
measures that can distinguish the HPV infected individu¬
als who are at risk of their lesions progressing to
dysplastic lesions from those regressing without treat-
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ment. So far it seems that infection with HPV type 16 is
associated with a higher rate of progression than types
6, 11, 18. Currently, however, little is known of the
progression rates of the more recently characterised
types.
Research into the epidemiology of HPV infections opens
up exciting new areas in molecular biology, immunology
and oncogenesis which could have ramifications through a
wide range of health care and human behaviour. However,
such studies need to be carefully designed to take ac¬
count of the many difficulties inherent in HPV-related
research. Only by obtaining a clear understanding of the
epidemiology of anogenital HPV infections can we hope to
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QUESTIONNAIRE - GENITAL DERMATOSIS STUDY
DATE /• • •/
CLINIC NO
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het / homo/ bi
CONDOMS never/ sometimes/ always CIGARETTE SMOKER yes/no
NO. OF LIFETIME SEX PARTNERS




























CIRCUMCISED? YES / NO
LESION SITE: glans/foreskin/shaft/frenulum/other
BIOPSY SITE: glans/foreskin/shaft/frenulum/other
URETHRAL SWAB: Y / N URINE SAMPLE: Y / N

















het / homo/ bi
CONDOMS never/ sometimes/ always CIGARETTE SMOKER yes/no
NO. OF LIFETIME SEX PARTNERS




























CIRCUMCISED? YES / NO
LESION SITE: glans/foreskin/shaft/frenulum/other
BIOPSY SITE: glans/foreskin/shaft/frenulum/other
URETHRAL SWAB: Y / N URINE SAMPLE: Y / N




QUESTIONNAIRE - URETHRAL GONORRHOEA STUDY
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het / homo/ b
CONDOMS never/ sometimes/ always
CIGARETTE SMOKER yes/no
NO. OF LIFETIME SEX PARTNERS
































PHONE NO Data of Birth
























HISTORY OF INFECTION IN PAST / PRESENT PARTNERS ?
(esp. warts )













Abdo oain - site




5.1. PREVIOUS 2/12 - type
DURATION OF CURRENT RELATIONSHIP
COITAL FREQUENCY (/wk)
MARITAL STATUS - Single
Cohabiting
Mcizr^r 0cl
Separated / Divorced / Widowed
COITARCHE NO OF LIFETIME PARTNERS









MOST RECENT CERVICAL SMEAR When ?
Normal ?
QUESTIONAIRE - MULTIFOCAL STUDY




- inguinal nodes - tender ?
- contents of scrotal sac
- circumcised ?
INITIAL APPEARANCE PHOTOGRAPHS ?
QUESTIONNAIRE - MULTIFOCAL STUDY
EXAMINATION - MALE 2
DATE
CLINIC NO
AFTER 3% ACETIC ACID PHOTOGRAPHS ?
BIOPSIES - Formal Saline
- Liquid Nitrogen
- DNA
( in OCT )
QUESTIONNAIRE - MULTIFOCAL STUDY







URINE - 20ml First voided ( pref. EMU
( into fixative )








BUCCAL SMEAR - Cytology
- D.N.A.















URINE - 20ml First voided (pref. EMU
( into fixative )
DATE
CLINIC NO












HIGH VAGINAL SWAB - For Candida
WET FILM MICROSCOPY T.V. / B.V. / Candida












OTHER INVESTIGATIONS ? - VAGINAL WASHING (for DNA)
QUESTIONNAIRE - MULTIFOCAL STUDY




- inguinal nodes - tender ?
- uterus - a/v or r/v ?
- adnexae - palpable ?
VULVA - MACROSCOPIC PHOTOGRAPHS ?
VULVA - AFTER 5% ACETIC ACID PHOTOGRAPHS
BIOPSIES - Formal Saline
- Liquid Nitrogen ( in OCT )
- DNA
QUESTIONNAIRE - MULTIFOCAL STUDY
EXAMINATION - FEMALE 2 DATE
CERVIX - BEFORE
PHOTOGRAPHS ? - Y / N
M = Mosaic
W = Aceto - white
L = Leukoplakia
CLINIC NO
AND AFTER APPLICATION OF 5% ACETIC ACID
P = Punctation
G = Grades 1-3
BIOPSIES - Formal Saline
Liquid Nitrogen ( in OCT )
DNA
APPENDIX V
CONTENTS OF SOLUTIONS USED
1 Selective medium for the growth of N. gonorrhoeae
GC Medium base with 1 vial of Isovitalex and 1 vial of
Antibiotic Cocktail
Isovitalex contains:













Vancomycin (3, 000/zg/ml) 10ml
Colistin (20,000 units/ml) 50ml
Trimethoprim (2, 500/xg/ml) 20ml
Amphotericin B (750/xg/ml) 20ml
2. Collection of samples












Stock solution = x 2
0.486g Tris
1.75g NaCl
0.84g Ethylenediaminetetraacetic acid (EDTA)
- tetrasodium salt
titrated to pH8.0 with concentrated HCl
made up to 100ml with ddl^O
3.2 SDS (Sodium Dodecyl Sulphate)
10% stock solution = lOOmg/ml
3.2 Lysis mixture
100fj.l sterile double distilled water (ddl^O)
2 8 ill 2.5% SDS (25mg/ml)
4fil of 0.8mg/ml t-RNA
32ul of lOmg/ml protease
The protease used was Pronase E, which is type XXV pro¬
tease, from Streptomvces ariseus (Sigma, St Louis, Mo,
U.S.A. )
3.4 TE-equilibrated phenol
Tris EDTA (TE) buffer (pH 8.0) = lOmM
Tris(hydroxymethyl)-methylamine (Tris) (pH 8.0) in ImM
disodium EDTA (pH 8.0)
Phenol crystals were dissolved at 65°C and 8-hydroxyqui-
noline added to give a yellow colour and to prevent
oxidation. The phenol was then equilibrated in an equal
volume of TE buffer and stored at 4°C.
4 . 15-qlobin primers
Kindly provided by the Medical Research Council AIDS
Directed Programme:
S-globin (14-33) ADP894.l/LAl-N:
5'ACA CAA CTG TGT TCA CTA GG 31
S-globin (123-104) ADP894.2/LA2-C:
5'CAA CTT CAT CCA CGT TCA CC 31
5. Polymerase chain reaction
5.1 General primers
Provided by the Medical Research Council, Clinical Re¬
search Centre, Harrow, Middlesex, England.
General Primer 5 = GP5 = 5'TTT GTT ACT GTG GTA GAT AC 31
(Sense strand)
General Primer 6 = GP6 = 51GAA AAA TAA ACT GTA AAT CA 3'
(Antisense strand)
5.2 Areas of the LI genome Amplified during the PCR
Sense strand
5' GP5 GPS 3'
tAAAAAAAAAAAAAAAAAAAf
region amplified during the PCR







HPV 6b 139 base pairs
HPV 11 139 base pairs
HPV 16 142 base pairs
HPV 18 145 base pairs
HPV 31 142 base pairs







5.3 PCR Reaction mixture
lOx Buffer Volume oer Stock
10 samples
500mM KC1 250/zl 2M
lOOmM Tris pH 8.3 100/xl 1M
3OmM MgCl2 3 0/zl 1M
0.01% gelatin 10/xl 10%
lOjixM General primer 5 100jul 100piM
10fxM General Primer 6 100 ixl 10 0/zM
2mM dNTP mix lOO/xl 2 OmM
ddH20 310/zl
Tag polymerase:
(Taq DNA polymerase, Thermus aauaticus, Gibco BRL,
Uxbridge, Middlesex, U.K.)
0.5/xl Taq polymerase of 5U//zl stock was made to lOOfxl
with ddH20.
Each experiment comprised lOOfxl of the reaction mix as
listed above, together with the Taq polymerase
5.4 Near full length genomic probes
Provided by kind permission of Dr H. zur Hausen, Heidel¬
berg, Germany.
These probes contain double stranded DNA of the whole
genomes of HPV types 11,16 and 18. The HPV 6 probe in¬
cluded 0.67 of the whole genome.
HPV 6 - 5300 base pairs
HPV 11 - 7945 base pairs
HPV 16 - 7945 base pairs
HPV 18 - 7945 base pairs
5.5 Oligonucleotide probes
Provided by the Medical Research Council, Clinical Re¬
search Centre, Harrow, Middlesex, U.K.
HPV 31 - 51TCT GTT TGT GCT GCA ATT GCA 51
HPV 33-5'CAC ACA AGT AAC TAG TGA CAG 31
6. Separation of DNA fragments by gel electrophoresis




6.2 SSC (Saline Sodium Citrate)





20 x Denhardt1s solution
0.5% SDS (5mg/ml SDS)
ImM disodium EDTA
75/xl salmon sperm DNA (50jug/ml) (Sigma, St Loius, Mo,
U.S.A.)
sterile dd^O
*Denhardt's solution consists of:
0.4% bovine serum albumin (Promega, Southampton, U.K.)
0.4% Polyvinyl pyrrolidone (Sigma, St Louis, Mo, USA)
0.4% Ficoll 400 (Pharmacia, LKB Biotechnology, Uppsala,
Sweden)
6.4 Random priming mixture
5/u.l Multiprime buffer solution RPN. 1601Y/Z (Amersham
International PLC, Aylesbury, Bucks, U.K.)




3/j.I P labelled dCTP (30Ci/mmol)
2/j.I (2 units) Klenow fragment of DNA polymerase 1
ddH^O (to make up to 5 0/xl)
6.5 End-labelling mixture
2/j.I 10 x kinase buffer (Polynucleotide Buffer, Amersham,
U.K.)
5/u.l P labelled dATP (50Ci/mmol)
lfj.1 (10 units) T4 polynucleotide kinase (Amersham, U.K.)
sterile ddl^O to make up to 2 0/xl volume
APPENDIX VI
The following publications have been derived from the
work of this thesis. Permission for the inclusion of
these publications in this thesis has been obtained from
the co-authors and publishers.
Genitourm M=d 1991 ;67:73
Value of performing biopsies in
genitourinary clinics
We read with interest the recent letter
in your journal concerning the value of
performing biopsies in genitourinary
clinics.'
Men with abnormalities of the skin
of the penis frequently present to
genitourinary physicians, who must
therefore also be skilled in der¬
matology. This is particularly so in the
light of the probable rc-dcfinition of
our specialty as "dermato-ven-
ereology" in the unified post-1992
European Community.
In order to assess the specific der-
matological problems encountered by
a busy genitourinary medicine clinic,
we set up an internal clinic for penile
dermatoses. The criteria for referral
were a penile dermatosis of uncertain
diagnosis for which the clinician
thought that a biopsy might prove
helpful. The technique used was that
of local anaesthesia followed by skin
snip biopsy. All patients were
thoroughly counselled before the
procedure, which was generally regar¬
ded by the patient as not being as
traumatic as initially envisaged.
Over a period of two months a total
of 18 biopsies were performed with the
following histopathological results: 5
nonspecific dermatitis, 3 viral warts, 3
lichen sclerosus et atrophicus, 2 lichen
planus, 2 symptomatic subclinical
papillomavirus infection, 1 granu¬
lomatous disease (currently under¬
going investigation) and 1 trauma
(probable dermatitis artefacta).
Although only a small sample was
taken, typically 0-5 mm in diameter, in
only one case did the biopsy prove
non-diagnostic.
It can be seen that in 11 out of 18 of
cases, a specific diagnosis was able to
be made for which a management plan
could be devised. We would draw
particular attention to the diagnoses of
lichen sclerosus et atrophicus (LSA).
Not only arc there multiple names for
the same histopathological condition
(LSA, balanitis xerotica obliterans
and kraurosis vulvae), but the malig¬
nant potential of this common2 condi¬
tion remains undefined and a standard
text' suggests six to twelve monthly
follow-up for life.
Despite the longstanding combina¬
tion of the specialties of dermatology
and venereology on the continent, the
literature on genital dermatology is
scant. The three specialties of genito¬
urinary medicine, dermatology and
urology have overlapping interests in
penile cutaneous disorders, but rarely
have in-depth knowledge. Unlike the
vulval cutaneous disorders,' for exam¬
ple, there is no standard textbook in
the English language on penile der¬
matoses. Furthermore, confusions
still exist over relatively common dis¬
orders, as described above. It is thus
important to develop and improve
lines of communication between gen¬
itourinary physicians, dermatologists
and histopathologists at regular audit
meetings.
We would therefore wholeheartedly
agree with the conclusion of Drs
Arumainavagam and Sumathipala
that penile biopsy is a very useful
diagnostic procedure in the setting of a
genitourinary clinic. The more wide¬
spread use of this simple and min¬
imally invasive procedure would allow
us to gain greater insight into the ill-
understood incidence and nature of
genital dermatoses.
R J HILLMAN
J R W HARRIS
Department of Genitourinary) Medicine
M M WALKER
Department of Histopathology,
St Mary's Hospital, Praed St,
'London \V2 INY, UK
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lesions of the male sexual part¬
ners: the diagnostic accuracy of
peniscopy
We were interested to read the article
by Hippelainen el al' concerning
peniscopy and the carriage of human
papillomavirus (HPV) DNA by male
partners of women who had abnormal
Papanicolaou smears. If we are to
assume that HPV is transmitted
predominantly by sexual contact,2 it
follows that men are involved in about
half of the epidemic. This factor does
not seem to be reflected in the current
literature, which, despite the
explosion of interest in the topic, still
constitutes only a small minority of the
publications. For example, only 20
(4-7%) of 424 papers presented at the
recent papillomavirus workshop in
Seattle directly concerned male
carriage of HPV. This paucity of data
is presumably, at least in part, due to
the lack of a male counterpart of the
Papanicolaou smear, which forms the
basis of much current epidemiological
"ork. The study of Hippelainen a al
is, therefore, a significant contribution
to the field. However, we would like to
raise several points.
The term "peniscopy" has been
used previously,2 but other authors
use terms such as "androscopy",4
"magnified penile surface scanning'"
and, probably the least appropriate
term, "colposcopy".' We suggest that
the term "penoscopy" should be
adopted, as its form is more consistent
with the words used to describe other
techniques which augment clinical
visualisation, such as gastroscopy and
bronchoscopy.
The whole area of HPV
epidemiology is bedevilled by the
absence of a universally agreed "gold
standard". Clearly, from the data
presented in this article, histology
alone cannot be relied upon, as only 34
(35-4%) of 96 biopsies that showed
histological criteria of HPV infection
contained HPV DNA. As detection
was not only by in situ hybridisation
but also by the PCR, it seems likely
that most of the lesions biopsied did
not contain the so-called "genito-
tropic" HPVs tested for. This is sur¬
prising, as in most studies DNA of the
genitotropic HPVs has been detected
in approximately 90% of condylomata
acuminata.7 Several explanations are
possible for these observations. Peno-
scopically abnormal areas may be
caused by HPV types which are dif¬
ferent from those usually found in
clinically apparent lesions. Alter¬
natively, such lesions may be
produced by mechanisms entirely dif¬
ferent from infection with HPV. The
fact that the authors, along with
others,' noted that penoscopic abnor¬
malities occurred commonly at sites of
likely epithelial trauma during inter¬
course, may be relevant. The finding
that males with a long contact history
had a lower incidence of abnormalities
might be consistent with the observa¬
tions that older genital HPV lesions
contain fewer viral particles than
fresher lesions' and are less infectious.2
It could be postulated that men who
have had long term contact with
women infected with HPV are, at the
time of sampling, being exposed to a
small viral load, and so are possibly
less likely to have penile abnormalities
attributable to HPV infection.
It is unfortunate that the men did
not undergo full testing for other
sexually transmitted diseases, for
example, a urethral smear to detect
non-gonococcal urethritis and syphilis
and HIV serology. Furthermore, the
finding that none of the men carried
Chlamydia trachomatis in the urethra
suggests that the population sampled
was an unusual one. Several reports10 "
suggest that other infectious agents
exist often in a large proportion of
those with condylomata acuminata,
and co-infection has been postulated
to affect the natural history of HPV
infections.12
The observation of a much greater
correlation between histological
criteria and the detection of HPV
DNA in meatal and distal urethral
biopsy specimens than elsewhere was
interesting. This may be related to the
fact that the epithelium in the meatus
and urethra is perhaps more akin to
some areas of the cervix, where more
experience has been gained in inter¬
preting histological changes. Most
interesting of all was the observation
that HPV DNA was not found in
histologically normal skin. This is in
agreement with our findings in a series
of penile biopsies that did not show
histological evidence ofHPV infection
(unpublished). HPV DNA was detec¬
ted using the PCR in only 1 (3%) of 35
biopsies. This is in contrast to the
findings in the female genital tract,
where HPV may be detected in histo¬
logically normal tissue" and suggests
that the epidemiology of HPV in men
may be fundamentally different.
Penoscopy undoubtedly has a role
in attempting to understand the
epidemiology of HPV infections.
However, in view of the limitations of
sensitivity and specificity highlighted
by Hippeliiinen ec al, enthusiastic calls
for its widespread introduction into
routine clinical practice1'1 should be
treated with caution. More disturbing
are the recommendations of some
authors* for extensive ablation of
penoscopically abnormal areas. In
view of the considerable anxiety
already suffered by some of these
patients, we prefer to wait for the
results of further carefully controlled
studies to determine the value of
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Anogenital wans are one manifestation of human
papillomavirus (HPV) infection of the anogenital
tract. Such HPV infections have an adjusted annual
incidence of about 8% in an unselectcd Scandinavian
female population,' and anogenital warts arc the
commonest viral sexually transmissible disease in
England.2 The padent's immune response probably
determines whether infection will become manifested
clinically and how well the resulting condylomas
respond to treatment. HPV DNA replicates in the
suprabasal cells of the epidermis, but the considerably
more antigenic complete viral particles are produced
only in differentiating keratinocytes, which are distant
from cutaneous immunological defences. HPV
infections may also be associated with local
immunoparesis.3-4 Whatever treatment is used,
efficacy probably depends on (a) removal of tissue
containing viral particles and (6) disruption and
release of previously sequestered viral antigens and
their exposure to the immune system.
Scientific evaluation of treatment is difficult. For
example, it may be hard to assess objectively the
severity and response of clinically apparent lesions.
Warts ofdifferent types and durationmay not respond
in the same way to different regimens, and the role of
HPV typing in terms of clinical behaviour and
therapeutic responsiveness has not been fully
explored.5 Patient variables such as sexual practices,
smoking, human immunodeficiency virus infection,
oral contraceptive use, and nutritional status may
likewise be important. Trials of therapy seldom
control for all these factors, tending to concentrate
instead on patients with newer lesions that are more
responsive to most treatments than are persistent
warts. Follow-up is often no more than 3 or 6 months,
despite the known propensity of warts to relapse and
to remit spontaneously.6 Reinfection during treatment
may be difficult to exclude, and use of condoms
during and after therapy may influence the results.
Another complication is that fomites may help to
maintain infection—in one trial7 the relapse rate was
increased in patients whose underwear contained
HPV DNA. It is unclear whether concurrent
treatment of sexual partners enhances the success of
treatment.
Fresher warts are associated with a more vigorous
immune response4 ahd are generally more responsive
to all the established treatments, so patients should be
encouraged to present early. Nevertheless, a large
minority of patients with anogenital warts do not
respond adequately to first-line treatment with
podophyllin, podophyllotoxin, or cryotherapy. The
considerable distress and pressure on sexual
relationships caused by the diagnosis are compounded
by patients' increased awareness of the putative link
between HPV infection and anogenital cancers.
Repeated courses of podophyllin have progressively
fewer benefits,9 and destructive methods such as
cryotherapy, electrodesiccation, and laser fulguration,
either separately or in various combinations, may be
necessary. Choice of treatment largely depends on
locally available skills and resources; cure rates vary
from 27 to 91% .' I0
Different types and doses of interferons given
locally 13 or systemically14 have been tried for various
lengths of time. Most trials have been on patients with
previously untreated warts, for which the chances of
cure are better than with older, larger, or recalcitrant
lesions.1531 For persistent warts, interferon combined
with a destructive method may improve the clearance
rate.17 Although the frequency, dose, cype, and
indications for interferons in the treatment of
anogenital wans remain to be fully established, use of
a combination of methods should lead to at least
temporary clearing of visible lesions in most cases;
repeated treatments may be necessary occasionally.
We do not know whether HPV DNA is eradicated
completely as a consequence of any of the wart
treatments.18Moreover, it will be some time beforewe
know whether elimination of the clinical
manifestations of genital HPV infection reduces
infecrivity for sexual partners or alters any risk of
subsequent anogenital cancer. One view is that
vigorous therapy should be used in the minority of
individuals whose wans harbour so-called high-risk
types (HPV 16, 18, 31, 33, 35, and 39); the more
common "low-risk" types are HPV 6 and 11.
However, several other factors influence the rate of
progression of lesions," and HPV typing is not
routinely available. Until these issues have been
adnressed, enthusiastic calls for widespread
destruction of skin with evidence of subclinical HPV
infection should be resisted.
Patients with anogcnital wans are likely to have put
themselves at risk of acquiring other sexually
transmitted infections, including human
immunodeficiency virus, so it is essential to offer
counselling and screening for these disorders. Such
screening not only allows treatment of previously
undiagnosed conditions but alsomay aidmanagement
of the wans, since epidermal irritation caused by
coincidental genital pathogens may encourage growth
of the lesions.20 Because wart treatment sometimes
extends over several months, screeningmay have to be
repeated as the patient's lifestyle changes. It is .
important to determine the patient's sexual history so
that recent partners can be offered screening. In view
of the concern about HPV and anogenital cancer,
cervical cytology is recommended, in addition to
biopsy of any atypical lesions.
The treatment of anogenitai wans has fostered a
rich heritage of folklore21 and the continuing
controversy surrounding existing regimens, none of
which is uniformly effective, safe, and cheap, shows
how little we understand the pathogenesis and
management of this infection. Ample scope here for
properly controlled and blinded trials of new
treatments.
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Granuloma annulare of the penis
R J Hillman, S Waldron, M M Walker, J R W Harris
Abstract
Granuloma annulare is an uncommon
skin condition, most often found on the
extremities of young females. A case of
granuloma annulare occurring on the
penis of a 61 year old man is reported
and the current literature associating
granuloma annulare and conditions
likely to present to genitourinary clinics
is reviewed.
Introduction
Granuloma annulare (GA), an uncommon
dermatological disorder, usually occurs on the
hands or feet of young women.1 We report a
case of penile granuloma annulare occurring
on the penis and discuss the implicatons.
Case history
A 61 year old man presented to the gen¬
itourinary clinic with a one year history of a
rash on his penis. He stated that the lesion was
neither painful nor pruritic, that he had no
other urogenital symptoms, and that he had
never had a similar lesion before. He had a
past medical history of adult onset asthma, for
which he was currently taking beclometha-
sone and salbutamol inhalers, but there was
no significant past history of any dermato¬
logical conditions, and no family history of
note. There was no known history of trauma
to the genital area, although the patient spilt a
large quantity of turpentine substitute on his
groin around the time of the development of
the lesion. He was not able to relate reliably
whether this accident preceded or followed
the development of his rash. The patient had
been employed as a driver for a laundry busi¬
ness for 5 years, but had no other known
history of exposure to potentially toxic
chemicals.
The patient was exclusively heterosexual
and had never been abroad. He had not indul¬
ged in any high risk activity likely to result in
the acquisition of HIV. His last sexual inter¬
course was reported to be with a regular
girlfriend, using a condom, several months
prior to presentation.
On examination a serpiginous, raised,
erythematous lesion 2 cm by 1 cm was noted
on the shaft of the penis (fig 1). Genital
examination was otherwise unremarkable;
there was no Ivmphadenopathy and a full
general examination failed to reveal any
abnormalities. Urethral microscopy was
unremarkable and culture of a swab from the
urethra failed to reveal Neisseria gonorrhoeae.
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treponemal antibody test, was negative.
Swabs from the lesion site failed to reveal
herpes simplex or Haemophilus ducreyi on
specific culture, and routine bacteriological
examination of a swab from the lesion show-en
normal skin fiora only.
Full blood count was normal, as were fast¬
ing blood glucose and thyroid function tests.
Antinuclear factor was detected in the
patient's serum, but the DNA binding test
was negative. Antibodies to mitochondria,,
smooth muscle, gastric parietal cells and
thyroid cells were not present in the patient's
serum. Following counselling, the panent
declined to undergo testing for the human
immunodeficiency virus (HIV).
In order to establish the diagnosis, a skin
snip biopsy was performed following infiltra¬
tion of the area with 2% lignocaine and 1 in
200,000 adrenalin for anaesthesia. The sample
was then placed in 10% formal saline for
routine histopathological examination. Sec¬
tions showed foci of collagen degeneration,
with a lymphohistiocytic infiltrate and sparse
giant ceil formation, as shown in fig 2. Acid
fast bacilli were not seen using the Ziehl
Nielsen technique and periodic acid Schiff
staining for fungi was negative.
When reviewed six weeks after the biopsy,
satisfactory healing of the biopsy wound had
occurred, and the lesion was markedly
reduced in size.
Discussion
Our patient presented with a lesion which was
clinically typical of GA and had the character¬
istic histological findings and a consistent clin¬
ical history.
GA can occur in either localised or general¬
ised forms, is commoner in females' than in
males, and tends to predominate in younger
age groups." The aetiology is unknown,2
however; local disease has been associated
with trauma,4 contact with irritant materials,'
fungal infection," adenovirus,' herpes zoster'
and diabetes mellitus.' Generalised granuloma
annulare has been associated with diabetes
mellitus,2 thyroid disease,10 chronic Lyme dis¬
ease," and the possession of HLA types A31,
B35'2 and B8'.
The lesions of GA occur most commonly
on the surfaces of the dorsum of the hand and
fingers,1 and, to the best of our knowledge,
there has only been one previous report of
granuloma annulare of the penis."
Lesions tend to disappear after 3 to 6
months. Trauma, such as the process of
biopsy itself may precipitate disappearance, as
happened in this case. Perforation of the
lesions is the only potentially serious con¬
sequence of GA. The efficacies of treatments
such as intralesional steroids, cryotherapy and
radiotherapy arc difficult to evaluate, in view
of the tendency of lesions of GA to relapse
spontaneously and remit.1
GA currently has no established associa¬
tions with other genitourinary conditions,
although there has recently been a report
linking it with scabies,14 and the condition has
been confused with annular syphilid." Other
potential clinical differential diagnoses of GA
occurring in the genital tract include ring¬
worm, annular lichen planus, sarcoidosis and
necrobiosis lipoidica.1 The histopathological
differential diagnosis includes necrobiosis
lipoidica, rheumatoid nodules and sarcoid.
Clinico-pathological correlation is important
in these cases.
One study2 has suggested that only 16% of
cases of GA can be related to a specific
precipitant. It is unclear whether the incident
with the turpentine substitute was a significant
factor in the development of our patient's
granuloma annulare, as he was uncertain of
the exact temporal sequence.
Several papers report the occurrence of
granuloma annulare in individuals infected
with HIV'"'"" and one article" documents
remission of generalised granuloma annulare
in association with the initiation of zidovudine
therapy.
Following counselling, our patient declined
to undergo testing for HIV. He was not con¬
sidered to be at particularly high risk, and had
no stigmata to suggest advanced HIV disease.
In view of the developing epidemic of
HIV, its possible association with GA and
the potential confusion of GA with other
genitourinary conditions, we believe that
genitourinary physicians should consider GA
in the differential diagnosis of any unusual
dermatological condition and proceed to
biopsy if there is any doubt.
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Penile dermatoses: a clinical and
histopathological study
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Objective—To assess the spectrum of gen¬
ital dermatologicai conditions affecting
men and compare the clinical and histo¬
pathological diagnoses.
Design—Prospective study over a one year
period.
Setting—A central London teaching hos¬
pital.
Patients—Seventy one patients with unre¬
sponsive penile dermatoses attending a
specific internal referral clinic within the
department of genitourinary medicine
and 36 patients undergoing penile biopsy
following attendance at other depart¬
ments within the same hospital.
Methods—Full dermatoiogicai assess¬
ment of patients attending the specific
clinic. Standard histopathological meth¬
ods were used in the diagnosis of biopsy
specimens.
Outcome measured—Clinico-pathoiogi-
cal diagnosis of cutaneous penile abnor¬
malities.
Results—Description of the range and
relative frequency of penile dermatolog¬
icai conditions. The most common histo-
pathologicai diagnosis was of non specific
dermatitis. Twenty seven percent (16 of 61)
of patients attending the specific clinic
and 33% (12 of 36) of men attending other
departments had conditions requiring
long term follow up.
Conclusions—The ranges of penile der¬
matoses presenting to the different
departments were broadly similar. Penile
biopsy was shown to be a safe and clini¬
cally informative procedure. In the geni¬
tourinary clinic setting, clinical diagnosis
prior to biopsy was found frequently to be
inaccurate.
Introduction
Penile dermatoses encountered in genitouri¬
nary medicine (GUM) clinics frequently pro¬
vide diagnostic difficulties. The diagnosis and
treatment of such conditions is often empirical,
based on the assumption chat the rash is likely
to be either fungal or eczematous. Not oniy is
this approach unscientific, but it often fails to
resolve, and in some cases, may exacerbate the
problem. Patients with such dermatoses may
persistently attend with relapsing rashes of
uncertain aetiology, and potentially serious
conditions can be overlooked. Presentation to
other specialties such as general practice,
urology, dermatology and general surgery also
occurs and such departments may lack the
resources to diagnose accurately the wide
range of sexually transmitted and other dis¬
eases affecting the penis
The true nature and extent of penile derma¬
tologicai conditions presenting to GUM clinics
is unknown. In view of this, we investigated
patients with persistent penile dermatoses by
careful clinical evaluation, including biopsy. In
addition, histopathological results from the
specific referral clinic were compared with
chose of similar specimens submitted to the
histopathologv department over the same peri¬
od from other departments.
Methods
A specific internal referral clinic, the Penile
Dermatosis Clinic (PDC), was set up within
the GUM department for men with persistent
penile dermatoses which did not respond to
treatment, or of which the diagnosis was in
doubt and the clinician felt that biopsy would
be helpful in establishing the diagnosis. .-\11
patients were screened for the commonly
occurring sexually transmitted pathogens, and
treatment was given where necessary. Patients
were asked to avoid any specific local treatment
to the area for a minimum of two weeks prior
to assessment.
During the 45 minutes allocated for each
patient, a full history, particularly including
that of any personal or family dermatoiogicai
conditions, was combined with a thorough
examination of skin and mucous membranes,
together with penoscopy. If a diagnosis could
not be made at that point, or significant
pathological changes could not be reasonably
excluded on clinical grounds, the patient was
counselled and offered a biopsy examination.
Under aseptic conditions the area to be
biopsied, which included, where possible, the
edge of the lesion and normal skin, was
infiltrated with 1 to 2ml of 2% lignocaine with
1:200,000 adrenalin. Once anaesthesia had
been achieved, the skin was gently pinched up
using toothed forceps and an ellipse of approx¬
imately 1mm by 2mm was removed using
scissors (fig). The biopsy specimen was then
placed in 10% formal saline, processed rou¬
tinely and stained by haematoxylin and eosin
for histological examination. Haemostasis was
achieved using silver nitrate sticks. In view of
the small biopsy site, primary closure was not
necessary, and the patient was given simple
hygiene advice.
Samples from patients attending other spe¬
cialties were received by the histopathoiogy
Figure Skin snip biopsy procedure
department in the course of routine clinical
practice, without the patient being referred to
the PDC. Mo patients were seen in more than
one department.
Standard criteria were observed for the
diagnosis of well recognised dermatological
conditions, for example lichen sclerosus, lichen
planus and dermatitis.1 Previously established
histopadiological criteria for the diagnosis of
wart virus infection and penile intraepithelial
neoplasia (PIN) were applied." All specimens
in which a histological diagnosis of nonspecihc
dermatitis (NSD) was made were additionally
stained by the periodic acid Schiff method.
The initial clinical diagnosis was made prior
to biopsy and compared with the final diag-
Table I Clinical diagnoses in patients not undergoing











Biopsy declined by patient
Wart virus infection
Atopic eczema
Table 2 Diagnoses in patients undergoing penile biopsy in the GUM department
Category Diagnosis So. of Panenis n—60
Infection Fungal infection 1
Wart virus infection 14 (23%)
vfart virus infection +■ dysplasia 1
Dermatosis Non specific dermatitis 16 (26%)
Lichen sclerosus (15%)




Neoplasia PIN 2 2 (3%)
prN 3 2 (3%)
Basal cell papilloma I
Miscellaneous Not diagnostic
Scamng








nosis which was based on the clinical features
and histological findings. Thus, an essential
part of the evaluation of the patient was
discussion between the clinician and the his-
topathologist.
Results
Patients seen in the PDC
Seventy-one patients were seen in the PDC
over a one year period. Seven (10%) of the
patients were homosexual and one of them was
known to be infected with the human immuno¬
deficiency virus. The age range of all patients
was 18-3 to 65-1 years (average 36*2 years).
Sixty patients underwent biopsy, two declined
to have biopsies and nine had clinical condi¬
tions for which biopsy was not considered
necessary (table 1). The age range of those
undergoing penile biopsy was 22-5 to 65-1
years (average 36-0 years). The age range of
those not having a biopsy was 18-3 to 56-2
years (average 37-3 years).
A short course of antibiotics for secondary
infection was required by three (5%) of the 60
patients undergoing biopsy, otherwise recovery
was satisfactory, with minimal or no scarring,
and return to full sexual activity usually within
two weeks.
The diagnoses based on biopsy examination
are shown in cable 2.
Histological findings were consistent with
the initial clinical diagnosis in 20 (33%) of the
60 patients undergoing biopsy. Lichen scler¬
osus (LSc) was diagnosed accurately prior to
biopsy in seven (78%) of nine cases, wart virus
infection in 7 (50%) of 14 cases, non specific
dermatosis in five (31%) of 16 cases and lichen
planus in one (25%) of four cases. Four (7%)
of the biopsies undertaken in the PDC showed
evidence of PIN, which had not been sus¬
pected prior to biopsy.
Patients seen in other departments
During the same period, the histopathology
department received penile biopsy specimens
from 36 patients attending other departments
within the hospital, comprising 28 from the
urologists and four each from the dermatolo¬
gists and the general surgeons. The age range
of these patients was 16-2 to 81-2 years
(average 46-4 years).
Less clinical information was available on
these patients. In view of this, clinical concord¬
ance was not assessed and the histological
diagnoses (table 3) were used only to define the
spectrum of pemle dermatoses presenting to
other departments. This was similar to that of
lesions seen in the GUM clinic, with 8 (22%)
patients with LSc, eight (22%) with non
specific dermatitis (NSD), six (17%) with wart
virus infection and one (3%) with PIN seen in
other departments.
The histological diagnoses of these biopsies
are shown in table 3.
Discussion
There is now considerable interest in vulval
cutaneous disorders,^4 but relatively little
Table 3 Diagnoses in patients undergoing penile biopsy in other departments
Department Diae'ium Ma of Patients (n - 36)
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information is available about the cutaneous
pathology of the penis.5 *
Penile biopsy is a procedure which is per¬
formed rarely in GUM and other clinics, in
contrast to many other specialties where the
value of diagnostic biopsy is now well estab¬
lished. Whilst reluctance on behalf of the
clinician and the patient may be easily under¬
stood, we have found the procedure to be
technically straight forward, well tolerated and
safe. Considerable clinically useful information
was obtamed, with few complications, and a
cosmetically acceptable end result.
The varety of skin types found in different
parts of the penis may account, at least in part,
for the diversity of cutaneous abnormalities
seen in this area. However, as with skin
elsewhere, penile skin can react only in a
limited number of ways to endogenous and
exogenous influences, so providing a restricted
number of clinical presentations. It may be
difficult, therefore, to diagnose conditions such
as plasma cell balanitis and PIN without a
biopsy.
It is currently unknown to what extent
treatment alters the histological features of
penile skin, and it might prove difficult to
obtain ethical approval for such a study.
However, given that all forms of treatment
were withheld for a minimum of two weeks
prior to biopsy, we felt that such effects had
been reasonably excluded.
We postulate that the relatively fragile gla¬
brous skin of the glans penis may be partic¬
ularly sensitive to external irritants, thus
explaining why NSD was found frequently in
our study, and its predominant location in the
preputial sac. The clinical course had typically
been a relapsing and remitting one, usually
helped transiently by the application of 1%
clotrimazole (Canesten) cream. The most fre¬
quent pre-biopsy diagnosis, therefore, was
fungal balanitis. However, such cases of "can¬
didal" or "fungal" balanitis were found to have
histological changes of NSD, rather than the
characteristic finding associated with fungal
colonisation. The pathological changes ofNSD
can be produced by a wide variety of clinical
conditions, including partially treated infec¬
tions. Clearly inadequate hygiene in uncircum-
cised men could cause changes of NSD, but
the patients seen were notably conscientious
about their penile hygiene. Although it is
difficult to cxclud** completely a diagnosis of
fungal infection, the majority of individuals
had either a family or personal history of atopy,
and it was considered that the most likely
diagnosis was eczema. In these cases, clo¬
trimazole cream may have been simply acting
as an emollient or by some mechanism other
than its antifungal activity.
The malignant potential of LSc is currently
unclear. In one study," LSc was found in 48
(61%) of 78 women with vulval squamous
carcinoma, either adjacent to the lesion or
elsewhere on the body. There is less informa-
non on penile LSc, although three cases of
penile squamous carcinoma have been repor¬
ted in association with LSc;,u other reports are
sporadic." 12 The finding of LSc in biopsy
specimens of genital cancer does not neces¬
sarily imply it is premalignant, particularly in
view of its frequent occurrence in males
circumcised for other reasons.11 However, in
view of the current uncertainty about possible
malignant development, long term monitoring
would seem wise.'4
Only 25% of cases of lichen planus (LP)
were suspected prior to biopsy, and no men
had any evidence of disease elsewhere. LP
affects mucocutaneous membranes and
exhibits characteristic histological features.1
Vulvai lichen planus can be solitary and ero¬
sive, which may be difficult to diagnose on
both clinical and pathological grounds." Our
experience would suggest that this is also true
of penile LP.
Current views on the aetiology are that LP is
a cell mediated immune disorder, in which the
primary antigen has not yet been identi¬
fied.1017 Oral LP has a malignant potential,
and it has been recommended that vulval LP
be followed up long term." Less is known of
penile LP. There have been two case reports of
LP found in association with PIN and verru¬
cous carcinoma of the penis,18 so it could be
argued that penile LP shouid also be mon¬
itored indefinitely.
The four cases of PIN seen in this study were
all referred on the grounds that they had
atypical appearances which were similar to
sessile warts. The concept of PIN has recently
developed as an extension of the ideas behind
the classification of cervical intraepithelial neo¬
plasia (CIN) and vulval intraepithelial neo¬
plasia. The histological features are well char¬
acterised," although the clinical manifestations
are less well reported. Like CIN, the malignant
potential of PIN has still to be fully eval¬
uated.
The range of histological diagnoses made in
the other departments was broadly similar to
that in the PDC. Men with penile dermatoses
present to a variety of specialties, but each
specialty may see only occasional cases. In view
of the understandable concern of many
patients that their penile dermatosis may have
a sexually transmissible component, GUM
physicians are ideally placed to exclude such
diseases and provide any appropriate treatment
and follow up. Our information indicates that,
given the current lack of knowledge concern¬
ing the malignant potential of LSc, LP and
PIN, 27% (16 of 61) of patients attending the
PDC and 33% of patients attending other
departments may need long term review.
Information concerning the aetiology, natu¬
ral history and treatment of penile dermatoses
is sparse. Our data suggest chat diagnoses
based on clinical appearance alone are inade¬
quate. The skin snip biopsy technique provides
a simple, minimally invasive procedure which
markedly improves the rate of diagnosis of
such conditions. Pathological diagnoses were
obtained in the majority of cases, thus allowing
definitive treatment where indicated, and the
chance to learn more in cases where our
understanding is limited. It is often reassuring
for the patient to know the diagnosis, even
where current treatment options are limited.
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Detection of Human Papillomavirus DNA in the Urogenital Tracts
of Men With Anogenital Warts
R. J. HILLMAN, MRCP, M. 30TCHER8Y, MSC. B. K. RYAIT, MSc, N. HANNA, MB, AND 0. TAYLOR-ROBINSON, FRCP
Increasing evidence suggests that human papillomavirus
(HPV) infection of the female anogenital tract is multifocal.
Less is known of the distribution of HPVs in men. To investi¬
gate this, a prospective study was conducted of 116 men consec¬
utively attending a clinic for ablative treatment of anogenital
warts. Wart tissue, urethral swabs, and urine were obtained
from each patient. HPV DNA was extracted from the speci¬
mens and amplified using the polymerase chain reaction
(PCR). HPV types 6, 11, 16, 18, 31, and 33 were identified
using Southern blotting of the PCR product, followed by hybrid¬
ization. HPV DNA was detected in 112 (96.6%) of 116 wart
specimens and there was urethra' infection with HPV in 26
(22.4%) of the men. Eleven (61.1%) of 18 urethral specimens
taken with a loop and 22 (20.0%) of 116 urethral specimens
taken using a cotton-tipped swab contained HPV DNA. One
(6.3%) of 16 urine samples tested contained HPV DNA. HPV
types o and 11 were found in the urethra most commonly when
warts were seen near the urinary meatus, although HPV oc¬
curred in the urethras of men without clinically apparent mea-
tal warts. The proportion of urethral samples with HPV DNA,
including HPV types 16, 18, 31, and 33, was independent of the
location of visible warts at the time of sampling.
THE WIDESPREAD AVAILABILITY of Papani¬
colaou staining of cervical scrapes and colposcopy ser¬
vices has resulted in a rapid growth in the understanding
of the interaction between human papillomavirus
(HPV) and the anogemtal regions of women. Less is
known of the corresponding relationship in men. Evi¬
dence suggests that the majority of anogenital HPV in¬
fections are sexually acquired,' so it would seem likely
that men play a significant role in the epidemiology of
the genitotropic HPVs.
Carriage of HPV in clinically normal cervices is now
well documented,2 and the suggestion has been raised
that such carriage may be important in resistance to
treatment and recurrence after treatment.J In view of the
observation4 that urethral squamous papillomas tend to
develop in areas of metaplastic squamous epithelium, it
has been postulated5 that such areas of the male urethra
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may be analogous to the transitional zone of the cervix,
and may act as a reservoir for infection with HPV.6
The presence of HPV DNA in genital warts has been
determined by a variety ofmethods.7 Currently, the poly¬
merase chain reaction (PCR) is the most sensitive tech¬
nique.2 Southern blotting9 allows the confirmation of
DNA sequences produced by the PCR and enables the
type ofHPV to be determined. In view of their combina¬
tion of sensitivity and specificity, the PCR and Southern
blotting techniques were chosen for the analysis of all
specimens in this study. The object of the study was to
assess the distribution of HPV in the male anogenital
tract. To achieve this, a group ofmen attending a genito¬
urinary department with clinically apparent anogenital
warts was selected on the assumption that they would be
likely to carry HPV in large quantities in their anogenital
regions. Samples of wart tissue were taken for analysis
and the results compared with urethral specimens ob¬
tained by two different methods.
Methods
Patients and Collection ofSpecimens
Informed consent was obtained from 116 men attend¬
ing consecutively a clinic for the surgical removal ofano¬
genital wans. Referral to this clinic was based on the
presence of warts that the clinician thought would be
best treated by surgical ablation, either because of their
anatomic location or their failure to respond to conven¬
tional treatment. All patients were offered screening for
the common sexually transmitted infections, and these
were treated before the patient entered the study.
Strict precautions against contamination of the speci¬
mens by HPVs were taken. Gloves were changed be¬
tween patients, and all instruments were hand-washed,
placed in an ultrasonic cleaner, and autoclaved before
reuse. Specimens were collected using a "no touch" tech-
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nique and placed in sterile, disposable bottles before anal¬
ysis in the laboratory.
Wart specimens were removed by a diathermy ma¬
chine (Surgitron STW-60; Meditronix, Barcelona,
Spain) and placed in phosphate-buffered saline (PBS). A
random selection ofbiopsy specimens also was placed in
formal saline and sent for routine histopathologic assess¬
ment.
Cotton-tipped swabs ("STD-Pen for Males"; Abbott
Laboratories, Chicago, IL) were inserted 2 cm into the
urethras of all 116 men; each swab was replaced in the
container provided and sent to the laboratory for analy¬
sis. Using a 10-ul plastic loop (Nunc; GIBCO, Paisley,
Scotland), an additional specimen from the distal 2 cm
of the urethra was taken from a randomly selected group
of 18 of these men; the loop was used before the swab in
9 of the men. The loop was broken off in 10 mi of PBS
and transported to the laboratory. Patients were asked to
provide a 10-ml sample of first-pass urine after all ure¬
thral specimens had been taken.
Processing ofSpecimens
To avoid cross-contamination ofDNA products, prep¬
aration of reagents, processing of patient material, and
the PCR and Southern blotting took place in separate
rooms. Positive displacement pipettes or single-use Pas¬
teur pipettes were used for distributing reagents for the
PCR and for adding the DNA samples to the reaction
mixtures. Positive and negative controls were included
in each experiment. Laboratory staff were unaware of
the clinical status of the men.
Urine samples were centnfuged for 10 minutes at
3,000 rpm and the sediment suspended in 160 ul of 2X
Summers' buffer (40 mM TRIS-HC1. 0.3 M NaCl, and
20 mM EDTA-tetra sodium salt), pH 8.0. Three sterile
glass beads were added to each wart sample and the tubes
vortexed for 1 minute to break up the tissue. Wart speci¬
mens disrupted by this method and urethral swabs were
then added directly to 160 /d of 2x Summers' buffer.
Twenty-eight microliters of 2.5% sodium dodecvl sulfate
(SDS), 4 fil of tRNA, and 100 «1 ofsterile double distilled
water (ddH;0) were added to the samples, which were
then incubated for 16 to 20 hours at 37 °C with pronase
E (10 mg/mi). DNA was isolated by a modification of
standard procedures,10 using two phenol extractions
(TE-equilibrated phenol), followed by a chloroform-is-
oamyl alcohol (24:1) extraction and an ethanol precipita¬
tion step for 1 hour at -70 °C. The DNA pellet was
collected by centrifugation for 10 minutes at 14.000
rpm, washed briefly with 70% ethanol, and dried under
vacuum for 30 minutes. The resulting DNA pellet was
resuspended in 40 /il ddFLO. From this, 20 id was used
to determine the presence ofDNA in the sample by re¬
striction enzyme digestion with Bam HI. Bands were
then observed on an ethidium bromide-stained aga¬
rose gel.
Polymerase Chain Reaction
Target sequences on the LI open-reading frame of
HPV types 6, 11, 16, 18, 31, and 33 were amplified using
general primers GP5 and GP6." Amplification was
carried out using a 100yd reaction mixture containing
sample DNA, 50 mM KC1, 10 mM Tris-HCl pH 8.3, 3
mM MgCL, 0.01% w/v gelatin, 200 y.M each of dATP,
dGTP, dTTP, and dCTP, 50 nmol each ofGPS and GP6
primers, and 2.5 units of Taq polymerase (GIBCO-BRL,
Paisley, Scotland, United Kingdom). This mixture was
overlaid with a few drops ofmineral oil to prevent evapo¬
ration, and subjected to 40 cycles of amplification using
a DNA thermal processor (Model HB-TR1, Hybaid,
Teddington. United Kingdom). Each cycle included de-
naturation at 94 °C for 20 seconds, primer annealing at
40 °C for 60 seconds, and chain elongation at 72 "C for
20 seconds.12-'3 Samples containing 100 pg of the full-
length genome ofHPV types 6. 11, 16, and 18 were used
as positive controls. Negative controls were a fibroblast
line (MRC-5) and ddH;0 (Figure 1). Titration experi¬
ments were performed for HPV types 6, 11, 16, and 18,
and the detection limit of this system was found consis¬
tently to be 10~14 g or less of HPV DNA. This corre¬
sponded to approximately 10 molecules HPV DNA/100
m1 reaction mixture. Using standard methods,l4the sensi¬
tivity of detection of HPV types 31 and 33 was estab¬
lished to be 10_l° g of HPV DNA.
Southern Blot Analysis
The products of the PCR were analyzed by agarose gel
electrophoresis with ethidium bromide staining. <5X174
DNA cut with Hae III restriction endonuclease was used
to enable estimation of the sizes of the PCR products.
Southern blotting was performed using a modification of
standard protocols.10 The agarose gel was denatured for
30 minutes in 1.5 M NaCl/0.5 M NaOH. followed by
neutralization for 60 minutes in 1.5 M NaCl/0.5 M Tris
pH 7.5/1 mM EDTA. The DNA products were then
transferred from the agarose gel to nylon membranes
(GeneScreen Plus; DuPont, Wilmington, DE) by a capil¬
lary blot procedure using 6x SSC (0.9 M NaCl, 0.09 M
sodium citrate) as the transfer buffer.
Hybridization for HPV types 6, 11, 16, and 18 was
carried out at 65 °C using full-length genomic probes
which had been labeled with 32P-labe!ed dCTP by the
random primer method. Hybridization for HPV types
31 and 33 was performed at 55 3C using oligonucleotide
probes that had been end-labeled with 32P-labeled dATP.
Hybridization was undertaken in a solution containing
6X SSC. 20X Denhardt's solution (0.4% bovine serum
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albumin, 0.4% polyvinyl pyrrolidone, 0.4% Ficoil 400),
0.5% SDS. I mM EDTA-disodium salt, and 50 Mg/ml
salmon sperm DNA.
Where full-length probes were used. Southern blots
were washed once for 60 minutes with 2X SSC/0.1%
SDS at 65 °C and once for 60 minutes with 0. IX SSC/
0.1% SDS at 65 °C to remove nonspecificallv bound
probe. In the case of oligonucleotide probes, the blots
were washed twice for 5 minutes with 2X SSC/0.1% SDS
at room temperature followed by one wash for 5 minutes
with 2x SSC/0.1% SDS at 55 °C. Autoradiography was
performed for 24 hours on Kodak (Rochester, NY) X-
OMAT S film between intensifying screens at —70 °C.
An example of this is shown in Figure 2.
Results
Clinical Features of the Patients
Fifty-four (46.6%) of the 116 men were homosexual,
50 (43.1%) heterosexual, 7 (6.0%) bisexual, and 5 (4.3%)
were of unspecified sexual orientation. The age range of
the men was 16.1 to 61.6 years (mean, 28.6 years). A
history of other previous sexually transmitted diseases
was given by 5 1 (44.0%) of the men. Two (5.9%) of 34
men who had undergone testing for the human immuno¬
deficiency virus within 3 years before sampling of their
warts were found to carry antibody.
The men had been aware of their warts for an average
of 18.1 months (range, 0.5-120 months) before undergo¬
ing biopsy. Fifty-four (46.6%) of the biopsy specimens
were assessed histologically, and all were found to have
changes consistent with wart virus infection.14 None of
the specimens showed evidence ofdysplasia. The clinical
appearance of the warts was described as classical condy¬
lomata acuminata in 94 (81.1%) of the men, planar in 10
(8.6%), hyperkeratotic in 26 (22.4%), mixed type in 13
(11.2%), and pigmented in 1.
At the time ofsampling, warts were seen at the meatus
in 7 (6.0%) of the men. the gians in 10 (8.6%), coronal
region in 10 (8.6%), foreskin in 8 (6.8%), shaft in 26
(22.4%), scrotum in 4 (3.4%), inguinal region in 5 (4.3%),
perineal area in 3 (2.6%), perianal area in 78 (67.2%),



































Fig. 2. Hybridization of polymerase chain reaction products with
human oapillomavirus (HPV) type 5-specific probe on nylon mem¬
brane after Southern blot. Abbreviations as for Figure 1. Positive
result seen for HPV type 6 control, warts nos. 3. 9. 10, 12, 13, 15.
and 16. and swao no. 14.
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Types ofHPVs in Anogenitai Warts
HPV DNA was detected in 112 (96.5%) of 116 wart
specimens. Types 6 and 11 were the most common
(84.8% and 82.1%, respectively) and types 31 and 33 the
least common (0.9% and 2.7%, respectively; Table 1).
Infection with two or more types of HPV was found in
84 (72.4%) of the warts. The most common multiple
infection was with types 6 and 11, which occurred to¬
gether in 58 (50.0%) of the men and in combination with
other HPV types in a further 21 (18.1%) men. HPV type
6 was found in 83 (99%) of the 84 multiple infections and
type 11 in 79 (94%) of such infections.
The distribution of HPV type found in the warts did
not vary significantly with the site of the biopsy or age of
the patient (data not shown).
Types ofHPVs in the Urethra
Swab specimens. Twenty-two (19.0%) of the 116 ure¬
thral swabs contained HPV DNA. Detection rate did not
vary with sexual orientation. Again, types 6 and 11 were
the most common, but type 16 was detected relatively
more often than it was in the warts (Table 1). Fourteen
(63.3%) of the 22 swabs contained a single HPV type.
Multiple HPV types were found in eight (36.3%) of the
swabs in which any HPV DNA could be detected. HPV
type 6 was found in seven (87.5%) of the eight swabs
containing more than one type, and HPV type 11 in all
eight. HPV type 16 was the most common single HPV
type detectable, being found in 7 (50%) of the 14 swabs in
which only one HPV type was found.
Loop specimens. HPV DNA was detected in 11
(61.1%) of the 18 urethral loop specimens. Detection
rate did not vary with sexual orientation. Whether the
loop or swab specimen was taken first had no apprecia¬
ble effect on the rate of detection. The distribution of
HPV types was similar to that seen with the swab speci¬
mens (Table 1). In 5 (27.8%) of 18 specimens there was
evidence of a single HPV type, which was HPV type 16
TABLE 1. Types of HPV DNA Found in Men With Anogenitai Warts
No. of Specimens Positive for Indicated Type
HPV Warts Swabs Loops
Type (n = 112) (n = 22) (n = 11)
S 95 (84.8)' 9 (40.9) 5 (45.5)
11 92 (82.1) 10 (45.5%) 5 (45.5)
16 10 (8.9) 3 (36.3) 6 (54.5)
18 20 (17.3) 5 (27.3) 4 (36.3)
31 1 (0.9) 2(9.1) 1 (9.1)
33 3 (2.7) 2(9.1) 1 (9-1)
n = no. of specimens containing HPV DNA.
'
Figures in brackets are percentages of samples containing HPV.















Meatus 7 ' (85.7) ; (66.7) 6(85.7
Glans 6 i (16.7) j (33.3) 2 (33.3
Corona 5 i (66.7) N.L. 4
Foreskin 4 O N.L. 0




Inguinal 2 02 N.L. 0
Perianal 57 if (14.9) f (60) 13 (19.4
Intra-anal 3 07 N.L. 0
n = Total numDer of patients or of samples taken: N.L. = no loot
sample taken.
" Location of clinically apparent warts seen nearest to the urinary
meatus at the time of biopsy.
t Total numoer of patients in each category with swabs or loop sped
mens containing HPV DNA.
+ Numerator signifies the number of samples with HPV DNA de¬
tected in that particular group.
in all cases. Of the six loop specimens in which multiple
HPV types were detected, HPV type 6 was always pres¬
ent and HPV type 11 found in five (83.3%).
Of the 11 men who had HPV-positive loop samples,
only 5 had urethral swabs specimens that also were
HPV-positive. In all cases where both loop and urethral
swab specimens contained HPV, at least one HPV type
was common to both specimens.
Urine specimens. HPV DNA was detected in only 1
(6.7%) of 15 urine samples tested. This was found ta
comprise HPV types 16 and 18. The patient had only
perianal warts and no history of warts elsewhere. Analy¬
sis of the wart specimen revealed HPV type 6 alone. No
urethral loop sample was taken and HPV DNA was not
detected in the urethral swab specimen.
Association Between Location of Warts at Time of
Biopsy and HPV Detected in the Urethra
The location of the visible wans in relation to the re¬
sults of HPV DNA detection in urethral specimens is
shown in Table 2. Six (85.7%) of the seven men who had
clinically apparent meatal wans had HPV DNA de¬
tected in their urethral swab specimens. Thereafter, it
can be seen that the further away visible warts were from
the meatus at the time of urethral sampling by swab or
loop, the smaller the proportion ofurethral samples con¬
taining HPV DNA. The association was not seen with
loop samples, but the number examined was small.
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Location" HPV DNA 6 or 11 31. or 33
Meatus 6 6(100) 5(83)
Glans 2 2(100) 1 (50)
Corona 4 1 (25) 3(75)
Shaft 3 1 (33) 2(67)
Scrotum 1 0 1
Perianal 13 3(23) 11 (85)
' Location of clinically apparent warts seen nearest to the unnary
meatus at time of biopsy.
Association Between HPV Types Delected in Warts and
in the Urethra
The relation between the location of warts and the
HPV type in the urethra is shown in Table 3. HPV types
6 or 11 were found in diminishing frequency in the ure¬
thra as the warts were located more distally from the
urethral meatus. In contrast, there topeared to be no
such association for HPV types 16, 18, 31, or 33.
Of the 22 swab samples in which HPV DNA was de¬
tected, 10 (45.4%) had at ieast 1 type in common with
the corresponding warts. Furthermore, 6 (54.5%) of the
11 loop samples in which HPV DNA was detected had at
least 1 HPV type in common with the corresponding
warts.
Discussion
There have been several studies to determine the fre¬
quency and type of HPV DNA in anogenital warts in
men. The rinding of HPV DNA in 96.6% of wart speci¬
mens is consistent with the 69%'5 to 100%16 found in
previous studies. The small proportion ofwarts without
detectable HPV DNA in our study presumably repre¬
sents infection, with HPV types not tested for. small
quantities of viral DNA, or inadequate extraction of
DNA from the samples.
The most common method for screening for the pres¬
ence of infection with HPV is by clinical examination. It
has been suggested that this should be supplemented by
microscopic examination of the skin after the applica¬
tion of 3% to 5% acetic acid.'7"'9 In addition to the time
and resources required to undertake such an examina¬
tion, however, studies suggest that response to acetic acid
staining is not specific for HPV infection.20-21 Most clini¬
cally apparent HPV-associated lesions of the urethra oc¬
cur in the terminal 1 cm.22 Only one study3 has been
concerned with the response of the urethra to acetic acid,
and in this the procedure was found to be unhelpful.
Urethroscopy is not only impractical in a clinic setting,
2
but also carries the theoretical risk of spreading HP
more proximaily.
Another approach is to attempt to detect HPV directl
in the anogenital area. The PCR is sufficiently sensitiv
so that sample size may be minimized to restrict genit;
trauma. The interpretation of the results of such e>
tremely sensitive methods, however, must take into at
count contamination of the patients genitalia from re
cent contact, as weil as that potentially introduced dui
ing sample collection and processing. Epithelial cells ai
easily removed from the urethra, a principle that is we
established in diagnosing urethritis in the male. Urethrz
swabs designed for the detection of Chlamydia trachc
matis and the 10-^1 "blue loop" routinely used for th
investigation of urethritis in the maie were chosen fo
this study because they have been found previously to b
both acceptable to patients and effective in sampling th
urethral epithelium for urogenital pathogens. Initial anal
ysis of urethral specimens by Southern blotting showei
that more DNA was present in the swab specimens thai
in those obtained by the loop method. It was on the basi
of this finding that swab samples alone were taken tron
the rest of the men. When both loop and swab sample
were taken from the same patient, five of the six patient
whose swabs contained HPV DNA also had HPV DNA
positive loop specimens. Furthermore, HPV DNA wa
detected in five loop samples but not in the correspond
ing swab. Use of the loop would therefore seem to bi
more sensitive for the detection of urethral HPV infec
tion than that of the swab.
Attempts to detect HPV in urine by cytologic assess
ment.23"23 dot blot,26 and Southern blotting27 have beei
disappointing. Several groups'2-25-29 have detected HP'''
DNA in urine using the PCR, so this too was included ii
our study; however, we did not find that testing urini
was useful. It is possible that we may have detected mon
HPV ifwe had collected larger volumes ofurine,12 or hat
used early morning urine samples.
Twentv-five men had HPV DNA detected in theirure
thras and a further man had HPV DNA in his urine
although whether the latter was urethral in origin couk
not be assessed. Thus, overall there was evidence ofgeni
tourinary tract infection with HPV in 26 (22.4%) of thi
men. This compares with one study3 in which HP\
DNA was sought in the urethra using a cytologic brusl
to remove cells and Southern blotting to determine thi
HPV type; 25 (33%) of 75 men with genital warts wer<
HPV-positive in the urethra and 9 (36%) of these 25 met
had HPV types 16, 18, or 31. Wikstrom et al,30 using the
PCR in combination with the dot blot method, fount
that 46 (89%) of 52 men with genital warts had HP\
DNA in their urethras. It is unclear whether this reflect
a true difference in the epidemiology of HPV betweer
the populations studied, or methodologic differences.
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The sample of men chosen in our study was unusual,
containing a large proportion of homosexual men with
perianal warts that had been present for some consider¬
able time. Because newer warts contain more viral pani¬
cles than older ones,31 it is possible that the urethral
carriage rate would have been greater if a larger propor¬
tion ofmen with newly developed warts had been exam¬
ined. Furthermore, urethral carriage was more common
when warts were visible near the meatus, and the pre¬
ponderance ofmen in this study with perianal warts may
have led to a further underestimation of the typical
carnage rate. It is noteworthy that the association of ure¬
thral HPV DNA carriage with proximity of clinically
apparent warts to the meatus occurs with HPV types 6
and 11, but not with the other types considered. We sug¬
gest that types 16, 18, 31, and 33 may be true colonizers
of the urethra, whereas the finding of types 6 and 11 in
the urethra may be occurring as a result of contamina¬
tion from adjacent warts.
Multiple infections with different HPV types have
been reported,'3-32'33 although this has been disputed by
others.34 Tne use of full-length genomic probes, high-
stnngency hybridization conditions, and positive con¬
trols for all the HPV types provides us with the confi¬
dence that our results are indicative of true multiple in¬
fections, rather than cross-hybridization. In comparison
to warts, urethral infections were less likeiy to occur with
multiple HPV types, but more commonly with type 16.
The latter finding is consistent with the predominance of
HPV 16 in penoscopically abnormal areas.33'36 The nigh
frequency of clinically inapparent infection with HPV
16 may be an important factor in the mechanism by
which "high-risk males"36,37 increase the likelihood of
their partners developing cervical cancer.
Only about half the men had one or more HPV types
in the urethra that were in common with those in the
warts. This mismatch is seen also, for example, in the
HPV types found in neonatal foreskins and those in the
maternal cervix.36 The common occurrence in the geni¬
tal tract ofmultiple infections with HPV and the failure
to detect all HPV types may help to explain these situa¬
tions.
Clearly, the PCR is not yet suitable for routine clinical
practice, but it may be of value in helping to understand
the epidemiology of HPV and thus to devise manage¬
ment strategies. Even if the PCR was more widely avail¬
able, it is currently unclear whether the detection of
HPV DNA in small quantities in the absence of clinical
disease implies that the person is infectious to his sexual
partners. Detectable HPV DNA probably implies that
viral particles are being shed from the epithelium, how¬
ever, and that the person is potentially infectious. Fur¬
ther studies are required to assess infectivity, and to de¬
termine how the presence of HPV varies with time, in
other groups of men, and in response to treatment.
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Human papillomavirus DNA in the urogenital
tracts ofmen with gonorrhoea, penile warts or
genital dermatoses
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Objective—To assess the presence of
human papillomavirus (HPV) DNA in
urethral and urine specimens from men
with and without sexually transmitted
diseases.
Design—Prospective study.
Setting—Two London departments of
genitourinary medicine
Patients—100 men with urethral gonor¬
rhoea, 31 men with penile warts and 37
men with genital dermatoses.
Methods—Urethral and urine specimens
were taken, HPV DNA extracted and
then amplified using the polymerase
chain reaction. HPV types 6, 11, 16, 18,
31 and 33 were identified using Southern
blotting followed by hybridisation.
Results—HPV DNA was detected in 18-
31% of urethral swab specimens and in
0-14% of urine specimens. Men with
penile warts had HPV detected in ure¬
thral swabs more often than did men in
the other two clinical groups. "High
risk" HPV types were found in 71-83% of
swab specimens and in 73—80% of urine
specimens containing HPV DNA.
Conclusions—HPV is present in the uro¬
genital tracts of men with gonorrhoea,
penile warts and with genital der¬
matoses. In men with urethral gonor¬
rhoea, detection of HPV in urethral
specimens is not related to the number of
sexual partners, condom usage, racial
origin or past history of genital warts.
HPV DNA in the urethral swab and urine
specimens may represent different
aspects of the epidemiology of HPV in
the male genital tract. The preponder¬
ance of HPV types 16 and 18 in all three
groups of men may be relevant to the
concept of the "high risk male".
(IGenuounn Med 1993;69:187-192)
Introduction
Genital warts are the most common of the
sexually transmitted viral diseases in the
United Kingdom.: Evidence suggests-' chat
the majority of condylomata acuminata are
sexually acquired, but the epidemiology of
subclinical and latent infections of the genital
tract with HPV is less well understood.'
DNA from the "genitotropic" HPV types
has been isolated from clinically normal cer¬
vices5 and it has been suggested'* that carriage
of HPV in adjacent histologically normal tis¬
sue may be an important factor in the recur¬
rence of disease after treatment. The male
counterpart of carnage of HPV in the absence
of disease has not been fully defined, but
HPV DNA has been detected in the genital
tracts of 5-8% of men with no evidence of
condylomata acuminata attending blood
donor and dermatology clinics.7
Men with urethral gonorrhoea form a well
characterised group,* whose lifestyles have
put them at risk of acquiring sexually trans¬
mitted diseases. In an attempt to improve the
rational basis for the counselling of such men,
we evaluated the frequency of carriage of
HPV DNA in their urethras and urine. The
results were then compared with tnose
obtained from studying a group of mr.n with
penile warts and a group of men with no evi¬
dence of sexually transmitted diseases.
Methods
Patients and collection of specimens
One hundred maie patients who attended
consecutively one of two genitourinary medi¬
cine clinics during the period 1 July 1990 to
31 December 1990 were selected. Selection
was on the basis of having symptoms or signs
of urethritis, finding intracellular Gram-nega¬
tive diplococci on the urethral smear, and no
condylomata acuminata visible on clinical
examination of the genitalia, including the
meatus. A urethral sample taken with a 10 /il
plastic loop (GIBCO, Paisley, UK) was
spread onto a glass slide for Gram staining
and subsequently smeared onto a selective
medium. Then, the plates were incubated at
37°C in an atmosphere of air and 6% C02
before transport to the laboratory for further
incubation and identification using standard
methods. Men were excluded if Neisseria gon¬
orrhoeae was found not to have been cultured
from the urethral swab.
After informed consent had been given, a
detailed clinical history was obtained using a
structured questionnaire. A second urethral
sample was taken using a cotton-tipped swab
("STD-Pen for Males", Abbott Laboratories,
Chicago, Illinois, USA) from all of the men.
This and the first sample from the two glass
urine test were kept for subsequent analysis in
88 of the cases.
Urethral swab and urine samples were also
taken in the same manner from 32 men who
attended the clinics with penile warts and
from 37 men presenting with genital der-
of 2-5% sodium dodecyl sulphate (SDS) and
4/d of 0-8 mg/mi tRNA. Unne samples were
centrifuged at 3000 rpm for 10 min and che
pellet resuspended in 320 //I of the same lysis
buffer. Samples were incubated at 37°C
overnight to allow lysis of the cells and dis¬
ruption of proteins. DNA was isolated from
the specimens by two TE-equilibrated phenol
extraction followed by a 24:1 ehloroform-
isoamyl alcohol extraction and ethanol pre-
cipitauon for I hour at -70°C. The DNA
pellet was collected after centrifugadon for 10
min at 14 000 rpm, washed briefly with 70%
ethanoi and dried under vacuum for 30 min.
The resulting pellet was then resuspended in
40//l ddH.O.
Figure I Ethidium bromide staining of agarose gel with positive controls (HPV types 6,
11,16 and 18), negative controls (MRC-5 and JJH O). molecular weight marker (M)
(<pX174 DNA cut until Hae III enzyme) and specimens of DNA from urine (U) and
swabs (S).
matoses but with no evidence of sexually
transmitted disease at the time of sampling.
None of the men had meatal warts.
Processing of specimens
Attempts were made to avoid cross-contami-
nauon of DNA products by preparing of
reagents, processing patient material, and
undertaking the polymerase chain reacdon
(PCR) and Southern blotting in separate
rooms. Positive displacement pipettes or sin¬
gle-use Pasteur pipettes were used to distnb-
ute reagents for the PCR and to add che
DNA samples to the reaction mixtures.
Positive and negative controls were included
in each experiment.
DNA extraction
Urethral swabs were immersed in 320 /d of
lysis buffer containing 160/d of 2 x
Summers' buffer / pH 8-0 (40 mM TRIS-
HC1, 0-3M NaCl and 20mM EDTA-cetra
sodium salt), 100/d double disulled water
(ddH,0), 32//I pronase E (10 mg/ml), 28/d
77le PCR
The method was based on chat of Saiki et alf
in which general primers GP5 and GP610
were used to amplify DNA from che LI open
reading frame of HPV types 6, 11, 16, 18, 31
and 33.
Amplification of DNA was performed
using 100/d of a reaction mixture containing
50mM KC1, 10 mM Tris-HCl pH 8-3,
0-01% w/v gelatin, 200 uM. each of dATP,
dCTP, dGTP, and dTTP, 3-5 mM MgCh,
2-5 units of Taq polymerase (GIBCO, BRL
Life Technologies, Uxbndge, Middlesex,
UK) and 50nM each of GP5 and GP6. The
mixture was overlaid with several drops of
mineral oil to prevent evaporation and sub¬
jected co 40 cycles of amplification using a
PCR processor (Hybaid, Teddington, UK).
Each cycle included denaturation at 94°C for
20 seconds, primer annealing at 40°C for 60
seconds and chain elongation at 72°C for 20
seconds." 12 Samples containing 100 pg of the
full length genome of HPV types o, 11, 16
and 18 were used as positive controls.
Negative controls were a fibroblast line
(MRC-5) and ddH.O (fig 1). Senal dilutions
of HPV DNA were tested and the detection
limit was found consistently to be 10 ug or
less of DNA. This corresponded to approxi¬




























Figure 2 Hybridisation of PCR products with HPV type 11-specific probe on nylon
membrane following Southern blot. Abbreviations as for fig I. Positive residt seen for HPV
type 11 control, urine no. 8 and swab no. 9.
Southern blotting
20 //I of each of the products of the PCR were
analysed by using agarose gel electrophoresis
with eihidium bromide staining. </>Xl74 DNA
cut with Hae III restriction endonuclease was
used to enable estimation of the sizes of the
PCR products. Southern blotting was per¬
formed using a modification of standard pro¬
tocols.13 The agarose gel was denatured for
30 min in 1-5M NaCl/ 0-5M NaOH, fol¬
lowed by neutralisation for 60 min in 1-5M
NaCl/0-5M Tris pH 7-5/lmM EDTA. The
DNA products were then transferred from
the agarose gel to nylon membranes (Gene-
Screen Plus, DuPont, USA) by a capillary
blot procedure using 6 * SSC (0-9M NaCl,
0-09M sodium citrate) as the transfer buffer.
Hydridisation for the detection of HPV
types 6, 11, 16, 18, 31 and 33 was performed
at 55°C for 16 co 24 hours using oligonu¬
cleotide probes which had been end-labelled
Table 1 Types ofHPV DNA found in urethra and unne
of men with urethral gonorrhoea








6 5 (281* 3 (27) 7(28)
11 3 (44) 6(54) 13(52)
16 6(33) 6(54) 10 (40)
IS 7 (39) 2 (18) 8 (32)
31 2(11) 0 2(8)
33 2(11) 0 2(8)
'Figures in brackets are percentage of swab or unne speci¬
mens with HPV DNA present.
with J:P-labelled dATP. Hybridisation was
undertaken in a solution containing 6 x
SSC, 20 x Denhardt's solution (0-4%
bovine serum albumin, 0-4% polyvinyl
pyrrolidone, 0-4% Ficoll 400), 0-5% SDS,
ImM EDTA-disodium salt and 50//g/ml
salmon sperm DNA (Sigma, Dorset, U.K.)
To remove non-specifically bound probe, the
Southern blots were washed in low stringency
conditions of 2 * SSC/0-1% SDS for 5 min
at room temperature, followed by one wash
with 2 x SSC/0-l%SDS for 5 min at 55°C.
Autoradiography was performed for 24 hours
on Kodak X-OMAT S film between intensi¬
fying screens at — 70°C. An example of this is
shown in fig 2.
The oligonucleotide probes (prepared
using a Milligen/Biosearch 7500 DNA
Synthesizer) were:
HPV 6 5' ACA TGC GTC ATG TGG
AAG AGT 3'
HFV 11 5' TAA ATC TGC TAC ATA
CAC TAA 3'
HPV 16 5' TCT ACT TCA GAA ACT
ACA TAT 3*
HPV 18 5' TGC TTC TAC ACA GTC
TCC TGT 3'
HPV 31 5' CAC ACA AGT AAC TAG
TGA CAG 3'
HPV 33 5' TCT GTT TGT GCT GCA
ATT GCA 3'
Results
Demographic and clinical features of the patients
Seventy-six of the 100 men with urethral gon¬
orrhoea described themselves as heterosexual,
19 homosexual, and five bisexual. Their age
range was 17 0 to 55-6 years (mean 26-7
years). Fifty-two of the men were Caribbean,
34 Caucasian, eight African and four from
Table 2 Single and multiple types ofHPVfoud in
urethra and unne ofmen with gonorrhoea













6, 11 and 16
6 and 18
11, 16 and 18
16, 18, 31 and 33
31, 33
other racial groups. Information on the ethnic
origin of two men was not available. The
mean number of lifetime sexual partners was
43, with a range of 3 to 200; in addition, one
bisexual man claimed to have had 1000 life¬
time sexual partners. A history of genital
wans was given by six of the men. One of 85
of the men who gave blood specimens at che
time of presentation had serological evidence
of syphilis. Fifty-eight of the men were ciga¬
rette smokers. Of the 98 men who provided
information on condom usage, 27 claimed
always, 59 sometimes and 12 never to have
used them.
The demographic and clinical features of
the men with penile warts or with no evi¬
dence of sexually transmitted diseases were
not appreciably different from the men with
gonorrhoea.
Types ofHPV detected in swab and unne
specimens from men with gonorrhoea
Eighteen of 100 urethral swabs and 11
(12-5%) of 88 urine specimens that were
obtained contained HPV DNA. Overall,
HPV DNA was detected in one or other
specimen from 25 men; this comprised 15
(25-8%) of the 58 cigarette smokers and 10
(27-8%) of the 42 non-smokers. HPV types
11, 16 and 18 were the most common in both
types of specimen (Table 1). The different
combinations of types of HPV found in the
specimens is shown in Table 2. DNA from
HPV types 16, 18 31 or 33 (the so-called
•'high risk" types) was found in 15 (83%) of
18 swabs and in 8 (73%) of 11 urine speci¬
mens in which any HPV DNA could be
detected.
HPV in relation to demographic and clinical
details ofmen with gonorrhoea
The occurrence of HPV types in urethral or
urine specimens was not associated signifi¬
cantly with racial origin, the number of life-
dme sexuai partners, a history of non-genital
warts, condom usage, or whether cigarettes
were smoked.
Twenty-one (28%) of the 75 men who
were 30 years or less had detectable HPV, as
compared to four (16%) of the 25 men who
were older. Twenty-two (29%) of the 76 het¬
erosexual men, three (16%) of the 19 homo¬
sexual men and none of the five bisexual men
had HPV detectable. One (17%) of the six men
with a history of genital warts had HPV present.
Table 3 Detection ofHPV in urethral swab and unne
specimens in relation to clinical group









Urethral swab 18/100 (18) 10/32 (31) 7/37 (19)
Urine 11/88 (13) 0/5 5/37 (14)
Urethral swab
or urine 25/100 (25) 10/32 (31) 9/37 (24)
"High risk" HPV types
Urethral swab
specimen 15/18 (83) 8/10 (80) 5/7 (71)
Urine specimens 8/11 (73) 0/0 4/5 (80)
Detection ofHPV in relation to clinical group
The results of testing urethral and urme spec¬
imens from men with gonorrhoea are com¬
pared with those from men with penile warts
and with genital dermatoses in Table 3. The
occurrence of HPV in the specimens from the
men and the proportion of those with "high
risk" types appear to be independent of clini¬
cal status.
Discussion
The results of several studies14~,M have shown
that 20%16 to 32%14 of men presenting to
genitourinary clinics with genital wans have
evidence of at least one other sexually trans¬
missible disease (STD). In panicular, the
incidence of gonorrhoea in such men varies
from ()%IT to 0-Q%.14 These studies rely on
the clinical identification of condylomata
acuminata, which probably represent only a
minority of HPV infections of the anogenital
area1'' and they do not address the subject of
this communication, namely the question of
how often men with gonorrhoea are infected
by HPV.
'Hie use of DNA technology, in particular
the PGR, has led to the detection of HPV in a
large proportion of cervical scrapes from
women with and without clinically apparent
disease.' Understanding the epidemiology of
HPV infection of the male genital tract has,
however, been hampered by the lack of a
satisfactory counterpart to the cervical scrape.
Urethral cytology3*"22 and HPV antigen detec¬
tion have been found insensitive for
detecting HPV. Furthermore, there seems to
be a poor correlation in men between cyto-
logicai abnormalities and the presence of
HPV DNA.:l Thus, the question of what
constitutes an appropriate approach to sam¬
pling in men is pertinent.
Anogenital infection with HPV seems to be
multifocal*"' and there is evidence of wide¬
spread subclinical infection which may be
visualised by acetic acid staining.-'0 However,
this method is neither specific27 nor sensi¬
tive,-'* and its general introduction for the
screening of men would have significant
resource implications with no clearly estab¬
lished benefit."'11
In contrast, samples obtained by applying
abrasive pads and brushes to the male
genitalia1"'*' have enabled specific detection of
HPV. The majority of urethral condylomata
acuminata develop in the distal 1 cm of the
urethra1' and it has been postulated32 that this
area of the urethra may be analogous to the
transitional zone of the cervical epithelium
and might act as a reservoir for infection with
HPV.:2 In view of these observations, the
finding1" that urethral swabs are as effective as
abrasive pads in detecting infection with HPV
in male genitalia, and that the men had a
urethral discharge, we undertook urethral
sampling of our patients. Cotton wool-tipped
swabs, designed originally for the detection of
C. trachomatis, were used, as they have been
found previously to be acceptable to patients
and effective in sampling the urethral epitheli¬
um for urogenital pathogens. As several
groups11 34 35 have detected HPV DNA in
urine, examination of urine also formed part
of our study.
The PCR, when used under carefully con¬
trolled conditions, is currently the most sensi¬
tive technique for the detection of HPV,'6
allowing detection of very few viral particles.
Sample size, therefore, may be small and
genital trauma minimised. As great care was
taken dunng the collection of clinical
matenal, and both positive and negative con¬
trols were used at ail stages of analysis of the
specimens, we are confident that the results
reflect the true occurrence of HPV in the
specimens, rather than contamination. Our
detection of HPV DNA in the urogenital
tracts of 24—31% of men attending the clinics
compares with the finding of HPV DNA in
the genital tracts of 31 (5-8%) of 530 men
attending a blood donation centre and a der¬
matology department,7 and of 7 (8%) of 89
Swedish army recruits,20 none of whom had
clinical evidence of anogenitai warts. Our
findings are consistent with the 20% of men
attending STD clinics in the UK24 and the
USA'7 without evidence of condylomata
acuminata but with HPV DNA detectable in
genital swabs. One other group of workers10
found HPV DNA in 191 (84%) of 228 men
attending a Swedish STD clinic. The validity
of this result has yet to be confirmed, the
authors accepting that they may have over¬
estimated the incidence.
In an attempt to assess the significance of
finding HPV in a proportion of the urethral
swab specimens from men with gonorrhoea,
we investigated two other groups ofmen from
the same clinics. Men with penile warts were
included in view of their clinically apparent
infection with HPV and because of evidence3''
suggesting that HPV may be found con¬
taminating the urethra as a result of passive
transfer from adjacent warts. Wc also includ¬
ed a group of men with no sexually transmit¬
ted disease at the time of sampling, that is,
those with genital dermatoses. Of particular
note is the observation that similar propor¬
tions of men with gonorrhoea and men with
no sexually transmitted disease had HPV
DNA detected in both their urethral swab
and urine specimens. Furthermore, this
observation suggests that urethral irritation
per sc in men with gonorrhoea is not a signifi¬
cant factor in the shedding of HPV from the
urethra. The small number of urine speci¬
mens taken from men with penile warts
makes interpretation of the results for this
group ofmen difficult.
The detection of HPV DNA in the urine of
0-14% of the men in our study contrasts with
that in the urine of 15 (88%) of 17 men with
meatal warts and none of 14 healthy controls
in one study,11 and with that in the urine of
two (22%) of 9 men whose partners had HPV
infection.'4 Condylomata acuminata occur
rarely in the bladder3" and there have been
conflicting reports of HPV DNA in the
prostate.M'4' As only a small proportion of
men in each clinical group had HPV DNA
detectable in both the urine and urethral
swab specimens, it may be that these different
sampling techniques enable results in assess¬
ment of different aspects of infection of the
urogenital tract with HPV.
The significance of detecting HPVs in the
male urogenital tract is difficult to determine.
It is possible that a few viral particles might
remain on the genitalia from recent sexual
contact, and even from underwear,4- without
actually representing active infection. The
natural history of subclinical HPV infection
and, in particular the infectiousness for sexu¬
al partners, is also unknown. Indeed, it is
currently unclear whether subclinical HPV
infection is sexually acquired43 as DNA of the
genitotropic HPV types has been found in
virgins,13 the foreskin of neonates41 and on
fomites.4' The lack of correlation between the
presence of HPV DNA and the number of
life-time sexual partners of the men seen in
our study argues against sexual transmission,
as does the reported condom usage, although
the reliability of such reported behaviour is
clearly open to question. Furthermore, the
minor differences that we detected in the
rates of HPV infection in men with and
without sexually transmitted diseases suggest
that sexual lifestyle may not be a major factor
in determining infection with HPV.
However, the greater incidence of HPV in
men in younger age groups is consistent with
sexual transmission. Other authors34 37 have
also found ambiguous evidence of sexual
transmission in clinically inapparent infec¬
tions.
Our finding of a larger proportion of "high
risk" HPV types than "low risk" types in
asymptomatic infections normally found in
condylomata acuminata, is consistent with
the results of other studies.-434" Further¬
more, our observations were independent of
both the sample type and patient group, and
may be relevant to the concept of the "high
risk male", whose sexual partner(s) are at
increased risk of cervical dysplasia.44 4' In view
of the evidence linking infection with HPV to
anogenital neoplasia in both women and
men," further work needs to be done to fully
evaluate the various methods for detecting
HPV infection. In particular, the role of sexu¬
al aenvity in the acquisition and maintenance
of genital HPV infection needs to be clarified.
Only then will it be possible to understand
the nature of this condition, and to develop
rational management strategies.
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ORIGINAL ARTICLE
Human papillomavirus DNA in the urogenital
tracts of men with genital dermatoses:
evidence for multifocal infection
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xDivision of Sexually Transmitted Diseases, Clinical Research Centre, Watford Road,
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Summary: !n an attempt to assess the multifocal nature of anogenital HPV infection
in men, skin biopsies, urethral swabs and urine specimens were obtained from 100
men with genital dermatoses. The specimens were examined for the presence of
human papillomavirus (HPV) types 6, 11, 16, 18, 31 and 33 using the polymerase
chain reaction and Southern blotting techniques. HPV DNA was detected in one or
more specimens from 39 patients, that is 29 of 100 biopsy specimens, 21 (25%) of 85
urethral swab specimens and 6 (10%) of 59 urine specimens. HPV DNA was more
common in men with at least 20 lifetime sexual partners and in those who gave a
history of anogenital warts. Twelve (18%) of 66 biopsy specimens with no histological
evidence of warty change or neoplasia had detectable HPV DNA. HPV DNA was
detected no more frequently in the urethral and urine specimens from men with
histological evidence of warts or neoplasia than from men without such changes.
HPV types 6 and 11 were most common in biopsy specimens with histological
changes of typical HPV infection. HPV type 16 was commonest in biopsy specimens
with neoplasia and type 18 with other changes. Furthermore, 'high-risk' HPV types
were found proportionately more often in urethral swab and urine specimens than
in biopsy specimens. There was generally a poor correlation between the detection
of HPV DNA at the different sites.
A greater understanding of the role of HPV in the production of genital
abnormalities is required in order to develop a rational approach to the management
of these patients.
Keywords: HPV, male urogenital tract, genital dermatoses
INTRODUCTION
There is increasing evidence linking human
papillomavirus (HPV) infection of the female genital
tract with neoplasia1. Tire lack of a male counterpart
to the cervical scrape, together with the lower
incidence of penile carcinoma compared to cervical
carcinoma2, and the difficulty in interpreting the
results of acetic acid staining of the male genitalia3
has led to less attention being paid to the interaction
of the male genital tract with HPVs. The majority
of the clinically apparent genital HPV infections are
sexually acquired4, so we postulated that the
frequency of genital HPV infection in men might be
similar to that in women. To address this issue
Correspondence to: Dr R ] Hiilman, The Ambrose King Centre,
The Royal London Hospital, VVhitechapel, London El IBB, UK
we chose to examine men with and without HPV-
associated disease who had clinical indications for
genital biopsy.
Infection of the female genital tract with HPV is
often multifocaP. To determine whether infection
of the male genital tract with HPV is also multifocal,
we examined samples taken from 3 different sites
on the male genitalia. The polymerase chain reaction
(PCR) in combination with Southern blotting were
used to detect HPV DNA, as these methods are
highly sensitive and specific6.
METHODS
Patients and collection of specimens
One hundred male patients consecutively under¬
going genital biopsy at a genital dermatosis clinic
were selected. Men were referred to this clinic from
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the main genitourinary department if they had
a persistent genital dermatosis which had not
responded to treatment and the clinician felt that
biopsy would help in confirming the diagnosis. In
addition, patients were seen whose genital lesions
were atypical in appearance and in whom a biopsy
was considered necessary to establish the diagnosis'.
Lesions of classical condylomata acuminata were
not biopsied. All patients were screened for the
commonly occurring sexually transmitted pathogens,
and treated when necessary. After informed consent
had been obtained, a detailed clinical history was
taken using a structured questionnaire. The genitalia,
including the meatus, were examined by naked eye
and a biopsy taken from a representative area using
the skin snip technique7. The sample was then cut
into 2 pieces; one was placed in formal saline for
subsequent histopathological analysis, and the other
in phosphate-buffered saline (PBS) for HPV DNA
analysis. Once haemostasis had been secured, a
urethral sample was taken with a cotton-tipped
swab ('STD-Pen for Males', Abbott Laboratories,
Chicago, Illinois, USA) using a 'no touch'
technique. The patient was then asked to provide
10 ml of first-pass urine. The results of one set of
samples were recorded per patient.
Processing of specimens
Standard techniques were used for making
histopathological diagnoses8'9. All specimens in
which a histopathological diagnosis of non-specific
dermatitis was made were additionally stained by
the periodic acid Schiff method.
To avoid cross-contamination of DNA products,
preparation of reagents, the processing of patient
material, and the PCR together with Southern
blotting were performed at separate sites. Positive
displacement pipettes or single-use Pasteur pipettes
were used to distribute reagents for the PCR and
to add the DNA samples to the reaction mixtures.
Positive and negative controls were included in each
experiment. Laboratory staff were unaware of the
clinical status of the men.
DNA was extracted from the biopsy specimens
and urethral swabs as described previously10. Urine
samples were centrifuged for lOmin at 3000 rpm
and the sediment suspended in 160 /xl of 2x
Summers' buffer (40 mM TRIS-HC1, 0.3 M NaCl and
20 mM EDTA-tetra sodium salt) pH8.0. Samples
containing 100 pg of the full length genome of HPV
types 6,11,16 and 18 were used as positive controls;
types 31 and 33 were not available. Negative
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Figure I. Elhidium bromide staining of agarose gel with positive controls (HPV types 6,11,16 and 18), negative controls (MRC-5 fibroblasts
and ddH.O), molecular weight marker (4>X17i) and specimens of DNA from biopsies (BX), swabs (S) and urine (U). Samples BX-2a and BX-2b
are from two different sites on the scrotum of one patient. Positive results are seen with samples BX-4, S-4, U-4, 8X-5, BX-6, U-6, BX-1,
S-l, 8X-2a. and BX-2b
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Figure 2. Hybridization of PCR products with HPV type ll-specific probe on nylon membrane following Southern blot. Abbreviations as for
Figure 1. Positive results are seen with HPV type U control. BX-4, S-4, BX-5, BX-6 and U-6
controls comprised a fibroblast line (MRC-5) and
ddHsO (Figure 1).
The PCR method was based on that of Saiki et
al.11 and is described elsewhere10. The products
were analysed by the Southern blot procedure,
using agarose gel electrophoresis with ethidium
bromide staining. Hybridization for the detection of
HPV types 6, 11, 16, 18, 31 and 33 was performed
at 55°C for 16 to 24 h using oligonucleotide
probes* which had been end-labelled with 32P-
labelled dATP. Examples of this are shown in
Figure 2.
RESULTS
Clinical features of the patients
The age range of the men was 18.6 to 68.6 yr
(mean 35.9 yr). Seventy-five were Caucasian,
'Oligonucleotide probes (prepared using a Milligen/Biosearch
7500 DNA Synthesizer):
HPV 6 5' ACA TGC GTC ATG TGG AAC AGT 3'
HPV 11 5' TAA ATC TGC TAC ATA CAC TAA 3'
HPV 16 5' TCT ACT TCA GAA ACT ACA TAT 3'
HPV 18 5' TGC TTC TAC ACA GTC TCC TGT 3'
HPV 31 5' CAC ACA AGT AAC TAG TGA CAG 3'
HPV 33 5' TCT CTT TGT GCT GCA ATT GCA 3'
10 Afro-Caribbean and 15 of other racial origins.
Eighty-five of the men were heterosexual, 11
homosexual and 4 bisexual. The men admitted to
a range of one to 1000 (median 20) life-time sexual
partners. No men had typical genital warts at the
time of biopsy. Twenty men were circumcised, 69
were not and this information was not recorded in
11 cases. Nineteen men gave a history of anogenital
warts, 76 did not, and this information was not
recorded in 5 cases.
The lesions had been noticed by the men over a
range of one to 180 months (mean 31 months). At
the time of sampling, the predominant location of
the dermatosis was on the glans penis in 44 of the
men, coronal region in 12, frenulum in 2, foreskin
in 14, shaft in 26 and scrotum in 2. The histological
diagnoses of the biopsy specimens are shown in
Table 1.
HPV in relation to possible risk factors and
demographic details
The proportion of biopsy, urethral swab and urine
specimens containing HPV are given in relation to
various possible risk factors and demographic
details in Table 2. Although the numbers are small,
there is a suggestion that infection with HPV is more
common in men admitting to at least 20 lifetime
sexual partners than those with fewer partners, and
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Table 1. Histopathological diagnoses of biopsy specimens from
100 patients
Category Histopathological diagnosis No. of
patients
Wart Typical wart virus infection 22















'Histopathological change not amounting to PIN 1
"Penile intraepithelial neoplasia
This group comprised: normal, not diagnostic, scarring,
granuloma annulare, plasma cell balanitis, lentigo, venous
haemangioma, sebaceous cyst wall, molluscum contagiosum,
folliculitis and drug rash
in those with a history of anogenit?J warts compared
to those without. An association between HPV
infection and other factors is less clear.
Detection of HPV in relation to specimen type and
to histopathological findings
HPV DNA was detected in one or more biopsy, swab
or urine specimens from 39 patients. The histo¬
pathological findings in the biopsy specimens in
relation to the HPV types detected in the 3 types of
specimens are shown in Table 3. The relation between
HPV type detected, specimen type and histo¬
pathological findings is presented in Tables 4 and 5.
HPV in biopsy specimens
HPV DNA was detected in 29 of 100 biopsy
specimens (Table 4). Seven (28%) of 25 biopsies from
the glans, 3 (30%) of 10 from the corona, one (50%)
of 2 from the frenulum, 9 (29%) of 31 from the
foreskin, 8 (27%) of 30 from the shaft and one (33%)
of 3 from the scrotum contained HPV DNA. Of the
20 circumcised men, 7 (35%) had HPV DNA in their
biopsy specimens, that is 3 (33%) of 9 from the glans
and corona and 4 (36%) of 11 from elsewhere on the
genitalia. Of the 69 uncircumcised men, 18 (26%)
had HPV DNA in their biopsy specimens, that is
5 (31%) of 13 from the glans, none of 6 from the
corona, one (50%) of 2 from the frenulum, 9 (29%)
of 31 from the foreskin and 3 (18%) of 17 from
elsewhere on the genitalia.
Of the 22 men who had histological evidence of
typical HPV infection, 6 (27%) had a history of
anogenitai warts; of the 12 men who had histological
evidence of neoplasia, 4 (33%) had a history of
anogenitai warts; of the 66 men who had no histo¬
logical evidence of either typical HPV infection or
neoplasia, 13 (20%) had a history of anogenitai warts.
HPV DNA was detected in 32% of biopsy
specimens with histological evidence of typical
warts, 83% of specimens with neoplasia and 18%
of specimens in which histological evidence of either
change was absent (Table 5).
Wart specimens were associated most frequently
with HPV DNA types 6 or 11, specimens showing
neoplasia most frequently with type 16 and
specimens having other histopathological changes
with a variety of HPV types, most commonly HPV
types 11 and/or 18 (Table 5). Of particular note, all
3 basal cell papillomata were associated with HPV
type 6 (Table 3).
Infection with 2 or more HPV types was found
in 7 (24%) of 29 biopsy specimens containing HPV
DNA (Table 4).
Table 2. HPV in different specimens in relation to possible risk factors and some demographic details
Proportion'' (percentage) ot specimens of indicated specimen type positive for HPV
Possible risk factors/
demographic details
Any specimen Biopsy Urethral swab Urine
$20 partners 22/45 (49) 16/45 (35) 14/44 (32) 5/30 (17)
<20 partners 12/39 (31) 9/39 (23) 5/37 (14) 1/28 (4)
History" 10/19 (53) 9/19 (47) 6/17 (35) 1/8 (12)
No history" 28/76 (37) 19/76 (25) 14/64 (22) 5/49 (10)
Condoms not used 12/29 (41) 10/29 (34) 6/28 (21) 1/17 (6)
Condoms used 20/55 (36) 13/55 (24) 13/50 (26) 4/37 (11)
Smoker 16/39 (41) 14/39 (36) 9/37 (24) 2/20 (10)
Non-smoker 17/44 (39) 11/44 (25) 9/42 (21) 4/36 (11)
<35 years old 24/57 (42) 17/57 (30) 13/49 (26) 5/32 (16)
$35 years old 15/43 (35) 12/43 (28) 8/36 (22) 1/27 (4)
Caucasian 28/75 (37) 20/75 (27) 16/67 (24) 4/46 (9)
Non Caucasian 11/25 (44) 9/25 (36) 5/18 (28) 2/13 (15)
Heterosexual 34/85 (40) 28/85 (33) 16/72 (22) 4/48 (8)
Homo/bisexual 5/15 (33) 1/15 (7) 5/13 (38) 2/11 (18)
'Proportion for each possible risk factor: number of men with that specimen type containing HPV DNA, expressed as a proportion
of all men with that risk factor and whose HPV status for that specimen type was known.
"History of anogenitai warts given by patient
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Table 2. HPV DNA types detected in relation to histopathological
findings
HPV DNA types detected in
Table 4. HPV in relation to type of specimen
No. oi specimens of indicated type
indicated specimens
Histopathological Biopsy Urethral Urine
findings swab
Wart 6, 11 6, 11, 18 ns
Wart 6 — —
Wart 18 — —
Wart 6 — —
Wart 6, 11 ns ns
Wart 16 11, 18 ns
Wart 6, 11 — —
Wart — 18 —
Wart - 33 —
Neoplasia
Basal cell papilloma 6 6 ns
Basal cell papilloma 6 - -
Basal cell papilloma 6 — —
Dysplastic wart 16 — —
PIN 1 6 — —
PIN 2 - 18 18
PIN 2 +wart 16 ns ns
PIN 2 16 18 ns
PIN 2 6 — —
PIN 3 16 — ns
PIN 3 16 16 ns
Other
NSD 18 — ns
NSD 18 18, 31 —
NSD 6, 11, 18 18, 33 ns
NSD 18 - —
NSD 11, 18 11 ns
NSD — - 16
NSD — 33 33
LS 11, 18 11, 18 ns
LS 18 6, 11 ns
LS — 18, 31 ns
LS 11 11 11, 18
LS — 18 —
LS 31 — —
Lichen planus 31 ns ns
Lichen planus 16 16 -
Psoriasis — 18 18
Psoriasis 11, 18 11, 31 ns
Plasma cell balanitis — — 6
Venous haemangioma - 6 -
positive for HPV
HPV type Biopsy Urethral swab Urine
(n = 100) (H = 85) (» = 59)
Anv HPV 29 21 6
6 10(34)" 3(14) 1 (17)
11 8 (27) 6 (29) 1 (17)
16 7 (24) 2 (9) 0(0)
18 10 (34) 11 (52) 3 (50)
31 3 (10) 2 (9) 0(0)
33 0 (0) 4 (19) 1 (17)
>1 type 7 (24) 8 (38) 1 (17)
'Figures in brackets are expressed as percentages of all that
particular specimen type containing any HPV DNA
Table 5. HPV in relation to histopathological findings ofbiopsy
specimens from men with genital dermatoses
No. (%) of men with specified
HPV tvpe in indicated speci¬
men, according to histo-
pathological diagnosis
HPV type Wart Neoplasia Other
(i. = 22) (" = 12) (u=66)
Any type in biopsy specimens 7(32) 10 (83) 12 (18)
urethral swab specimens 4 (21)" 4 (36)" 13 (24)"
urine specimens 0 1 (14)" 5 (13)"
any specimen 9(41) 11 (92) 19 (29)
Type 6 in any specimen 5 (23) 4(33) 4(6)
Type 11 in any specimen 4(18) 0 6(9)
Type 16 in any specimen 1(5) 6 (50) 2(3)
Type 18 in any specimen 4(18) 2(17) 12 (18)
Type 31 in any specimen 0 0 4(6)
Type 33 in any specimen 1 (5) 0 3(4)
> 1 type in any specimen 4(18) 1 (8) 7(11)
— = No HPV DNA detected; ns = no specimen obtained:
PIN = penile intraepithelial neoplasia; NSD = non-specific
dermatosis; IS-lichen sclerosus
HPV in urethral swab specimens
Urethral swab specimens were obtained from 85
men. Of these specimens, 21 (25%) contained HPV
DNA (Table 4).
HPV DNA was more commonly detected in
urethral specimens from men with histological evi¬
dence of neoplasia than from men with histological
evidence of warts or other histological abnormalities
(Table 5). HPV type 18 was the type most frequently
detected in urethral swab specimens. Infection with
more than one HPV type was found in approxi¬
mately one-third of the swab specimens in which
HPV DNA could be detected (Table 4).
'Urethral swab and urine specimens were not obtained from all
men. The figures in these instances refer to those men from whom
urethral swab or urine specimens were taken
HPV in urine specimens
Urine specimens were obtained from 59 men. Of
these specimens, onlv 6 (10%) contained HPV DNA
(Table 4).
HPV DNA was detected in urine specimens from
no men with histological evidence of warts, and
only a small proportion of those with neoplasia or
other histological abnormalities (Table 5). HPV type
18 was the type most frequently detected in urine
specimens. Infection with more than one type
occurred on one occasion (Table 4).
Correlation between presence or absence of HPV
and type of specimen
A correlation between biopsy and swab and
between biopsy and urine was less obvious than
between swab and urine findings (Table 6). Ten
(28%) of the 36 patients with HPV present in biopsy
or urethral swab specimens had at least one HPV
type in common.
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Table 6. Correlation between presence (+) or absence (-)ofHPV
DNA and type of specimen
Biopsy Biopsy Swab
+ - + - + - ns
Swab Urine Urine
+ 13 8 + 15 + 4 2 0
- 13 51 - 12 41 - 6 46 1
ns 3 12 ns 16 25 ns 11 16 14
ns = no specimen obtained
DISCUSSION
The detection rate of HPV DNA may depend on the
population studied1. It is difficult to determine the
prevalence rate of HPV infection in the general
population. We chose men with clinical indications
for genital biopsy not in the belief that they
represented the general male community but that
they would do so more closely than patients
with 'conventional' sexually transmitted diseases.
Furthermore, men with genital dermatoses require
biopsy procedures for full investigation. Although
recruited from a department of genitourinary
medicine, the men were unusual for this source in
that they were generally older, had fewer lifetime
sexual partners, and did not have any clinically
apparent sexually transmitted disease at the time of
biopsy.
It has been suggested12 that the wide variations
in reported prevalence rates of genital HPV infections
may be related, at least in part, to the use of different
detection methods. The PCR allows the detection
of very small quantities of DNA and Southern
blotting with hybridization enables the specific
detection of the products. The 'genitotropic' HPV
types, that is, types 6, 11, 16, 18, 31 and 33
were investigated, as these seem to be some of
the commonest papillomaviruses infecting the
anogenital region13.
In order to investigate the multifocal nature of
male genital HPV infections, we used three sample
sites. Skin biopsy provides a sample,which includes
the lower epidermis, an area which is difficult to
access by other sampling techniques, yet is the site
of productive infection with HPV14. The biopsy
procedure also has the advantage of allowing the
simultaneous assessment of pathological changes
which might be associated with the presence of
HPV. However, it only permits the detection of
abnormalities in a small area and thus may lead to
an underestimation of the infection rate. Urethral
sampling allows collection of material from a larger
area, the distal urethra, which is proposed as the
male counterpart of the squamo-columnar junction
of the cervix15. We also tested urine samples since
HPV has been detected in the urine of men16'17.
Acetic acid staining of the genitals was not used as
it is neither sensitive18 nor specific3'19 when applied
to men.
Condylomata acuminata appear to be sexually
acquired in the majority of cases4. However, there
is less convincing evidence for the role of sexual
behaviour in the development of other types
of clinically apparent and inapparent disease
associated with HPV infection of the female uro¬
genital tract20. Data from our study suggest that
HPV DNA is more commonly found in those with
larger numbers of lifetime sexual partners, an
observation consistent with sexual transmission.
The detection of HPV DNA more commonly in
smokers than in non-smokers is consistent with the
finding of condylomata acuminata more commonly
in smokers21. Furthermore, the observation that
HPV was more commonly detected in men with a
history of anogenital warts than in those without
is compatible with the concept of latent infection.
The lower incidence of HPV DNA in biopsies from
homosexual and bisexual men compared to hetero¬
sexual men contrasts with the converse in urethral
swab and urine specimens. The reasons for this are
obscure, but it is tempting to speculate that different
sexual practices may be a contributory factor.
Clearlv, however, larger studies are needed to
investigate this matter.
The observation that HPV DNA was found in
approximately similar proportions of biopsies from
whatever site of the male genitalia, and regardless
of whether the patient was circumcized, confirms
the widespread distribution of HPV infection in
men. Disruption of skin integrity may promote
infection with HPV at sites of genital dermatoses,
but we cannot exclude the possibility of a uniform
distribution of HPV DNA throughout the intact
male genital tract. Such a distribution contrasts with
the occurrence of condylomata acuminata at specific
sites, frequently those traumatized during inter¬
course4, and suggests that other factors may be
involved in the development of clinically apparent
disease.
Our finding of HPV DNA in only 32% of genital
warts may reflect the unusual sample of warts. Only
genital lesions which were clinically atypical were
referred for biopsy, so that classical condylomata
acuminata were not seen. It is thus possible that our
sample may have contained a large proportion of
warts caused by non-genitotropic HPV types.
However, the observation that HPV types 6 and 11
were the most common in biopsies with histological
evidence of warty change is consistent with
previous reports22-23. Furthermore, the detection of
HPV type 16 in the majority of biopsy specimens
with histological evidence of dysplasia is in
agreement with the findings of others9-24.
Eighteen per cent of biopsy specimens with no
histological evidence of warts or dysplasia contained
HPV DNA. This is contrary to the observations of
some other groups investigating the male urogenital
tract, who have not been able to find HPV DNA in
biopsy specimens with no histological evidence of
warts or dysplasia25"8. It is, however, in agreement
with reports of others who have investigated the
male genital tract29. Furthermore, DNA from the
genitotropic HPV types has been detected in the
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absence of histological abnormalities in the cervix30,
neonatal foreskin31, the oropharynx32 and conjunc¬
tiva33. The finding of HPV DNA in a substantial
proportion of biopsies from men with aHariety of
dermatoses not typically associated with HPV infec¬
tion is of interest. More work is required, however, to
establish whether there is any causal association.
In the current study, HPV DNA was found in 25%
of urethral swab specimens and 10% of urine
specimens. These figures compare closely with
those for a group of 116 men with anogenital warts;
in these men, we detected HPV DNA in 20% of
urethral swab and 6.3% of urine specimens10.
Contrary to our expectations, HPV DNA was
found less frequently in the urethral swab and urine
specimens from men with histological evidence of
HPV infection or dysplasia than in those from men
with no such changes (Table 5). In addition, the
correlation between the presence or absence of HPV
DNA and type of specimen was generally poor
(Table 6). Furthermore, there was no discernible
relationship between HPV types found in the
different specimens from the same man (Table 3).
These 3 observations lead us to suggest that the 3
different sampling methods measure distinctly
different aspects of the epidemiology of HPV
infection in the urogenital tracts of men.
We are not surprised to have found HPV types
6 and 11 most commonly in biopsy specimens with
histological changes of HPV infection. We are
surprised, however, to have found 'high-risk' types
proportionally more often in urethral swab and
urine specimens. HPV type 16 is frequently found
in dysplastic lesions such as PINr and penile
carcinoma27, and a causal link has been postulated34.
However, due to the fact that HPV infection of the
male urogenital tract by 'high-risk' HPV types is
widespread, any proposal to link infection by these
types with neoplasia must take the common
occurrence into account. Indeed, it provides a
situation not dissimilar from that encountered in
establishing a causal link between 'high-risk' HPV
types and cervical carcinoma1 against a background
of commonly occurring 'high-risk' types.
Finally, a clearer understanding of the epidemiology
of urogenital HPV infections and any associated
histological abnormalities is required before rational
management strategies may be devised.
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Objectives—To investigate the relation¬
ship between clinical findings and the
detection of human papillomavirus
(HPV) DNA in a range of anatomical
sites in patients with and without
anogenital warts.
Subjects—Men and women with a clini¬
cal diagnosis of anogenital warts, or a
current partner with anoge-itai warts.
Setting—A department of genitourinary
medicine in central London.
Methods—The anogenital areas of the
patients were thoroughly examined using
a colposcope before and after application
of acetic acid. Different types of speci¬
mens were taken from a variety of
anatomical sites. Superficial skin sam¬
pling was performed by the application
of slides covered with "Superglue" (SG)
to clinically normal and abnormal areas
of anogenital skin. The presence of
human cells in the SG samples was con¬
firmed by detection of the /f-globin gene
using the polymerase chain reaction
(PCR). HPV DNA was extracted from
the specimens and amplified by using
consensus primers with the PCR. HPV
types 6,11,16,18,31 and 33 were identified
by Southern blotting followed by hybrid¬
isation.
Results—In women, HPV DNA was
detected in 83% of wart biopsies, 29% of
cervical biopsies, 36% of cervical
scrapes, 25% of urethral loop specimens,
37% of vaginal washes and 33% of rectal
swab specimens. In men, HPV DNA was
detected in 67% of wart biopsies, 37% of
urethral loop specimens and 12% of rec¬
tal swab specimens. Of the SG samples
containing the ,/i-giobin gene, 49% from
women and 50% from men contained
HPV DNA. HPV DNA was not detected
in buccal scrapes and serum samples
from women or men. Of all specimens
with detectable HPV DNA, there was
evidence of a single HPV type in 41%,
multiple types in 48% and undetermined
types in 11%. Samples taken from differ¬
ent sites of a patient tended to have HPV
types in common. Sexual partners, how¬
ever, did not consistently have HPV
types in common.
Conclusions—HPV DNA was distributed
widely in the anogenital area, in warts,
acetowhite areas and clinically normal
skin. The SG technique was- well toler¬
ated by patients and produced results
consistent with other findings. Sampling
from a single site of the genitalia on one
occasion may significantly underestimate
the infection rate with HPV. Multifocal
infection of the anogenital area with HPV
should be taken into consideration when




Although there is considerable evidence that
condylomata acuminata are usually sexually
transmitted,1: the .pidemioiogy of clinically
inapparent infection with gemtotropic human
papillomavirus (HPV) types is less weil
understood.' Studies of the uterine cervix
have shown that HPV infection is common,
may not be associated with cytological4 or
histological5 abnormalities and has epidemio¬
logical characteristics which suggest that sex¬
ual transmission may not be the only mode of
acquisition.' Furthermore, the reianonship
between the detecnon of HPV and. the develop¬
ment of histological and/or clinical changes is
imperfectly understood, and the relationship
may vary with time.7
In an attempt to characterise the multifocal
nature of HPV infection and its possible
change with time, we took a variety of sam¬
ples over several months from panents with
and 'without genital warts. The panents com¬
prised those, with anogenitai warts and their
partners who may or may not have had warts.
Following extraction of DNA from the speci¬
mens, the polymerase chain reaction (PCR)
was used, as dais is currently the most sensi¬
tive technique for the detection of HPV.S
Southern blotting' was chen performed, as ic
allows the highly specific confirmation of
DNA sequences produced by the PCR and
enables the type of HPV to be determined.
Patients and methods
COLLECTION OF SPECIMENS
Patients were invited to take part in the study
if either they or their sexual partner had clini¬
cally apparent anogemtal warts. A standard
history was taken and all patients were
screened for the commonly occurring sexually
transmitted diseases, and treated when appro¬
priate. The genital and perigenitai areas were
then examined with the naked eye and any
abnormalities documented diagrammarically.
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After application of 3-5% acetic acid to these
areas, microscopic examination using a Zeiss
coiposcope was undertaken.
Informed consent was obtained from the
patents and then samples were taken in the
conventional manner as follows: 10 fi\ plastic
loops (Nunc, Gibco, Paisley, Scotland) for
urethral specimens, Avre's spatulas for cer¬
vical scrapes and cvtological brushes
'("Cytobrush", Rocket, London, UK) for
endocervical specimens. Anal samples were
obtained by inserting a Cytobrush 1cm into
the anal canal and rotating it through 360°.
Tongue depressors were drawn along the
buccal surface of both sides of the mouth to
obtain buccal scrapes. The nps of the sam¬
pling instruments used in the aforementioned
procedures were broken off into individual
disposable bottles containing 10 ml of phos¬
phate-buffered saline (PBS). A vaginal sam¬
ple was obtained by washing the vaginal walls
and cervix with 10ml of normal saline using a
sterile syringe, aspirating the fluid and repeat¬
ing the procedure. Blood was obtained using
the "Vacutainer" (Becton Dickinson, Cowley,
UK) system. Superficial layers of the skin
were sampled by usmg "Supergiue" (SG)
cvanoacrylate glue (Bison™, Perfects Chemie
B.V., Goes, Holland). One drop of SG was
placed on a clean slide which was immedi¬
ately applied to the skin. After one minute,
the slide was gently removed and piaced in an
individual slide box. This procedure was well
tolerated by patients. If possible, SG samples
were taken from areas of skin containing
warts, or areas of skm including acetowhite
changes. Biopsies of the external genital area
were taken by the skm snip technique10 fol¬
lowing iocai anaesthesia. Biopsy specimens
were taken from wans and acetowhite areas
in women but only from warts in men.
Cervical biopsy samples were obtained by
cervical biopsy forceps W'iout anaesthesia.
Biopsy specimens were piaced in PBS for
DNA analysis and in formal saiine for
histopathological assessment.
Stria precautions against contammanon of
the specimens by HPVs were taken. All sam¬
pling instruments, except those used for tak¬
ing biopsy specimens, were sterile and
disposable. Biopsy specimens were taken with
re-usable equipment which was hand-washed,
placed in an ultrasonic cleaner (Olympus
Kevmed KS-2; Keymed, Southend on Sea,
UK) for 15 min and autoclaved at 134°C for
20 min (Little Sister 2, Eschmann Bros &
Walsh Ltd, Lancing, UK) before re-use. All
specimens were colleaed using a "no touch"
technique and placed in sterile, disposable
bottles prior to analysis.
To facilitate interpretation of results, speci¬
mens were divided into three groups.
"Biopsy" specimens consisted of specimens
from clinically abnormal and acetowhite
areas. SG specimens consisted of samples
obtained usmg the SG technique. The term
"non-biopsy" is used to describe all other
types of specimens.
Clinically apparent warts were treated in
the usual maimer for the clinic, namely, the
application of liquid nitrogen and 15%
podophyllin, both twice weekly until clinical
disappearance. Warts that recurred were
treated in a similar manner and any subse¬
quent recurrence managed by excision under
local anaesthesia.
Patients were counselled and kept fully
informed of any abnormality. Male patients
and male partners of patients were advised to
use condoms for the whole study penod.
PROCESSING OF SPECIMENS
In order to avoid cross-contamination of DNA
produas, preparation of reagents, processing
of patient material, and the PCR and
Southern blotting took place in separate
rooms. Positive displacement pipettes or sin¬
gle-use Pasteur pipettes were used for distrib¬
uting reagents for the PCR and for adding the
DNA samples to the reaction mixtures.
Positive and negative controls were included
in each experiment, including the SG samples.
DNA EXTRACTION
Wan and biopsy specimens were placed in
320 ft\ of lysis buffer containing 160 fil of 2 x
Summers' buffer, pH 8-0 (40 mM TRIS-
HC1, 0-3M NaCl and 20 mM EDTA-tetra
sodium salt), 100 id of double distilled H20
(ddH,0), 32 n\ of pronase E (lOmg/ml), 28
/d of 2-5% sodium dodecvl sulphate (SDS)
and 4 u 1 of t-RNA (0-8mg/ml). Sterile glass
beads were added to the biopsy specimens
to facilitate the disruption of cells during
vortexing.
SG slides were abraded with a sterile dis¬
posable scalpel blade and the resulting mater¬
ial immersed m 320 ft\ of lysis buffer. SDS in
the lysis buffer dissolved the cyanoacrvlate in
the specimen, releasing the sample material
into the buffer.
Wart, biopsy and SG specimens were incu¬
bated in the buffer at 37°C overnight to help
cells and disrupt proteins. DNA was isolated
from the specimens usmg phenol extraction,
followed by a chloroform-isoamvl alcohol
(24:1) extraction and ethanol precipnanon
for 1 hr at — 70°C. The DNA pellet was col¬
leaed after centrifugauon for 10 mm at
10,000 g, washed briefly with 70% ethanol
and dried under vacuum for 30 min. The
resulting pellet was then resuspended in 40 ul
ddH,0 and stored at — 70°C until further
analysis.
Urethral loops, cervical and buccal scrapes
and Cytobrush specimens were agitated in 10
ml of PBS, of which 1-5 ml was subsequently-
used for analysis. Vaginal washes were tested
directly. These samples were subsequently
denatured by heating to 95°C for 10 mm and
then centrifuged at 10,000 g for 2 min to
remove cellular debris and other extraneous
material. The supernatant fluid was then used
for the PCR.
Blood samples were centrifuged at 2000
rpm for 5 mm and the serum decanted. This
was used directly for the PCR.
DETECTION OF /1-GLOBIN GENE
In order to determine whether human DNA













Figure I Ethidium bromide staining of agarose gel
comprising positive controls (HPV Types 6,11,16 and 18),
negative controls (MRC'5 fibroblasts and ddH,0),
molecular weight marker bXl 74 (<jtXl 74 DNA cut with
Hae III enzyme) and specimens ofDNA from patient F3.
Abbreviations for the specimen descriptions are as follows:
SG = Superglue specimen; AW ~ specimen taken from
acetowhtte area; LLMN ~ left labium minus; LLAslJ -
left labium ma;us; F ~ fourchette; C = clitoris; 3S =
buccal smear; CS - cervical scrape; CW = cervical wart;
W - external wart; RC = rectal cytoorush; P ~ perianal
area. Positive results seen for HPV controls, SG specimens
from the fourchette and perianal area, as wed as an
acetowhue area on the left labium minus. Cervical scrape,
cervical wart and vulval wart specimens also contain HPV
DNA.
was detectable in the SG samples, part of the
human /?-giobin gene was amplified.
Amplificanon was earned out using 100 ,/zl of
reaction mixture containing 50mM KC1, 10
mM TRIS-HC1 pH 8-3, 0njl% w/v geiatin,
200 uM each of dATTf dCTP, dGTP, and
d I'll', 3-5 mM MgCl,, 2-5 units of Taq poly¬
merase (GEBCO-3RL, Paisley, Scotland) and
0-2 //M each of two ji-globin primers'1 (kindly
provided by che Medicai Research Council
AIDS Directed Programme): ji-globin (14-
33) ADPS94-1/LA1-N: 5'ACA CAA CTG
TGT TCA CTA GG 3' and /i-gloom (123-
104) ADP 394-2/LA2-C: 5'CAA CTT CAT
CCA CGT TCA CC 3'. The specimens were
then subjected to 40 cycles of amplification.
Each cycle included denaturanon at 94°C for
30 s, primer annealing at 55°C for 30 s and
chain elonganon at 72°C for 60 s. Posinve
controls were a fibroblast line derived from
embryonic lung dssue (MRC-5) and an
epithelial cell line derived from cervical carci¬



























Figure 2 Hybridisation of PCR produce with HPV type
11-specific probe on nyion membrane following Southern
blot. Abbreviations as for jig I and as follows: G = fans;
RLMJ - right Labium mams; S - scrotum; SH — shaft.
Positive results seen for HPV type 11 control. SG specimen
from the scrotum ofpatient ,Vf2 and SG specimen from the
fourchette of patient F2.
DETECTION OF HPV DNA
In the case of SG samples, only those con¬
taining detectable human /7-globin DNA were
tested for HPV DNA, whereas all specimens
obtained by other methods were tested. The
DNA extracted was amplified by 40 cycles of
the PCR using general primers GP5 and GP6
which amplifies DNA from HPV types o, 11,
16, 18, 31 and 33.12 Amplificanon was ear¬
ned out using 100 til of reaction mixture con¬
taining 50 mM KCI, 10 mM Tns HCI pH
8-3, 3 mM MgCU, 0*01% w/v gelatin, 200
//moles each of dGTP, dATP, dTTP and
dCTP, 10 //moles each of GP5 and GP612
primers and 2-5 units of Taq polymerase
(GIBCO-BRL, Paisley, Scotland). This mix¬
ture was overlaid with 100 ,zzl of mineral oil to
prevent water loss and subjected to 40 cycles
of amplificanon using a PCR processor
(Hybaid, Teddington, UK). Each cycle
included denaturanon at 94°C for 20 s,
annealing at a0°C for 60 s and chain elonga-
non at 72°C for 20 s. Samples containing 100
pg of the full length genome of HPV types 6,
11, 16 and 18 were used as posinve controls.
Negative controls were a fibroblast line
(MRC-5) and ddH,0 (fig 1). Detection of
the products of the PCR was by agarose gel
electrophoresis, confirmed by Southern blot¬
ting'3 and hybndisanon -with radiolabeiled
oligonucleonde probes.14 Positive controls
were fuil length genomic probes for HPV
types 6, 11, 16 and 18. Neganve controls
were MRC-5, ddH,0 and "Supergiue".
Examples of this can be seen in figs 2 and 3.
Results
CHARACTERISTICS OF PATIENTS.
Nine women and nine men took part m the
study. All panents were heterosexual. The
mean age of the women was 24-0 years (range
16-1 to 36-2) and that of the men 28-4 years
(range 22-9 to 36-3). Clinical details of che
panents are shown in cables 1 and 2; there


























Figure S Hybridisation of PCR products with HPV type
11-specific probe on nyion membrane following Southern
blot. Abbreviations as for fig I and as follows: 3 — biopsy,
SHW ~ shaft wart; GW - glans wart; C3 = cervical
biopsy; VB — vulval biopsy. In women, biopsies were
either from acetowhtte areas or from clinically apparent
warts. In men biopsies were always taken from ciintcally
apparent warts. Positive results seen for HPV cype 11
control, biopsies from patients M2 and F2, and warts from
F9 andM4.
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Table 1 Clinical, histological and cytological details offemale patients
Sites of Sites of Status Cervical
visible aceunohtte of biopsy:
Pt warts change partner histological changes
Fl none cemx warts (M3)S NAD
F2 fourchette cervix warts (M8)§ ns
F3 fourchette, cervix
fourchette, cervix
labia warts (M2)§ GIN 1, WVI
F4 cervix, labia wans NAD
F5 fourchette, cervix labia, cervix no warts koil
F6 none cervix no warts NCI
F7 none labia no warts (M9)§ ns
F8 none labia warts ns
F9 fourchette, labia labia no warts ns
Abbreviations used tn tables:
Pt = patient code.
§ = partner in the study as indicated,
ns = no specimen obtained.
NAD = no histological or cytoiogicai abnormality detected.
wart = histological changes of condviomatous wart virus infection.
CIN 1 = cervical intraepithelial neoplasia grade 1.
NCI = histological changes of non-condvlomatous HPV infection.
koil = koiiocyuc atypia.
Time = duration in months since first sample taken,
neg = HPV types 6, 11, 16, 18, 31 and 33 not detected.
* = biopsy from clinically apparent wart.
•+• = specimen contained HPV of types other than those tested for, ft = /3-giobin gene not
detected.
— = HPV of indicated type not detected.
Table 2 Clinical and histological details ofmale patients
Sues of Sites of Status
visible ucezowhtte of
Pi warts Jiange partner
Ml shaft none cervical dysplasia
M2 Shaft, inguinal gians warts fF3)§
M3 shaft gians no warts (Fl)§
M4 meatus, glans g!an< no warts
M5 shaft, inguinal none no warts
M6 corona corona warts
M7 shaft, gian* gians warts
M8 shaft gians warts (F2)§
M9 gians glans no warts (F7)§
OCCURRENCE OF HPV DNA IN BIOPSY,
NON-BIOPSY AND SG SPECIMENS
Biopsy specimens
HPV DNA was detected in five (83%) of six
biopsy specimens, with histological evidence
of HPV infection, from women (tables 1 and
3) and in six (67%) of nine from men (table
4). None of four biopsies of acetowhite areas
in the women contained HPV DNA, nor did
the biopsy of the skin tag (table 3). Two
(29%) of seven cervical biopsies contained
HPV DNA, of which one was histologically
abnormal (tables 1 and 3).
Non-oiopsy specimens
In women (table 3), HPV DNA was detected
in the following specimens: four (36%) of 11
cervical scrapes, two (25%) of eight from the
urethra, three (37%) of eight from the vagina,
two (33%) of six from the rectum and none
of five buccal scrapes (patients Fl, F2, F3,
F4 and F7). Patients F4 and F5 had border¬
line cervical cytological changes. Both these
cervical samples contained HPV DNA (table
3).
In men (table 4), HPV DNA was detected
in the following specimens: three (37%) of 8
from the urethra, 1 (12%) of 8 from the rec¬
tum and none of five buccal scrapes (patients
Ml, M2, M3. M6 and M9).
Serum samples from all nine men and six
of the nine women did not contain HPV
DNA.
F3-M2 and F7-M9), the partners of the
other patients not being available for study.
Panent F6 was referred by her general practi¬
tioner because of a suspicion of genital warts
seen at the nme of taking a cervical scrape.
There was no evidence of anogemtai warts at
the ame of assessment in the clinic, but a
papillary lesion noted in the vagina was biop¬
sied and found to be a skin tag. Four women
(Fl, F2, F5 and F7) and two men (Ml and
M2) did not have skin biopsies. Apart from
these, all other biopsies taken from clinically
apparent warts were confirmed histologically
as such. Biopsy of acet^white changes on the
labia of patient F8 showed changes of HPV
infection.
SG specimens
Forty SG samples were taken from women
(table 5) and 41 from men (table 4). Thirty-
seven (92%) of those from women and 18
(44%) of those from men contained the (f-
globin gene. Of the samples containing the B-
globin gene, 18 (49%) from women and tune
(50%) from men contained HPV DNA,
detection rates which compare favourably
with those of non-biopsy procedures.
Of SG samples from acetowhite areas,
HPV DNA was detected in those from the
labia of four of five women (tables 1 and 5)
and in those from the glans of two of four
men (tables 2 and 4).
Of the six men with shaft warts (table 2),
HPV DNA was detected in the shaft SG
specimens of four of the five men whose shaft
Table 3 HPVDNA tn biopsy and non-biopsy specimens from women in relation to types of specimens and times at
which taken
HPVDNA in sues and types of specimen indicated
Vulval Cervical. Cervical Urethral Vagmal Rectal
Pi Time biopsy biopsy• scrape loop wash stoao
Fl 0 neg 6 ns neg neg neg
4 neg neg neg neg neg ns
12 ns ns neg ns neg ns
F2 0 6, 11, 31* ns ns ns ns ns
4 ns neg neg ns 18,31 6, 11
F3 0 6, 11* ns 6, 11, 33 6, 11, 33 ns ns
2 6, 11* 6,11* neg ns ns ns
F4 0 6* neg* 6 6 fi¬ 6
F5 0 neg* neg* 6 neg ns ns
F6 0 neg ns neg neg neg neg
F7 0 neg ns ■+• neg 16 ns
F8 0 neg neg neg ns ns neg
F9 0 6, 11* neg neg neg neg neg
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Table 4 HPV DNA in biopsy, non-bioosy and SG specimens from men in relation to types of specimens and times at
which taken
HPV DNA in sites and types of specimen indicated
SG specimens from
Pt Time Biopsy Urethral loop Rectal swab Glans Shaft Scrotum Anus
Ml 0 as as as if /t- ns aeg
M2
7 as as as it- 18 neg li-
a as as aeg it- ti¬ o, 11, 18 lt-
4 6. 11 6 aeg aeg ns ns ns
M3 a neg as as aeg 18 as as
4 as neg aeg aeg aeg li¬ as
M4 0 o. 11 6, 11, 16 6, 11 6, 11 ■+■ as ti¬
3 as as as neg it~ ti¬ lt-
M5 0 6 neg aeg 18 6 ns as
M6 0 6 aeg aeg 6, 31 li- as as
M7 0 as as as li¬ it- as as
1 6, 33 6 aeg tis ns as as
•J 6, Li as as as as as as
3 as as as if aeg ti¬ 0-
M8 0 neg aeg aeg It- 18 ns aeg
M9 0 a aeg as it- it- it- li¬
SG wart specimens contained the //-giobin
gene (table 4). Similarly, HPV DNA was
detected in the fourchette SG samples from
all 3 women with fourchette warts who had
this sample taken (tables 1 and 5).
HPV DNA .AND TYPES IN RELATION TO SAMPLE
SITE .AND TLME OF SAMPLING
Site and time of sampling
Of the 12 possible sites in women (tables 3
and 5) from which samples could have been
taken on each occasion, 0-8 (mean 2-8) con-
tamed HPV DNA. Of the eight possible sites
in men (table 4) from which samples could
have been laken on each occasion, 1-5 (mean
1-25) contained HPV DNA.
Of the 3 panents from whom samples were
taken on more than one occasion (tables
3-5), live had HPV DNA detected in fewer
sites ana cwo 'in more sites than when lirst
seen. In one patient, the number of sites in
which HPV DNA was detected inidally
increased, but then decreased.
Types of HPV detected
Of the 56 samples in which HPV DNA was
detected, 23 (41%) had evidence of infecdon
with a singie type. 27 (48%) with multiple
cvpes and six (11%) with undetermined types
tables 2-5).
The distribution of HPV types in the vari¬
ous categories of specimens from women and
men is shown in table o. HPV types 6 and 11
were found most frequendy in the majority of
specimen categories. However, the other
types sought were found predominantiv in the
non-biopsy and SG specimen categories.
Samples taken from different sites of the
same panent frequendy contained the same
HPV cype. This is illustrated by samples from
patients F4 and M4, the majority of which
contained HPV cype 6. However, in patients
Table 5 HPV DNA findings in SG specimens from women in relation to types of specimens and times at which taken
HPV DNA in SG specimens from
ft Time Left labia Riqht labia Fourchette Clitoris Anus
Fl 0 aeg aeg as as aeg
4 — 18 as ns —
12 aeg aeg aeg as aeg
F2 0 o, 11, 33 33 6, 11,33 as 18, 33
4 o aeg aeg if as
F3 0 6, 11, 18, 33 as as as 6, 11
aeg aeg +- aeg as
F4 3 6, 11 o, 16, 18 as as 6, 11, 13
F5 0 0 aeg 6 ns as
F6 0 as ff aeg aeg as
F7 0 aeg aeg aeg as neg
F8 0 as as as as as
F9 0 6, 11 if 11 as as
Table 6 HPV type in relation to types of specimens




cype wart biopsy Non-biopsy SG Wart Non-oiopsy SG
0 5 (50) 2(67) 7 (41) 11 (34) 7(64) 4(57) 4(31)
11 4(40) 1 (33) 3(17) 3(24) 3(27) 2(29) 2(15-5)
16 — — I (6) I (3) — I (14) —
18 — — I (6) 5 (15) — — 5 (38-5)
31 1 (10) — I (6) — — — I (7-5)
33 — — 2 (12) 5(15) 1 (9) — —
+• — — 2 (12) 3 (9) — — 1 (7-5)
Total 10 (100) 3 (100) u noo) 33 (100) 11 (100) 7(100) 13(100)
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in whom multiple HPV types were detected,
not all the types were found in each
specimen.
HPV in pairs ofpartners
Parmer pairs F1-M3, F2-M8 and F3-M2
had HPV types in common. Parmer pair
F7-M9 did not (tables 3-5).
Discussion
The PCR allows the detection of very small
quantities of DNA,7 so that strenuous efforts
must be taken to avoid contamination of
specimens. The combination of strict clinical
and laboratory protocols, repeated use of
positive and negative controls throughout
the experiments, together with the use of
Southern blotting and hybridisanon to confirm
results give us confidence in their validity.
HPVs have been detected in biopsy speci¬
mens from genital warts," acetowhite areas"
and normal genital skin." They have also
been found m cervical scrapes from women
with warts,18 urethral samples,"20 vaginai
samples,2122 rectal swabs,23 buccal scrapes24
and serum samples.25 All these specimens, as
well as SG samples, were included in our
study in order to invesngate the multifocal
nature of anogenital KPV infecnons. The SG
technique has been used to assess changes in
the stratum corneum.2' In our study, this
technique was chosen as it allowed the sam¬
pling of the skin surface with minimal
trauma. Not only is this process more accept¬
able to patients than formal biopsy, but it also
allows the monitoring of HPV-induced
changes without inducing the marked inflam¬
matory response associated with biopsy. Such
a response may alter the natural history of
HPV infection27 and thus assessment of the
natural history should involve a sampling
process which minimises this mduced
response. Although the number of cells har¬
vested by the SG technique is small, the use
of the PCR for the detection of the human /?-
globin gene allowed us to confirm that
human cells were present and thus observe as
closely as possible the natural history of HPV
infection.
The detection of HPV DNA in 11 (65%)
of 17 biopsies with histological evidence of
HPV infection is consistent with the findings
of some," although the proportion is smaller
than that found by others.17 Infection with
HPV types other than those sought by us is a
possible explanation for this small proportion
and is supported by the large numbers of
specimens noted to contain untyped HPVs.
The detection of HPV DNA in 12-36% of
non-biopsy specimens suggests that they are
valuable to obtain. Cervical scrapes have been
investigated frequently for the presence of
HPV DNA but, until recently, few other
specimen types had been assessed. In fact,
our data suggest that other non-biopsv speci¬
men types are just as likelv to contain HPV
DNA as cervical scrapes.
The proportion of SG samples containing
the /i-globin gene was much larger in women
than in men. However, the proportion of /?-
globin-containing SG samples containing
HPV DNA did not differ between men and
women. It is possible that this observation
may be related to the fact that the skin of the
male external genitalia is more comified than
the female counterpart. The surface layers of
comified skin predominantly contain anucle-
ate squames which do not contain the fi-glo-
bin gene. The ability to harvest infected cells
by the SG method was confirmed by the
observation that the majority of SG samples
taken from areas with clinically apparent
warts contained HPV DNA.
The presence of HPV DNA in /J-globm
containing SG samples from areas which did
not develop acetowhite staining is consistent
with the finding of HPV DNA in histologi¬
cally normal skin.'7 Furthermore, it suggests
that staining with acetic acid may have lim¬
ited value in evaluating the extent of infection
with HPV and in assessmg response to treat¬
ment. It is possible that areas without ace¬
towhite changes but with detectable HPV
DNA may represent passive contamination of
the skin with HPV from another site of the
patient, or from a sexual partner; or they may
represent infection of the epithelium with
HPV which has not produced sufficient cellu¬
lar changes to generate visible changes follow¬
ing the application of acetic acid. The failure
to detect HPV DNA in four biopsies and in
three of nine SG samples from acetowhite
areas is consistent with the knowledge25 that
not all acetowhite areas develop as a result of
infection with HPV. Furthermore, the finding
of HPV DNA in only four of six /i-globm-
containing SG samples from men with ace¬
towhite areas of the glans is in agreement
with the suggestion2' that acetowhite changes
of the glans may develop as a result of sub¬
clinical balanitis not related to infection with
HPV.
The frequent occurrence of multiple HPV
infecnons has been disputed,50 but our data
concerning the co-existence of multiple HPV
types are consistent with those of others.51
For a given patient, specific HPV types were
frequently found in common in biopsy, non-
biopsy and SG specimens, as were multiple
HPV types. The failure to show cross-
hybridisation during the repeated experi¬
ments in which there were positive and
negative controls indicates that the observa¬
tions regarding multiple HPV types are not
spurious.
The persistence of HPV at various sample
sites after treatment supports the findings of
others32 that treatment of clinical and histo¬
logical abnormalities may not necessarily
eradicate infection. It is likely that persistent
infection explains, at least in part, the high
recurrence rate of warts regardless of the
method of treatment.33 However, the occur¬
rence of common HPV types in sexual part¬
ners noted in the current study and
previously," suggests that there may be an
opportunity for reinfection also to play a role
in the persistence of disease.
Multifocal infection of the anogenital area
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is recognised to occur in infection with
Neisseria gonorrhoeae, Chlamydia trachomatisM
and, most recently, human papillomavirus."
Furthermore, neoplasia of the female anogen-
itai tract, a condition thought to be related to
HPV infection,7 is frequently multifocal."
Our data suggest that, if a sample had been
taken from only one site, and at only one
time, the occurrence of HPV infection,
including infection with multiple HPV types,
would have been underestimated. To deter¬
mine the true extent of anogemtai HPV infec¬
tion, multiple samples need to be taken,
possibly over several months. Studies in
which single sites are sampled may lead to a
serious underestimate of the rate of infection
with HPV.
Samples from clinically uninfected areas
contained a larger proportion of the "high
risk" HPV types, namely types 16 and 18,
than the "low risk" HPV types, 6 and 11,
found predominandy in warts. This differ¬
ence was pardculariy marked in the samples
obtained by the SG technique. The prepon¬
derance of "high risk" HPV types in speci¬
mens other than those taken from clinically
apparent warts has been noted previously, for
example in specimens obtained from ace-
towhite areas,16 cervical scrapes'8 and urethral
swab specimens."" Our understanding of the
epidemiology of anogemtai HPV infecnon, in
pamcular the development of neoplasia, must
take into account the detecnon of HPV in
specimens from areas without clinically
apparent disease. The problem has arisen
because of the use of the highly sensitive PCR
which is capable of detecting a few virus par¬
ades. Other factors, including quannry of
virus present and host immunity," may be at
least as important as the mere presence of a
few viral parades in the development of any
clinical abnormaiines. However, only by
obtaining a dear understanding of the epi¬
demiology of anogemtai HPV infections will
it be possible to develop rational approaches
to their management.
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ASYMPTOMATIC URETHRAL CARRIAGE OF HPV DMA IN MEN WITH ANO-
GENITAL WARTS
Hillman RJ. *Hanna N, Botcherby, M, Ryait BK, *Harris JRW,
Taylor-Robinson D. From the Division of Sexually Transmitted
Diseases, MRC Clinical Research Centre, Watford Road, Har¬
row, England and the Department of Genitourinary Medicine,
St Mary's Hospital, London, England.
One hundred patients attending a Genitourinary clinic for
ablative therapy for persistent anogenital warts provided a
urethral specimen taken to 4cm with a cotton wool swab. At
the same time, biopsy specimens were taken from the clini¬
cally apparent warts.
All samples were tested for HPV types 6,11,16 and 13 by
Southern blotting, and for types 6,11,16,18, 31 and 33 by
the PCR. PCR results were confirmed and the types assessed
by DNA hybridisation.
Of 64 patients so far analysed on the basis of Southern
blotting, 3 (5%) had HPV DNA in their urethral swabs, and
52 (82.5%) had HPV DNA in their wart biopsy specimens. Of
the specimens from 90 patients analysed by the PCR, 37 (41%)
urethral swabs and 87 (97%) biopsies contained HPV DNA.
The higher rate of detection of HPV DNA by the PCR is
consistent with the greater sensitivity of this method
compared to Southern blotting. Our results confirm the
suggestion that HPV is carried asymptomatica1ly in the
urethras of men with anogenital warts. This may have impli¬
cations for the infectivity of warts, and recurrence follow¬
ing apparently full ablative treatment.
Abstract Spring Nfeeting of the l%3ical Society far the Study of Venereal Diseases,
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Multifocal anogenital HPV infection in patients with and
without anogenital warts
RJ Hillman. BK Ryait, M Botcherby, D Taylor-Robinson
MRC Clinical Research Centre, Harrow, Middlesex
Objectives - To investigate the relationship between clini¬
cal findings and the detection of Human Papilloma Virus
(HPV) DNA in a range of anatomical sites in 9 women and 9
men with and without anogenital warts.
Methods - Following examination of the anogenital areas,
specimens were taken from a variety of anatomical sites.
Superficial skin sampling was performed by the application
of slides covered with "Superglue" (SG). The presence of
human cells in the SG samples was confirmed by detection of
the B-globin gene using the polymerase chain reaction (PCR).
HPV DNA was extracted from the specimens, amplified by using
consensus primers with the PCR and identified by Southern
blotting.followed by hybridisation.
Results - In women, HPV DNA was detected in 83% of wart
biopsies, 29% of cervical biopsies, 36% of cervical
scrapes, 25% of urethral loop specimens, 37% of vaginal
washes and 33% of rectal swab specimens. In men, HPV DNA was
detected in 67% of wart biopsies, 37% of urethral loop
specimens and 12% of rectal swab specimens. No HPV DNA was
detected in buccal scrapes and serum samples from women or
men. Of the SG samples containing the B-globin gene, 49%
from women and 50% from men contained HPV DNA. Of all speci¬
mens with detectable HPV DNA, there was evidence of a single
HPV type in 41%, multiple types in 48% and undetermined
types in 11%. Samples taken from different sites from one
patient tended to have HPV types in common.
Conclusions - HPV DNA was distributed widely in the anogeni¬
tal area, in warts, acetowhite areas and clinically normal
skin. The SG technigue was well tolerated by patients and
produced results consistent with other findings. Sampling
from a single site of the genitalia may significantly under¬
estimate the infection rate with HPV.
